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Thesis Abstract 
 
Public speaking anxiety (PSA) is a common problem, and in some cases 
can lead to significant social and occupational difficulties. While exposure 
therapy combined with cognitive restructuring is currently the most 
effective treatment available, approximately 25% of individuals fail to 
respond.  
Acceptance and Commitment Therapy (ACT), a third-wave behavioural 
approach predicated on supposed different mechanisms of change, may 
have additional benefits to more traditional interventions, and may be 
more acceptable to those individuals with PSA who find exposure based 
therapy too difficult.  
A multiple single-case design was used to examine the effects of a self-
help ACT intervention for PSA on self-reported, implicit, imaginal, and in-
vivo outcomes, across six replications.  
All participants reported a reduction in speech anxiety, with evidence of 
reliable change in three cases. The four participants who reported an 
increase in willingness to approach a feared public speaking scenario, also 
completed an in-vivo voluntary speech task. Triangulation of quantitative 
(daily and weekly measures) and qualitative data (change-interview) 
indicate that mindfulness (self-as-context and present-moment 
awareness) may be a key mechanism of change in ACT for individuals 
with PSA.  
The findings offer support for ACT delivered in a self-help format to treat 
speech anxiety, however, further research is needed to generalise these 
findings and examine the long term effects. 
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Public speaking anxiety is a common problem. A review 
in 1989 suggested that treatment consisting of 
exposure, cognitive restructuring and skills training was 
effective. A systematic review was conducted to 
investigate the efficacy of treatments currently available 
in light of developments in psychological therapies and 
their delivery since the last review. Embase, Medline, 
PsycINFO, and Web of Science databases were searched. 
Reliable evidence suggests that exposure-based 
treatments are most effective in reducing speech 
anxiety. Technological advancements allow this form of 
therapy to be delivered using a virtual audience that can 
be accessed in the client’s home or by using head-
mounted equipment with therapist support. Other 
developing therapies show promise, however more 
rigorous research is required to determine their effects 
reliably. The implications of these findings and directions 
for future research are discussed.   
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1.  Introduction 
1.1 Public Speaking Anxiety: Impact and Theory 
Fear of public speaking, often referred to as public speaking anxiety 
(PSA), is the anxiety experienced when talking or preparing to talk in 
front of others. PSA is the most common form of social phobia1, with 
prevalence rates thought to be as high as 85% in the general population.2 
In some cases, the level of anxiety associated with speaking in public can 
result in a reduced chance of continued education, work-related distress 
or unemployment.3 Unfortunately, many of those who experience PSA do 
not seek treatment,4 possibly due to feelings of shame or embarrassment, 
or simply because of the nature of the disorder. If left untreated, social 
phobias such as PSA generally become chronic.5 
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The Diagnostic and Statistical Manual of Mental Disorders IV6 allows 
clinicians to separate clinical presentations of social anxiety disorder 
(SAD) into generalised or non-generalised type; PSA is classed as a non-
generalised SAD when restricted to the single domain of public speaking, 
or generalised SAD if it is part of a wider phobia related to social 
situations.  
There are a number of common theories for the occurrence of PSA. These 
theories have influenced the development of treatments for those willing 
to access them. 
 The cognitive perspective links the fear caused by public speaking 
to the thoughts the individual has about his or her inability to 
perform, an attentional bias towards somatic responses and the 
likelihood of receiving negative evaluation from others.7,8 Treatment 
grounded in this perspective therefore seeks to modify the thoughts 
associated with public speaking to alleviate the distress.    
 
 Behavioural understanding, grounded in learning theory, suggests 
that an individual develops a phobia related to speaking in public 
because they associate the context with aversive consequences.9 
Treatment involves learning that public speaking is not aversive by 
remaining in the feared situation until anxiety reduces 
(exposure/habituation).  
 
 Another perspective suggests an individual experiences 
apprehension when delivering a speech because he or she does not 
possess the requisite skills.10 Treatment from this perspective 
focuses on developing these skills.  
 
1.2 Effective Treatments 
In a meta-analysis of the effectiveness of treatments to reduce PSA, Allen 
et al.11 suggested that PSA interventions could be categorised as either 
cognitive modification, exposure, or skills training (reflecting the three 
theoretical models outlined above). These authors concluded that all 
treatments resulted in a reduction in PSA, but that the most efficacious 
form of treatment included all three elements.   
Although the conclusions could be used to inform clinician treatments for 
PSA, this meta-analysis did not provide definitive support for one 
treatment rather than another. The authors suggested that their 
conclusions reflected the use of outcome measures that lacked the 
specificity to accurately measure the construct of PSA and advised that 
more refined scales should be used in the future. This review was also 
limited to interpreting self-reported outcome data, precluding analysis of 
behavioural measurements and clinician ratings, which may prove useful 
in understanding how treatments affect an individual’s ability to deliver a 
speech. The effects of demand characteristics (e.g. responding to 
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therapist expectations) mean that self-reported data alone can be 
unreliable,12 and may not provide a good indication of the success of an 
intervention. The authors of this review did not comment on the 
methodological rigour of the studies included, other than to say that the 
typical sample size was small; it is therefore difficult to gauge how much 
confidence one should have in the reliability of their conclusions.   
Although subsequent evidence suggested that exposure treatment 
combined with cognitive restructuring could be effective in treating social 
anxiety disorders such as PSA13, this form of therapy is not effective for 
around a quarter of those who receive treatment.14 This could be due to 
the distress elicited during exposure therapy, and the resulting inability of 
some patients to remain in the aversive situation for long enough for 
habituation to take place, with the consequence that their negative 
associations involving public speaking are not reduced. 
Since the previous review of treatments for PSA,11 a number of more 
accurate measures of PSA (e.g. the Self-Statements during Public 
Speaking-SSPS15) and new therapies have been developed (e.g. 
Acceptance and Commitment Therapy16). Technological advancements 
have also changed the way in which therapy is delivered (e.g. Virtual 
Reality Exposure17).  
1.3 Rationale and Aims 
It is 25 years since a systematic review of the effectiveness of 
psychological treatments for PSA was conducted. Forms of therapy, 
outcome measures, and the methods by which therapy is delivered have 
altered, so an update review of the evidence to determine whether Allen 
and colleagues11 recommendations are still valid or whether there are 
now other, better treatment options for those seeking support for PSA 
seemed timely. Although new treatments may well be categorised 
according to Allen et al.’s11 broad treatment types, there may also have 
been innovations in technology and delivery which may improve access to 
such therapies. This review seeks to provide a comprehensive synthesis of 
knowledge about the most effective treatments for PSA, and is based on 
the research conducted since the previous review. Reviews of this type 
are an important means of informing clinicians treating PSA about the 
most effective therapies available. A greater understanding of effective 
treatment options may improve treatment of patients who find traditional 
methods of exposure-based therapy ineffective. 
The aims of this systematic review were: 
 To synthesise the findings from research on psychological 
treatments for PSA conducted since the previous review.11 
 
 To determine the most effective psychological treatments for PSA 
and the most effective methods of delivering these treatments.    
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 To assess the quality of studies to determine how much confidence 
can be placed in their findings. 
 
A secondary aim was: 
 To examine whether self-report and observational measures of PSA 
are concordant in their responsiveness to treatment.    
 
2. Method 
2.1 Search and Screening Procedures 
Evidence for the effectiveness of psychological treatments for PSA was 
assessed by conducting a systematic review of the research evidence. The 
Embase, Medline, PsycINFO, and Web of Science databases were 
searched electronically for literature published between January 1987 and 
June 2014. The start date was chosen so that relevant research was 
captured that might not have been published when the previous review 
was produced.11 A list of keywords was created to retrieve relevant 
articles from these databases. Keywords covered the concepts of anxiety, 
public speaking, psychological intervention and outcome measurement.  
The databases were searched with the following terms on the 14th June 
2014: 
1.anxiety; 2.anxious; 3.fear; 4.phobia; 5.fright; 6.speech; 7.speak; 
8.speaking; 9.talk; 10.public; 11.therap*; 12.intervention* 
13.training; 14.psycho*; 15.treatment; 16.outcome; 17.measure; 
18.report.  
 
Terms not relevant to the review were removed from the search 
using the Boolean operator NOT. These were; 1.Mute; 2.stut*; 
3.children; 4.depress*.  
 
The titles and abstracts retrieved in this initial search were assessed by 
the research team using the inclusion and exclusion criteria below. The 
full texts of potentially eligible studies were retrieved. Full text articles 
were again reviewed against the inclusion and exclusion criteria and a 
final set of articles was chosen for inclusion in the review. Hand searching 
revealed additional relevant articles which were then included in the 
review. 
2.2 Inclusion Criteria 
1.) Articles that had been peer reviewed. 
2.) Studies that used an adult sample (18 years or above). 
3.) Studies that compared at least one psychological treatment of 
PSA to a passive control (e.g. no treatment, waiting list). 
4.) Studies using at least one outcome measure designed to identify 
reduction of PSA.  
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5.) Studies including participants who were screened to confirm they 
had PSA. 
6.) Articles in English.  
 
Only peer reviewed journal articles were included to ensure minimum 
levels of quality and credibility in the articles reviewed. The review was 
limited to the treatment of adults with PSA and therefore excluded studies 
with a sample including children or adolescents; factors such as 
developmental stage and the impact of education may be relevant to 
treatment of this population and the subject therefore deserves an 
exclusive investigation. 
The criteria also stipulated research comparing at least one form of 
psychological therapy with a passive control group (a group receiving no 
treatment). Use of a control group enables the effect of an intervention to 
be calculated in comparison to the effects of receiving no treatment at all 
and allows more robust conclusions about treatment effectiveness to be 
drawn. Use of control groups is one method of assessing possible threats 
to internal validity (such as the effects of history and/or maturation), for 
example, if a reduction in PSA is found in a waiting list control group at 
the post-intervention assessment, then one must assume that changes in 
the other groups may have been due to factors other than the 
psychological treatment.  
Mohr18 suggested that new treatments should first be compared to ‘doing 
nothing at all’ (no-treatment or waiting list); only if they pass this 
preliminary test of efficacy is it worth comparing them to ‘treatment as 
usual’ or alternative treatment groups. As this review seeks to investigate 
the effects of new treatments and methods of treatment delivery, it is 
important to establish their effectiveness relative to a passive control 
group as a first step. 
The American Psychological Association’s definition of a ‘psychological 
therapy’19 was used to decide whether an intervention was eligible for 
inclusion. This criterion ensured that only studies measuring PSA were 
included. The criteria also required that participants should have a 
minimum level of PSA, determined by a structured interview and/or a 
relevant measure. This ensured that samples in reviewed studies were 
representative of the population of adults with PSA, and enabled the aims 
of the current review to be addressed. 
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2.3 Exclusion Criteria 
 Studies using participants engaged in public 
speaking/communication classes. 
 
This exclusion criterion was applied because (a) such a sample is unlikely 
to be representative of the broader PSA population and (b) it is difficult to 
separate the effects of an experimental intervention from the confounding 
variables present in the context of a class designed to reduce PSA. 
2.4 Eligible Studies 
Electronic searches identified 1,569 citations once duplicate records were 
removed. The titles and abstracts were assessed for their relevance to the 
review (stage 1 screening), resulting in a set of 33 potentially eligible 
publications. Three additional papers were identified through hand 
searches. Full texts of all these publications were obtained. Inclusion and 
exclusion criteria were applied to the full texts of these 36 publications 
(stage 2 screening), resulting in the exclusion of 26 papers. A set of 10 
publications were included in the systematic review (Figure 1). 
 
Figure 1. QUORUM Diagram Outlining the Search and Screening Process 
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2.5 Data Extraction, Quality Rating, and Synthesis 
A data extraction sheet was created to record the author(s), publication 
date, characteristics of the sample, country of origin, design, type of 
control, group allocation procedure, treatment(s) investigated and the 
duration of treatment for all included studies. 
The outcomes of interest extracted were: 
 Change in self-report measures of PSA. 
 Change in clinician rating/behavioural measures of PSA.  
 Whether the effects of treatment remained at follow-up. 
 Whether the experimental treatment group improved relative to the 
control group. 
 Whether the experimental treatment group improved relative to 
alternative treatment groups. 
 
Effect sizes (ESs) were calculated as Cohen’s d20 and recorded for each 
condition in the reviewed studies. The ES provides a measure of the 
magnitude of difference between groups, and demonstrates the difference 
in outcomes between groups, in this case experimental treatment groups, 
no-treatment control group and sometimes alternative treatment groups. 
As a general rule of thumb Cohen20 suggested: 
 0.2 represents a small effect  
 0.5 a moderate effect 
 0.8 or above, a large effect 
 
As not all the studies reviewed reported sufficient data to enable ESs to 
be calculated, a narrative synthesis approach was adopted. 
The psychotherapy outcome study methodology rating form (POMRF21) 
was used to assess the quality of the reviewed studies. This 22-item scale 
assesses methodological elements such as whether therapists were 
adequately trained and whether power analysis was conducted. As this 
review included studies with a passive control group, question 22, 
‘Equality of therapy hours - for non-waitlist control designs only’ was 
omitted. The maximum score on this adapted scale was 42. A high score 
indicates rigorous methodology. The POMRF was chosen to assess the 
quality of the research as it possess good psychometric properties, 
including good internal consistency and good inter-rater reliability (.86 
and .75 respectively21). 
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3.  Results 
3.1 Overview  
Ten studies were included in the review (Table 1). The most common 
form of treatment examined was Virtual Reality Exposure therapy (VRE; 
n=4), followed by Internet-delivered Cognitive Behavioural Therapy 
(ICBT; n=2). Other forms of treatment investigated were Acceptance and 
Commitment Therapy (ACT; n=1), Communication-Orientation Motivation 
therapy (COM; n=1), Eye Movement Desensitisation and Reprocessing 
(EMDR; n=1), and enhancement of Cognitive Behavioural Therapy (CBT) 
with hypnosis (CBT-H; n=1). 
3.2 Sample  
Sample sizes ranged from 1122 to 13623, with an average sample size of 
68.3. The mean age of participant ranged from 19.4 to 40.31. A high 
proportion of the studies recruited university students (70%). On average 
samples were 70.8% female, indicating a gender bias. The majority of the 
studies took place in the United States of America (70%).     
3.3 Study Design 
Waiting list groups were the most common form of control (n=9), with 
one study using a no-treatment control group. CBT was the most 
commonly used alternative active treatment (n=4). Seven studies 
employed a randomised controlled trial (RCT) design; the rest used 
another between-groups design. The average treatment period was just 
under six weeks (5.8 weeks). 
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Table 1 
 Reviewed Studies by Intervention Type 
Study N Age M age % 
female 
Population Country Design Ctrl Ran/al Intervention Length 
ACT            
Block et al. 22  11 - - 63.6 U USA BG WLC N ACT vs. CBT 4 wks 
 
COM            
Ayres et al. 23 136 18-52 19.4 - U USA RCT WLC Y COM vs. SD 1 wk 
 
EMDR            
Foley et al. 24 40 - - 77.5 U USA RCT NTC Y EMDR 2 sessions 
 
ICBT            
Gallego et al. 25 41 19-57 39.29 68.3 C Holland RCT WLC Y ICBT 6 wks 
Botella et al. 26 127 18-84 24.4 79.2 U/C Spain RCT WLC Y ICBT vs. CBT 8 wks 
 
CBT-H            
Shoenberger et al 27 62 18-56 - 67.7 U/CT USA RCT WLC Y CBT-H vs. CBT 5 wks 
 
VRE            
Harris et al. 28 14 - - - U USA BG WLC N VRE 4 wks 
Wallach et al. 29 88 - 27 79 U Israel BG WLC N VRE vs. CBT 12 wks 
Anderson et al. 30 97 19-69 39.03 62 C USA RCT WLC Y VRE vs. EGT 8 wks 
Price et al. 31 67 - 40.31 69 C USA RCT WLC Y VRE vs. EGT 8 wks 
 
Notes. Number of participants: N; Mean age: M age; Percentage female: % female; Clinical: C; University: U; Community: CT; Randomised controlled trial: RCT; Other 
between-groups: BG; Control type: Ctrl; Waiting list control: WLC; No treatment control: NTC; Random allocation: Ran/al; Acceptance and commitment therapy: ACT; 
Exposure group therapy: EGT; Cognitive behavioural therapy with hypnosis: CBT-H; Communication-Orientation motivation therapy: COM; Eye movement desensitisation 
and reprocessing: EMDR; Internet-delivered cognitive behavioural therapy: ICBT; Virtual reality exposure therapy: VRE. 
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3.4   Outcome Measures and Assessment Tools  
All studies used self-report measures to assess change in PSA over time 
(Figure 2).  
 
Figure 2. Frequency of measures used in the reviewed studies 
Within the reviewed studies the self-report measures demonstrated good 
internal consistency (.69-.94) and test-retest reliability (.78-.94) 
suggesting that scales used were sufficiently reliable to capture reductions 
in self-reported PSA. Clinician ratings and behavioural measures were less 
commonly used (n=4).24–26,30 
3.5 Assessment of Quality 
The POMRF was used to assess the methodological rigour of the studies 
(Table 2). The maximum score that could be obtained on this adapted 
scale was 42, indicating the highest possible methodological quality. The 
lowest score possible was 0, indicating the lowest possible methodological 
quality. Table 2 displays the quality scores achieved by the studies. The 
range of POMRF scores was large, from 5 to 29, with a mean score of 
15.20 across the 10 studies. Following Swain et al.32 the standard 
deviation (7.77) was used to calculate thresholds for categorising the 
studies according to methodological quality. Studies that scored one SD 
(rounded to the nearest whole number) below the mean were rated as 
‘well below average’ (0-7), within one SD of the mean rated as ‘below 
average’ (8-15), then ‘above average’ (16-24) and ‘well above average’ 
(25 – 42).  
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Two studies were classed as ‘well below average’ and three studies as 
‘below average’. Only one study was rated ‘well above average’, with the 
remaining four rated ‘above average’. A recent meta-analysis 
investigating CBT treatment for anxiety disorders reported an average 
POMRF score of 27.8,21 which suggests the quality of the studies in the 
current review was low in comparison to research into anxiety disorders 
more generally.  
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Notes: Psychotherapy outcome methodology rating form: POMRF; Outcome – Acceptance and commitment therapy: ACT; Anxiety disorders interview schedule 4: ADIS-IV; Clinician Rated: CR; 
Behavioural assessment of speech anxiety: BASA; Cognitive behavioural therapy: CBT; Cognitive behavioural hypnotic therapy: CBT-H; Communication orientation motivation therapy: COM; Effect 
size: ES; Eye movement desensitisation & reprocessing: EMDR; Excluding: exc.; Exposure group therapy: EGT; Fear of negative evaluation: FNE; Follow-up: FU; Heart rate: HR; Internet CBT: 
ICBT; Moving sound: MS; Not significant: ns.; No treatment control: NTC; Personal report of communication apprehension: PRCA; Personal report of confidence as a speaker: PRCS; Resting eyes: 
RE; Self-report: SR; Self-statements during public speaking: SSPS; Structured clinical interview for the DSM-IV: SCID; Subjective units of distress: SUDS; Systematic desensitisation: SD; Validity 
of cognition: VOC; Virtual reality exposure: VRE; Wait list control: WLC; Willingness to communicate scale: WTC. 
a Authors did not report descriptive statistics or conduct statistical analysis. ES could not be obtained.                                                                                                     b ESs were not 
calculable from the data provided.                                                                                                                                                                                   c Authors did not provide information 
on the control group’s post intervention scores, so not ES comparison between VRE and the control group could be calculated.  
Table 2 
POMRF Score and Outcome of Reviewed Studies by Intervention Type 
Study N POMRF 
score 
POMRF  
rating 
Outcome ES vs. 
control 
(SR) 
ES vs. alt 
treat 
(SR) 
ES vs. 
control 
(CR) 
ES vs. alt 
treat 
(CR) 
ACT         
Block et al.22 11 8 Below average ↓ SR, ACT = CBT > WLC. 
a
 
- - - - 
 
COM         
Ayres et al.23 136 7 Well below average ↓ SR, COM = SD > WLC & placebo (exc. WTC) COM>WLC 
0.52 
COM>SD  
0.28 
- - 
EMDR         
Foley et al.24 40 11 Below average ↓ SR, EMDR = MS/RE >NTC (exc. SUDS & VOC), 
EMDR/MS/RE = NTC on BASA & HR - ns. 
b
 
- - - - 
ICBT         
Gallego et al.25 41 16 Above average ↓SR, ICBT>WLC, at post 30.8% ≠ diagnosis on 
ADIS-IV. 
ICBT>WLC 
0.86 
 
- ICBT>WLC 
0.58 
- 
Botella et al.26 127 22 Above average ↓SR ↓ CR, ICBT=CBT >WLC, at post-60%/FU-55% 
≠ diagnosis on ADIS-IV. 
ICBT>WLC 
0.35-1.17 
CBT>ICBT 
0.03-0.33 
ICBT>WLC 
1.39 
 
CBT>ICBT 
0.26 
CBT-H         
Schoenberger et al.27 62 13 Below average ↓ SR, ↓ CR, CBT-H = CBT > WLC. 
 
CBT-H>WLC 
1.64 
CBT-H>CBT 
0.51 
CBT-H>WLC 
1.17 
CBT-H>CBT 
0.70 
VRE         
Harris et al.28 14 5 Well below average ↓SR, VRE >WLC on PRCS. All other outcomes ns. VRE>WLC 
1.79 
- - - 
Wallach et al.29 88 22 Above average ↓ SR, VRE = CBT > WLC (exc. FNE). 
CR = VRE & CBT=WLC ns. 
VRE>WLC 
0.70 
CBT>VRE 
0.18 
VRE>WLC 
0.1 
CBT>VRE 
0.06 
Anderson et al.30 97 29 Well above average ↓ SR at post and FU (exc - FNE), VRE = EGT >WLC, 
FU = 25% ≠ diagnosis on SCID. 
VRE>WLC 
1.44 
EGT>VRE 
0.70 
VRE>WLC 
0.85 
EGT>VRE 
0.18 
Price et al.31 67 19 Above average ↓SR, VRE = EGT (SSPS & PRCA). 
c
 
- VRE>EGT 
0.24-0.63 
- - 
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The methodological quality of the studies was varied. Only two studies 
blinded the therapist to the treatment condition.27,30 Therapist allegiance 
to the treatment under investigation may have biased the results 
reviewed here in favour of the experimental treatments. Checks for 
therapist competence and adherence to treatment protocols were 
completed in only two studies.30,31 This is not necessarily a reflection of 
poor methodology; because many of the treatments investigated were 
in their infancy there may have been no standard treatment protocol in 
many cases. 
Reflecting the inclusion criteria, the studies used good outcome 
measurement methods and recruited representative samples (n=10). 
Eight studies also used an alternative treatment group. 
3.6 Outcomes 
Table 2 displays the outcome of each study grouped by type of 
treatment. All treatments produced a reduction in PSA, so it was 
important to synthesise these findings in order draw conclusions about 
their relative effectiveness on the basis of factors such as ES and the 
methodological quality of the studies of the treatment. 
3.7 Virtual Reality Exposure (VRE) 
The most common form of treatment investigated was VRE (n=4). VRE 
involves the client wearing head-mounted equipment to immerse him or 
herself in a virtual public speaking environment. The therapist can then 
manipulate the audience in a controlled manner to provide different 
exposure environments (e.g. an angry audience).  
All studies investigating VRE reported a large reduction in self-reported 
PSA compared to control conditions (d=0.70-1.79). In a study with 
significant methodological weaknesses, Harris et al.28 assigned a small 
group of university students to a VRE group (n=8) or a waiting list 
control (WLC) group (n=6). Participants in the VRE group showed a 
significant improvement on a self-reported measure of PSA compared to 
the control group after four weeks of treatment (d=1.79). All other self-
reported and physiological measures (e.g. heart rate) were similar in the 
two groups after the intervention. The low POMRF score (5) for this 
study reflects the small sample size, failure to allocate participants 
randomly, and use of a control group containing participants who were 
exposed to public speaking situations during the study and thus received 
informal exposure treatment which affected their ‘control’ status. 
Although the findings from this study should be treated with caution, 
more rigorous research has shown VRE to be an effective treatment for 
Page 31 of 259 
 
PSA. In three studies comparing VRE with existing evidence-based 
treatments in the form of CBT29 or exposure group therapy (EGT),30,31 
VRE was shown to be efficacious in reducing self-rated PSA (d=0.70–
1.44). In a study comparing VRE with CBT, Wallach et al.29 found both 
treatments were effective in reducing self-reported PSA in comparison 
with a control condition. Although the CBT group showed a slightly 
greater reduction in PSA than the VRE group (d=0.18), this difference 
was trivial showing support for VRE as a treatment option for those with 
PSA. Although this study was of ‘above average’ methodological quality, 
nearly 80% of the sample were female university students, and the 
average age of participants was 27 years old, so the generalisability of 
the findings may be limited. Although classed as a RCT, due to early 
drop-out rates, participants were weighted to the CBT condition, 
suggesting participants were not truly randomised. Checks for 
adherence to treatment fidelity were abandoned due to technical 
failures, suggesting therapists may not have stayed true to their 
respective treatments. Interestingly, there was no significant difference 
between the VRE group and the WLC group on the measure of ‘fear of 
negative evaluation’. This finding was replicated in another study of VRE 
for PSA.30 This indicates that although VRE may be effective in reducing 
avoidance of public speaking, it may not reduce the fear of negative 
appraisals. 
A further two RCT studies30,31 compared the effects of VRE and EGT in 
treatment of PSA. Both studies reported that VRE produced a significant 
reduction in PSA; however only Anderson et al.30 reported data that 
allowed the effect of treatment to be compared to a WLC group 
(d=1.44). Price et al.31 found no significant difference between VRE and 
EGT in terms of self-reported reduction in PSA, but in this case, the VRE 
group was slightly more effective (d=0.24-0.63). Price et al.’s study had 
some important flaws. Although the treatment arms were evenly split, 
those in the VRE group received individual therapy whereas those in the 
EGT group received treatment as a group. The findings from this study 
may reflect the different effectiveness of individual and group therapy 
for PSA, rather than the difference between two treatment types.  
In an attempt to improve the methodological rigour of research in this 
area, Anderson et al.30 measured the initial and long-term effects of VRE 
on PSA. The results were promising and post-intervention data on 
behavioural measures (d=0.18) and self-reported measures of speech 
anxiety (d=0.70) suggested that VRE was a more effective treatment for 
PSA than EGT. Although there was no significant group difference in 
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speech performance, those in the VRE group spoke longer and reported 
less anxiety than the WLC group. Treatment gains remained at follow-up 
for both VRE and EGT groups. Again, however, those in the VRE group 
received individual therapy, and may therefore have received a ‘higher 
dose’ intervention which may have biased the results in favour of VRE.  
3.8 Internet-delivered CBT (ICBT) 
ICBT was the second most commonly studied treatment for PSA in this 
review. Two studies investigated a novel ICBT intervention entitled ‘talk 
to me’. This self-help internet-based programme uses education, 
exposure and cognitive re-structuring and is self-administered. Like 
VRE, the ’talk to me’ intervention consists mainly of an exposure 
element. The patient is required to deliver speeches to an increasingly 
intimidating audience, until their reported anxiety reduces. In the first 
RCT to investigate the efficacy of this programme, Botella et al.26 
compared ICBT with therapist-delivered CBT for PSA. Both treatment 
groups showed a significant reduction in PSA, with the ICBT group 
improving significantly on self-rated (d=0.35-1.17) and clinician-rated 
(d=1.39) measures compared with the WLC group. No significant 
difference was found between the treatment groups, with the effects of 
treatment slightly favouring therapist delivered CBT (d=0.33). After the 
intervention, there was no significant difference between the ICBT group 
and the WLC group on self-rated performance during a speech task. 
Treatment gains were evident in both treatment groups 12 months after 
therapy. Similar results were found in a test comparing the same ICBT 
programme with a WLC group in a study using Dutch participants.25 In 
this study self-report measures showed a reduction in PSA in the ICBT 
group relative to the WLC group (d=0.86) but post-intervention, there 
was no significant difference in clinician assessments of speech 
performance. Although these results are promising, the attrition rates in 
the ICBT conditions were extremely high in both studies (45.8% and 
51.6%) suggesting that around half of the samples did not engage in 
the treatment, or simply did not find it effective. Although both studies 
received an ‘above average’ POMRF rating, there seem to be a number 
of methodological problems which are common in this area of research. 
Both samples consisted predominantly of well-educated women (68.3% 
and 79.2%) and there was inconsistent recording of measures in control 
groups in both these studies. Trials have only been conducted using 
Spanish and Dutch samples to date. 
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3.9 Individual Treatment Trials 
The current review also encompassed a further four studies 
investigating other treatments for PSA, namely ACT, COM, EMDR and 
CBT-H. Table 3 provides a description of these therapies.  
Table 3: 
Description of Additional Treatments Included in the Current Review 
Treatment  Key components  
Acceptance and Commitment 
Therapy (ACT) 
ACT encourages acceptance, value 
driven behaviour and mindfulness 
strategies to reduce the distress 
associated with public speaking.  
 
Communication-Orientation 
Motivation (COM) 
COM uses cognitive restructuring 
methods to shift the clients focus 
from a performance orientation to a 
communication/information giving 
orientation to reduce their anxiety 
related to public speaking.   
 
Eye Movement Desensitisation and 
Reprocessing (EMDR) 
EMDR assumes that a person’s PSA 
developed because of an aversive 
public speaking experience. EMDR 
encourages the client to recall this 
experience whilst engaging in side to 
side eye movements that allows this 
aversive memory to be processed, 
thus relieving the anxiety associated 
with public speaking.  
 
Hypnosis-enhanced CBT (CBT-H) Hypnotic enhancement in CBT 
involves the therapist labelling the 
relaxation component of therapy as 
‘hypnotic’ to enhance the effects of 
treatment by increasing the client’s 
outcome expectancy. 
 
All four of these studies received a POMRF rating of ‘below average’ or 
worse (7-13). Common methodological weaknesses were: 
 Over-representation of women in the sample (63.6%–77.5%) 
 Poorly trained or inexperienced therapists 
 Lack of control over concomitant treatments during the study. 
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The study with the lowest POMRF score (7) of these four, compared 
COM, systematic desensitisation, a placebo and a WLC group. Ayres et 
al.23 found that participants who read a self-help COM book rated their 
PSA as significantly less than the WLC group and the placebo group 
(who were instructed to read a book about ‘great speeches’) after the 
intervention (d=0.52). There was no significant difference between the 
COM group and the treatment comparison group, who watched a self-
help systematic desensitisation video (d=0.28).33 None of the groups 
showed improvement on the ‘willingness to communicate’ scale 
indicating that although systematic desensitisation and COM may alter 
perceived anxiety about public speaking, they may not improve 
willingness to undertake public speaking.  
One therapy thought to encourage willingness to experience anxiety,34 
and therefore willingness to undertake public speaking, is ACT. Only one 
study in this review investigated ACT as a treatment for PSA. In a study 
using a small sample of university students (n=11) Block et al.22 
compared ACT with cognitive behavioural group therapy (CBGT) and a 
WLC group. After four weeks of treatment, participants in the ACT and 
CBGT groups showed a reduction in anxiety and greater willingness to 
undertake public speaking relative to the WLC group. However, 
willingness was measured on an untested index created by the authors 
and scores may not have reflected the target construct accurately or 
reliably. No behavioural test was conducted to determine whether the 
participants would actually be willing to undertake a speech task. 
Participants in the ACT group were also encouraged to complete 
exposure exercises throughout the intervention, so exposure may have 
been an important factor in the changes reported. Owing to the many 
limitations of this study, only a tentative endorsement of the use of ACT 
to treat PSA can be given at this stage. 
Exposure to the feared stimulus, in this case public speaking, was a 
common feature of many successful treatment programmes. The 
importance of exposure was highlighted by a study of EMDR conducted 
by Foley et al.24 In this dismantling study, three treatment groups were 
compared with a no-treatment control group. The treatment groups 
followed a standard EMDR treatment protocol with eye movements, 
resting eyes instead of eye movements, or a moving sound stimulus 
instead of eye movements. The results suggested that all treatment 
groups displayed a significant reduction in self-rated PSA compared with 
the no-treatment control group. The relative effectiveness of the 
different treatments could not be calculated from the data provided but 
the authors concluded that the exposure element of EMDR was the 
‘active ingredient’. However, there was no significant difference between 
the treatment groups and the control group on performance during a 
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speech task, indicating that the effects of treatment did not lead to an 
observable change in public speaking behaviour. 
Schoenberger et al.27 demonstrated that CBT treatment for PSA could be 
enhanced simply by labelling relaxation elements of the treatment as 
‘hypnosis’. In this study, 62 participants were randomly allocated to a 
CBT treatment group, a CBT-H group or a WLC group. Following the five 
week intervention, participants in the CBT-H group showed a significant 
reduction in self-rated measures of PSA (d=1.64), and clinician ratings 
of performance on a speech task (d=1.17) compared with the WLC 
group. There was no significant difference between treatment groups on 
either measure; however the effects of the treatment favoured CBT-H 
compared to CBT (d=0.51/0.70). Many participants in the control group 
did not return for post-intervention assessment (52.4%), resulting in a 
large proportion of missing post-treatment data for the control group. 
This may have resulted in an exaggeration of the effects of CBT-H 
because of the uneven group sizes.  
 
4. Discussion 
This systematic review set out to determine which forms of 
psychological therapy were effective in treating PSA. The focus was on: 
(a) literature published in the last 25 years, in order to update findings 
from a 1989 review11 and investigate the evidence on recent innovations 
in therapy for PSA and (b) studies with no-treatment control conditions, 
in order to control for traditional threats to internal validity and 
investigate whether novel therapies were superior to no intervention (a 
minimum standard for evaluation of effectiveness, which is useful when 
reviewing recent innovations and inchoate evidence18). Applying this 
selection criterion enabled the calculation and comparison of ESs across 
the studies.  
All psychological treatments reviewed were effective in reducing PSA 
according to self-reports. All therapies except EMDR were found to be 
similar in effectiveness to treatments suggested to reduce PSA in the 
previous review.11 A comparison of ESs indicated that exposure-based 
treatments (VRE) were most effective in reducing self-reported PSA, 
followed by treatments combining exposure with cognitive restructuring 
(CBT-H; ICBT) and then treatments using cognitive restructuring only 
(COM). All treatments also included elements of psycho-education or 
skills training, suggesting this may be an important contributor to their 
effects. ESs for studies of ACT and EMDR could not be calculated from 
the data available in the publications; therefore, conclusions about these 
treatments are limited.   
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Like the earlier review by Allen et al,11 treatments for PSA fell into the 
broad treatment categories reflecting common psychological theories of 
PSA (behavioural exposure/habituation based accounts, cognitive 
appraisal-based accounts and skills deficit-based accounts). Moreover, 
the average effect of the treatments investigated in the current review 
(d=1.06) was similar to the average effects of treatments (using within 
group comparisons) investigated in the previous review (d=1.19). 
However, changes in how these treatments are delivered, utilising 
technological innovations or methods to encourage people to engage in 
exposure may benefit patients who are too anxious or embarrassed to 
seek face-to-face treatment,4 or find traditional in-vivo exposure too 
anxiety provoking, and therefore ineffective.14  
Although all treatments produced reductions in self-rated PSA, some 
produced no improvements relative to a no-treatment control group on 
measures of speech performance,24,25,29 or fear of negative 
evaluation.26,29,30 This indicates that although psychological treatments 
for PSA may increase ability to undertake public speaking, they may not 
improve speech performance or reduce fearful cognitions associated 
with being evaluated. These findings could, however, reflect the fact 
that the majority of the treatments reviewed were exposure-based and 
produced outcomes consistent with the theoretical foundation for 
exposure therapies, namely they reduced anxiety associated with the 
stimulus - in this case public speaking situations - but did not alter 
cognitions or necessarily improve performance.  
4.1 Limitations of the Included Studies 
Although the results reviewed here are encouraging and offer evidence 
for the effectiveness of a number of therapies in reducing PSA, the 
methodological quality of the studies was generally poor. All the studies 
used predominantly female samples. University students were also 
commonly used. Although every study ensured that participants had a 
minimum level of PSA prior to treatment, the average sample size in the 
reviewed studies was low. In view of these limitations the 
generalisability of the findings is limited. More rigorous research is 
needed before the majority of these treatments can be recommended 
with confidence.  Nevertheless, the quality of research in the areas of 
VRE and ICBT is encouraging, which gives confidence in the reliability of 
these findings, and therefore these therapies as suitable for treating 
PSA.  
Of the studies that conducted follow-up investigations, only one 
measured speech performance. Therefore, little is known about the long 
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term impact of psychological treatment on behavioural change, and 
whether speech performance improves over time.      
4.2 Evaluation of the Review 
The search strategy provided comprehensive coverage of the field and 
resulted in retrieval of a large number of potentially relevant studies. 
Inclusion and exclusion criteria were applied and this reduced the 
number of studies considered to 10. Only peer-reviewed publications 
reporting studies that used appropriate psychometric measures, passive 
control groups and participants with a confirmed minimum level of PSA 
were included. This produced a reasonably parallel set of studies for 
review, which allowed for descriptive comparisons of effect sizes; 
nonetheless, the heterogeneity of studies (e.g., variability in terms of 
intervention model, length of treatment, and allocation to groups) 
precluded meaningful use of formal meta-analysis. The methodological 
quality of the reviewed publications was assessed to inform the 
comparative analysis and estimate the reliability of the findings. 
The review was subject to a number of limitations which may have 
influenced the findings. The decision to include only peer-reviewed 
articles may have resulted in exclusion of relevant data from grey 
literature. The sample of studies selected for review may have been 
affected by publication bias, insofar as they may have been published 
because they reported positive findings. This might explain why all the 
therapies investigated produced a reduction in PSA. Inclusion of grey 
literature might have extended the evidence base and allowed more 
definite conclusions to be made about which forms of psychological 
treatment are most effective, rather than making the general assertion 
that there was some evidence to suggest that all the psychological 
treatments reviewed were effective in treating PSA.  
The POMRF was useful in determining the reliability of the reviewed 
studies. Although the average POMRF score for the sample indicated 
that the methodological quality of the studies was generally poor, these 
ratings may reflect failure to report that certain procedures were 
followed rather than failure to follow them. Adhering to journal word 
limits may make it difficult to provide a comprehensive report of 
methods used. The standard of research in this area may therefore be 
more rigorous than is indicated by the POMRF scores. It is also 
important to bear in mind that this review considered treatments in the 
early stages of development. The POMRF scores may therefore reflect 
the fact that some of the studies reviewed were pilot studies or RCTs 
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conducted to demonstrate a treatment effect to warrant further, more 
rigorous investigation.  
 
5. Conclusion 
A systematic review of psychological interventions for the treatment of 
PSA, focusing on studies published after 1987, employing no-treatment 
control groups was presented. Many of the studies in this field have 
methodological shortcomings; the most reliable evidence of 
effectiveness was found for psychological interventions focusing on 
exposure as these studies were the most rigorous. It has been 
demonstrated that exposure treatment for PSA is effective when 
delivered via the Internet as a self-help therapy and when exposure is 
to virtual audiences accessed using head-mounted equipment. Although 
other therapies such as ACT, COM, and EMDR were effective, more 
rigorous replications of the relevant results is required before they can 
be confidently recommended as treatments for PSA.  
5.1 Implications 
These findings have positive implications for individuals who find 
traditional in vivo exposure too anxiety-provoking, and therefore 
ineffective.14 Technological advances mean that exposure-based 
treatment for PSA can be delivered to a client in his or her home, or 
administered by a therapist in a controlled manner with the aid of virtual 
reality technology. Although this technology is not widely available at 
present, the cost is relatively low.29 Services should therefore consider 
how technological innovations could improve accessibility and usability 
of exposure-based therapies for populations who have previously found 
this form of therapy unsuccessful or difficult to access. There is evidence 
that individuals with PSA and other SAD-related difficulties may be 
deterred from seeking treatment if this requires clinic attendance,4 so 
self-help interventions delivered over the Internet may be considered as 
a method of making early interventions accessible to individuals who 
may be at risk of developing more general social phobia if left untreated.  
5.2 Future Research 
Although the results of this review show promise for alternative 
treatments delivered in innovative ways, it must be remembered that 
this review set out to investigate the effect of these treatments when 
compared to doing nothing. As such, the size of the effects reported 
may give an inflated impression. As suggested by Mohr,18 now initial 
efficacy has been demonstrated (stage 1), future studies should 
continue to compare interventions directly (stage 2), particularly looking 
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at how virtual or other methods compare with previously established 
‘gold standard’ treatments (exposure combined with cognitive 
restructuring). Although some studies have begun to do this, future 
investigations should address the methodological limitations of current 
research in this area. Studies should use a representative, gender-
balanced sample and a design which is sufficiently powerful to detect 
effects of the expected size. Therapies should be delivered by 
appropriately trained clinicians and compliance with treatment protocols 
should be verified; therapists should be blind to the experimental 
condition. Further investigations should focus on the relationship 
between self-report and behavioural measures of PSA; re-administration 
of behavioural measures at follow-up would enable a better 
understanding of the long-term effects of psychological treatments on 
speech performance. 
 
Acknowledgements  
The authors wish to thank the University of Lincoln’s inter-library loans service for providing articles for 
review that were not accessible via electronic means and Chris Priestley for proofreading the manuscript.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 40 of 259 
 
References 
1.  Ruscio AM, Brown TA, Chiu WT, Sareen J, Stein MB, Kessler RC. 
Social fears and social phobia in the USA: Results from the national 
comorbidity survey replication. Psychological Medicine. 
2008;38:15–28.  
2.  Motley MT. Overcoming your fear of public speaking: A proven 
method. Boston: Houghton Mifflin; 1997.  
3.  Aderka IM, Hofmann SG, Nickerson A, Hermesh H, Gilboa-
Schechtman E, Marom S. Functional impairment in social anxiety 
disorder. Journal of Anxiety Disorders. 2012;26:393-400.  
4.  Bebbington PE, Meltzer H, Brugha TS, Farrell M, Jenkins R, Ceresa 
C, et al. Unequal access and unmet need: Neurotic disorders and 
the use of primary care services. Psychological Medecine. 
2000;30:1359–1367.  
5.  Craske MG. Anxiety disorders: Psychological approaches to theory 
and treatment. New York: Basic Books; 1999.  
6.  American Psychiatric Association. Diagnostic and statistical manual 
of mental disorders: DSM 4. Washington: American Psychiatric 
Association; 1994. 
7.  Meichenbaum D. stress inoculation training. New York: Pergamon; 
1985.  
8.  Clark DM, Wells A. A cognitive model of social phobia. In: 
Heimberg RG, Liebowitz MR, Hope DA, Schneirer FR (eds.) Social 
phobia diagnosis, assessment, Treatment. New York: Guilford 
Press; 1995. p69-93.  
9.  Marshall WL, Parker L, Hayes BJ. Treating public speaking 
problems: A study using flooding and the elements of skills 
training. Behaviour Modification. 1982;6:147–170.  
10.  Fremouw WJ, Zitter R. A comparison of skills training and cognitive 
restructuring-relaxation for the treatment of speech anxiety. 
Behaviour Therapy. 1978;9:248–259.  
Page 41 of 259 
 
11.  Allen M, Hunter JE, Donohue WA. Meta‐analysis of self‐report data 
on the effectiveness of public speaking anxiety treatment 
techniques. Communication Education. 1989;38:54–76.  
12.  De Jong PJ, Pasman W, Kindt M, Van Den Hout MA. A reaction time 
paradigm to assess (implicit) complaint-specific dysfunctional 
beliefs. Behaviour Research and Therapy. 2001;39:101–113.  
13.  Gould RA, Buckminster S, Pollack MH, Otto MW, Massachusetts LY. 
Cognitive-behavioral and pharmacological treatment for social 
phobia: A meta-analysis. Clinical Psycholology: Science and 
practice. 1997;4:291–306.  
14.  Dalrymple KL, Herbert JD. Acceptance and commitment therapy for 
generalized social anxiety disorder: A pilot study. Behaviour 
Modification. 2007;31:543–568.  
15.  Hofmann SG, Dibartolo PM. An instrument to assess self-
statements during public speaking: Scale development and 
preliminary psychometric properties. Behaviour Therapy. 
2000;31:499–515.  
16.  Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment 
therapy: An experiential approach to behavior change. New York: 
Guilford Press; 1999.  
17.  Parsons TD, Rizzo AA. Affective outcomes of virtual reality 
exposure therapy for anxiety and specific phobias: A meta-
analysis. Behaviour Therapy and Experimental Psychiatry. 
2008;39:250–261.  
18.  Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD, 
et al. The selection and design of control conditions for randomized 
controlled trials of psychological interventions. Psychotherapy and 
Psychosomatics. 2009;78:275–284.  
19.  American Psychological Effectiveness. APA: Recognition of 
psychotherapy effectiveness. 
http://www.apa.org/about/policy/resolution-psychotherapy.aspx 
(accessed 21 June 2014). 
20.  Cohen J. Statistical power analysis for the behavioral sciences. 2nd 
ed. Hillsdale, New Jersey: Lawrence Earlbaum Associates; 1988.  
Page 42 of 259 
 
21.  Ost L-G. Efficacy of the third wave of behavioral therapies: A 
systematic review and meta-analysis. Behaviour Research and 
Therapy. 2008;46:296–321.  
22.  Block JA, Wulfert E. Acceptance or change: Treating socially 
anxious college students with ACT or CBGT. Behaviour Analyst 
Today. 2000;1:1–55.  
23.  Ayres J, Hopf T, Peterson E. A test of communication-orientation 
motivation (COM) therapy. Communication Reports. 2000;13:35–
44.  
24.  Foley T, Spates CR. Eye movement desensitization of public-
speaking anxiety: a partial dismantling. Journal of behavior 
therapy and experimental psychiatry. 1995;26:321–329.  
25.  Gallego, M J, Emmelkamp, P, M G, Van der Kooij M, Mees H. The 
effects of a Dutch version of an internet-based treatment program 
for fear of public speaking : A controlled study. International 
journal of clinical health psychology. 2011;11:459–472.  
26.  Botella C, Gallego MJ, Garcia-Palacios A, Guillen V, Baños RM, 
Quero S, et al. An internet-based self-help treatment for fear of 
public speaking: a controlled trial. Cyberpsychology, Behaviour and 
Social Networking. 2010;13:407–421.  
27.  Schoenberger NE, Kirsch I, Gearan P, Montgomery G, Pastyrnak 
SL. Hypnotic enhancement of a cognitive behavioral treatment for 
public speaking anxiety. Behaviour Therapy. 1997;28:127–140.  
28.  Harris SR, Kemmerling RL, North MM. Brief virtual reality therapy 
for public speaking anxiety. Cyberpsychology and Behaviour. 
2002;5:543–550.  
29.  Wallach HS, Safir MP, Bar-Zvi M. Virtual reality cognitive behavior 
therapy for public speaking anxiety: A randomized clinical trial. 
Behaviour Modification. 2009;33:314–338.  
30.  Anderson PL, Price M, Edwards SM, Obasaju M a, Schmertz SK, 
Zimand E, et al. Virtual reality exposure therapy for social anxiety 
disorder: A randomized controlled trial. Journal of Consulting and 
Clinical Psychology. 2013;81:751–760.  
Page 43 of 259 
 
31.  Price M, Anderson PL. Outcome expectancy as a predictor of 
treatment response in cognitive behavioral therapy for public 
speaking fears within social anxiety disorder. Psychotherapy 
(Chicago). 2012;49:173–179.  
32.  Swain J, Hancock K, Hainsworth C, Bowman J. Acceptance and 
commitment therapy in the treatment of anxiety: A systematic 
review. Clinical Psychology Review. 2013;33:965–978.  
33.  Ayres J, Hopf T. Coping with speech anxiety. Norwood, NJ: Ablex; 
1993.  
34.  Walser R, Westrup D. Acceptance and commitment therapy for the 
Tteatment of post-traumatic stress disorder and trauma-related 
problems: A practitioner’s guide to using mindfulness and 
acceptance strategies. Oakland, CA: New Harbinger Publications; 
2007.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 44 of 259 
 
Journal Article 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 45 of 259 
 
This journal paper has been prepared for submission to the journal of 
Behaviour Research and Therapy1. 
Acceptance and Commitment Therapy for Public Speaking 
Anxiety - A Case Series Study of Effects on Self-reported, 
Implicit, Imaginal, and In-vivo Outcomes 
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Lincoln LN6 7TS, UK 
Abstract 
 
Public speaking anxiety (PSA) is a common problem, and in some cases 
can lead to social and occupational difficulties. While exposure therapy 
combined with cognitive restructuring is currently the most effective 
treatment available, approximately 25% of individuals fail to respond.  
Acceptance and Commitment Therapy (ACT), a third-wave behavioural 
approach predicated on supposed different mechanisms of change, may 
have additional benefits to more traditional interventions, and may be 
more acceptable to those individuals with PSA who find exposure-based 
therapy too difficult.  
A multiple single-case design was used to examine the effects of a self-
help ACT intervention for PSA on self-reported, implicit, imaginal, and 
in-vivo outcomes, across six replications.  
All participants reported a reduction in speech anxiety, with evidence of 
reliable change in three cases. The four participants who reported an 
                                                             
1 Please see https://www.elsevier.com/wps/find/journaldescription.cws_home/265?generatepdf=true for 
the guide for authors 
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increase in willingness to approach a feared public speaking scenario, 
also completed a speech task. Triangulation of the quantitative (daily 
and weekly measures) and qualitative data (change-interview) indicate 
that mindfulness (self-as-context and present-moment awareness) may 
be a key mechanism of change in ACT for PSA.  
The findings offer support for ACT to treat speech anxiety, however, 
further research is needed to generalise these findings and examine the 
long term effects. 
Keywords: public speaking anxiety; social anxiety disorder; treatment; 
acceptance and commitment therapy 
*Corresponding author: University of Lincoln, Life and Social Sciences, 1st Floor, Bridge House, Brayford 
Pool, Lincoln LN6 7TS, UK. Tel: +44 1522 886029; fax: +44 01522 837390. E-mail address:                                                                                                                                           
j.priestley86@gmail.com (J. Priestley). 
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Introduction 
 
Public Speaking Anxiety 
 
Fear of public speaking, often referred to as public speaking anxiety 
(PSA), is the anxiety experienced when talking or preparing to talk in 
front of others. PSA is the most common form of social phobia (Ruscio 
et al., 2008), with prevalence rates thought to be as high as 85% in the 
general population (Motley, 1997). Although PSA is a common difficulty, 
the distress associated with PSA lies on a continuum (Bogels et al., 
2010); thus, some people may experience mild distress, while others 
may find the difficulty debilitating. In some cases, the level of anxiety 
associated with speaking in public can result in a reduced chance of 
continued education, work-related distress or unemployment (Aderka et 
al., 2012; Stein, Walker, & Forde, 1996). Unfortunately, many of those 
who experience PSA do not seek treatment (Bebbington et al., 2000), 
possibly due to feelings of shame or embarrassment, or because of a 
fear of negative appraisal from others (Olfson et al., 2000). If left 
untreated, social phobias such as PSA generally become chronic 
(Craske, 1999). 
 
[See Extended Paper 1.1 for a discussion on the epidemiology and 
impact of PSA] 
 
Research indicates a sizable minority (10%) of the general population 
meet the Diagnostic and Statistical Manual of Mental Disorders’ (DSM 
IV; American Psychiatric Association, 1994) criteria for social anxiety 
disorder (SAD), based on their fear of public speaking (Stein, Walker, & 
Forde, 1996). The current version of the DSM (DSM-V; American 
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Psychiatric Association, 2013) recognises PSA as a non-generalised SAD 
if characterised by a marked and persistent fear of performance 
situations where embarrassment might occur and exposure to this 
situation causes an immediate anxiety response. 
 
Theories of PSA 
 
There are a number of established theories for the occurrence of PSA. 
These theories have influenced the development of treatments for those 
willing to access them: 
 The cognitive perspective links the fear caused by public speaking 
to the thoughts the individual has about his or her inability to 
perform, an attentional bias towards somatic responses, and the 
likelihood of receiving negative evaluation (Clark & Wells, 1995; 
Meichenbaum, 1985). Treatment grounded in this perspective 
therefore seeks to modify the thoughts associated with public 
speaking to alleviate distress.    
 
 Behavioural understanding, grounded in principles of respondent 
and operant conditioning, suggests that an individual develops a 
phobia related to speaking in public because they associate the 
context with aversive consequences (Marshall, Parker, & Hayes, 
1982; Ramnerö & Törneke, 2008). Treatment involves learning 
that public speaking is not aversive by remaining in the feared 
situation until anxiety is reduced (exposure/habituation).  
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 An alternative learning perspective suggests an individual 
experiences apprehension when delivering a speech because he or 
she does not possess the requisite skills to adequately fulfil the 
task (Fremouw & Zitter, 1978). Treatment from this perspective 
focuses on developing these skills.  
 
[See Extended Paper 1.2 for a discussion on theories and treatment of 
PSA] 
 
Treatment  
  
A recent review found that cognitive behavioural therapy (CBT – a 
treatment informed by both cognitive and behavioural theories 
described above) can be effective in treating PSA (Pull, 2012). As most 
people with generalised SAD also experience PSA (England et al., 2012), 
treatment is largely guided by the SAD literature (Knappe et al., 2011). 
Meta-analysis has found that exposure treatment, and exposure 
treatment combined with cognitive restructuring for SAD, produce a 
large effect size (d=.80; Gould, Buckminster, Pollack, Otto, & 
Massachusetts, 1997). However, shortcomings still remain, as 
approximately 25% of patients fail to respond to this type of therapy 
(Dalrymple & Herbert, 2007; Heimberg & Magee, 2014), and may 
continue to seek further treatment following intervention, or remain 
functionally impaired (Orsillo et al., 2005).  
 
Foa and Kozak (1986) suggested that in some cases, patients can 
engage in cognitive avoidance strategies during exposure, causing them 
to ‘disconnect’ from the feared situation, thereby impairing the 
habituation process. Acceptance and Commitment Therapy (ACT; Hayes, 
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Strosahl, & Wilson, 1999) seeks to target such avoidant behaviour, by 
encouraging an accepting stance, whilst also fostering present-moment 
awareness (Hayes & Strosahl, 2004); thereby enhancing willingness to 
engage in anxiety provoking situations (such as public speaking), whilst 
reducing problematic behaviours (such as cognitive avoidance) that may 
hinder the habituation process.  
 
The ACT Model of Distress and Anxiety  
 
Grounded in functional contextualism (Hayes, Hayes, Reese, & Sarbin, 
1993) and Relational Frame Theory (RFT; Barnes-Holmes, Hayes, 
Barnes-Holmes, & Roche, 2001), ACT posits that most individuals who 
experience psychological distress do so as a result of experiential 
avoidance (the act of trying to reduce or avoid aversive private 
experiences in the form of thoughts, images, physiological sensations 
and emotions), psychological rigidity (which prevents an individual from 
acting in line with their values), and cognitive fusion (merging 
distressing thoughts with perceptions of the self). According to the ACT 
model, in order to alleviate psychological distress, one must actively 
accept unwanted thoughts, images, and bodily sensations (termed 
‘private events’), whilst engaging in behavioural change (committed 
action), in accordance with one’s values (Hayes & Smith, 2005). 
ACT is a non-disorder-specific therapy that essentially encourages 
willingness, value clarification, and mindfulness (Smout, Hayes, Atkins, 
Klausen, & Duguid, 2012). From an ACT perspective, anxiety is seen as 
a normal response that becomes pathological when a person is unwilling 
to accept it. Research into the efficacy of ACT has found support for the 
notion that it is attempts to control or avoid anxiety that produce 
psychological suffering (Hayes et al., 1999). Anxiety disorders are 
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therefore considered to be the result of this avoidance behaviour and 
are perpetuated until the client’s relationship with anxiety changes. 
Hence, the ACT approach focuses on achieving a change in this 
relationship by empowering the client to accept, and develop willingness 
to experience unpleasant private events and feared situations, in the 
context of pursuing values-based ends.  
[See Extended Paper 1.3 for a discussion on ACT and its application to 
PSA] 
Evidence for the ACT Approach 
 
There is a growing body of evidence that supports the use of ACT to 
treat a number of disorders such as depression, psychotic disorders and 
anxiety disorders (Öst, 2014). Although the current research base is 
small, a review by Sharp (2012) supports the notion that the ACT model 
may be beneficial in conceptualising and treating many anxiety 
disorders, including PSA. 
In one such study reviewed by Sharp (2012), ACT was compared with 
cognitive behavioural group therapy (CBGT – an empirically supported 
treatment for SAD)  and a non-treatment control group, for the 
treatment of PSA (Block & Wulfert, 2000). Both active treatments 
produced a decrease in anxiety and an increase in willingness associated 
with a speaking task when compared with the control group; however, 
measures of willingness increased the most in the ACT group. The 
researchers stated that these findings were true to the philosophical 
underpinnings of ACT, and suggested that the ACT participants’ 
willingness would continue to increase beyond the study. However, this 
was never substantiated, as the study did not include a follow-up 
investigation.   
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In a partial replication of the above study, Block (2002) again found that 
both ACT and CGBT effectively reduced PSA; however, those undergoing 
ACT showed a significant decrease in their levels of avoidance of a public 
speaking situation when compared with the CGBT group. Although these 
studies highlighted ACT as a valid alternative to CBT-informed treatment 
for PSA, they did not analyse temporal precedence or mediation that 
would suggest why changes occurred and whether the ACT model 
predicted these changes. 
Single case studies into the efficacy of ACT have proved useful in 
beginning to understand the mechanisms of change that may play a role 
in anxiety reduction. One noteworthy case illustration of a man with PSA 
highlighted that increases in his willingness to accept anxiety, his value-
driven behaviour and a reduction in his cognitive fusion following a 12-
week ACT intervention, led to ameliorative change (Eifert et al., 2009).  
Such results should be treated with caution, however, as it is difficult to 
establish whether those treated with ACT experienced change as a result 
of the unique properties of the therapy or whether they were simply 
reporting perceived changes using the ACT vernacular to which they 
may have become accustomed. Nevertheless, it seems that those who 
undergo ACT treatment are more willing, and able to spend longer in 
public speaking tasks, than those who have undergone CBT (Block, 
2002). This indicates that ACT may be a valid and possibly more 
effective treatment for PSA than the current recommended approach of 
CBT (National Institute for Health and Clinical Excellence, 2013). 
Preliminary research on the use of ACT for PSA is therefore promising, 
however, this exploration is still in its infancy, with an over-reliance on 
group studies and trials that have not been designed to tease out 
mediating processes or demonstrate replications. The current study 
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therefore aimed to extend the existing knowledge on the use of ACT to 
treat PSA by taking an in-depth look at the processes of change on an 
individual level, using multiple subjects. A single case experimental 
design (SCED) was used to examine the possible mechanisms of change 
in ACT for the treatment of PSA. As a recent review supported the 
delivery of ACT in a self-help format (Cavanagh, Strauss, Forder, & 
Jones, 2014), a guided self-help treatment method was used in the 
current study. This also allowed for the components of ACT to be 
examined in a standardised manner across multiple cases.  
[See Extended Paper 1.4 for a discussion on the efficacy of self-help 
psychological interventions] 
Implicit Measurement  
 
The present study investigated the effects of ACT on self-reported, 
behavioural (in-vivo and imaginal), and implicit indices of PSA. An 
implicit measure was included as such measures appear to be sensitive 
to cognitions that are potentially less amenable to self-reporting. 
Evidence for this comes from research showing divergent responses to 
implicit versus explicit measures of the same construct (Power, Barnes-
Holmes, Barnes-Holmes, & Stewart, 2009) and that responses on 
implicit measures are harder to control or deliberately manipulate in 
response to instruction (McKenna, Barnes-Holmes, Barnes-Holmes, & 
Stewart, 2007). Within the mainstream cognitive literature, theorists 
characterise implicit measures as measuring relatively fast/automatic 
responses that occur with reduced awareness or control (e.g., 
Gawronski & Payne, 2010). Research has demonstrated that responses 
on implicit measures have been shown to predict overt behaviour and 
potential markers of clinical change (Fazio & Olson, 2003). In other 
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words, implicit measures may capture responses that might be 
important for predicting (and potentially influencing) behaviours of 
interest.  
The Implicit Relational Assessment Procedure (IRAP) is an implicit 
measure with the ability to measure complex (e.g., ‘propositional’ or 
‘relational’) implicit cognitive processes (Hughes & Barnes-Holmes, 
2011). The IRAP has been used to effectively examine implicit 
differences between a broad range of clinical and non-clinical 
populations (Barnes-Holmes, Murtagh, Barnes-Holmes, & Stewart, 
2010; Parling, Cernvall, Stewart, Barnes-Holmes, & Ghaderi, 2012). 
Moreover, the IRAP has been shown to be sensitive to ACT treatment 
(cognitive defusion) (Ritzert, Forsyth, Berghoff, Barnes-Holmes, & 
Nicholson, 2015), thus supporting the notion the IRAP may be used to 
measure ACT treatment effects accurately. 
Implicit measures purportedly offer a means of measuring responses 
that are less sensitive to demand characteristics or response sets 
(McKenna, Barnes-Holmes, Barnes-Holmes, & Stewart, 2007) (e.g., 
faking 'good' in order to please the researcher/therapist, with whom 
participants may have developed a bond - or possibly faking 'bad' to 
undermine study results). As such, inclusion of the IRAP allowed us to 
triangulate and interpret self-report responses, especially if explicit 
responses suggested therapeutic change (from pre- to post-
intervention) but implicit responses remain unchanged. Hence, under 
ideal conditions, we expected implicit and explicit responses to be 
concordant. 
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The IRAP was therefore chosen in the current study to measure implicit 
changes over the course of the intervention, and explore whether 
changes in implicit responses (1) needed to occur for reductions in PSA 
to take place, and (2) predicted the willing completion of a public 
speaking task.  
[See Extended Paper 1.5 for a further discussion on implicit measures 
and the IRAP]  
Aims and Purpose of the Investigation 
 
The principal aim of the study was to use a multiple single case 
experimental design to examine the effects of a self-help ACT 
intervention on PSA, by measuring self-reported, implicit, imaginal, and 
in-vivo outcomes. Specifically, the research aimed to examine whether 
the self-help ACT intervention: 
 reduced PSA, as measured by the self-statements during public 
speaking scale (SSPS; Hofmann & Dibartolo, 2000). 
o and if so, which elements of the ACT intervention appeared 
to produce this reduction (as measured by daily and weekly 
measures)   
 
 reduced the participant’s distress and avoidance of an imagined 
public speaking scenario, whilst increasing his or her willingness to 
approach it.  
 
 led to an increase in psychological flexibility (as measured by the 
daily time-series measure) that preceded reductions in PSA. 
 facilitated willing completion of a voluntary public speaking task.  
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 altered implicit responses towards public-speaking-related stimuli.   
 
Hypotheses 
 
As ACT seeks to increase one’s willingness to experience distressing 
situations and private events (Hayes & Strosahl, 2004) we hypothesised 
that the intervention would lead to an increase in willingness to 
approach a feared imagined public speaking scenario as a result of 
increased psychological flexibility. We also hypothesised that this 
increase in willingness and psychological flexibility would facilitate the 
completion of an in-vivo public speaking task. Although ACT does not 
seek to reduce anxiety per se, we also hypothesised that a secondary 
effect of the intervention would be a reduction in anxiety associated with 
public speaking, in line with previous findings (e.g., Block & Wulfert, 
2000; Block, 2002; Eifert et al., 2009); however, no hypotheses were 
made regarding the mechanisms of change involved or the effect the 
intervention would have on implicit responding.  
 
Clinical Relevance 
 
This study is clinically relevant because it aims to provide evidence for 
the use of ACT, in a self-help format, to treat PSA. This is important as 
ACT may be a valid treatment option for individuals with PSA who find 
existing forms of exposure therapy too anxiety provoking or ineffective, 
or for individuals who wish to address their PSA without clinic 
attendance. Moreover, the delivery of ACT in a self-help format may 
provide a cheaper alternative to direct therapy for services tasked with 
treating PSA.  
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The exploratory elements of this research may also inform clinicians 
treating PSA about the most valuable ACT processes to focus on in the 
treatment of PSA, and whether implicit measures such as the IRAP may 
have a clinical utility in measuring treatment effect.  
[See Extended Paper 1.6 for a further discussion on the clinical 
relevance of the study] 
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Method  
 
 Participants 
 
Prospective participants answered advertisements posted around the 
University of Lincoln and via the university’s e-mail system. On 
contacting the researcher, participants were initially sent a further 
information sheet about the nature of the study (Appendix A), and 
completed a brief online questionnaire to ensure they satisfied the 
following inclusion criteria: 
1. Score ≥ 6 on the Self-statements during public speaking scale – 
Negative (SSPS-N) (within one standard deviation of a speech 
phobic sample; Hofmann & Dibartolo, 2000), indicating at least a 
moderate fear of public speaking. 
2. ≥ 18 years of age. 
3. Not currently receiving, or due to receive, psychotherapy or 
anxiolytic medication (participants taking non-anxiolytic 
psychotropic medication were considered). 
4. English speaker, with good comprehension (based on the 
researcher’s judgement during the initial meeting).   
[See Extended Paper 2.1 for a further discussion on the inclusion 
criteria] 
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Design and Procedure 
 
[See Extended Paper 2.2 for a discussion on the epistemological position 
taken, and the single case experimental design] 
 
In order to investigate the effectiveness of ACT to treat PSA, an A-B 
multiple baseline single case series (Barlow, Nock, & Hersen, 2008) was 
used. If participants were eligible, and agreed to take part in the study, 
they completed the initial battery of tests and completed a no-treatment 
baseline phase for at least five days. During this time, a daily ACT 
process measure was completed (see Measures). This baseline period 
acted as each participant’s control phase, and was completed until a 
stable or declining trend was achieved (indicating stable or declining 
psychological flexibility). Once a stable baseline was achieved, 
participants began the intervention phase. As participants came forward 
to take part in the study over a four-month period, no participant began 
the intervention stage at the same time as another, satisfying the (non-
concurrent) multiple-baseline design. As the average number of 
participants in SCED research is six (Smith, 2012), recruitment 
continued until a minimum number of six participants had completed the 
study (See Figure 3. for an overview of the SCED). 
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Figure 3. Overview of the SCED used in the present study. 
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Each participant began the intervention phase by reading the self-help 
ACT workbook, Get out of Your Mind and Into Your Life (Hayes & Smith, 
2005) over the course of six weeks. The chapters of this workbook were 
arranged according to the six ACT processes, so participants read 
chapters pertaining to a different ACT process each week (see Table 4).  
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Table 4 
Participant Reading and Measures Completed by Week 
Intervention 
stage 
ACT process Chapters Chapter title/s 
Overview of ACT 
(given to 
participants after 
the initial test 
battery) 
N/A Intro, 1, 2  Introduction; 
Human Suffering; 
Why Language 
Leads to Suffering 
Week 1 Acceptance 3,4,9,10 The Pull of 
Avoidance; Letting 
go; What 
Willingness is and 
is not; 
Willingness; 
Learning to Jump 
 
Week 2 Cognitive 
Defusion 
5, 6 The Trouble with 
Thoughts; Having 
a Thought vs. 
Buying a Thought 
 
Week 3 Self as 
Context 
7 If I’m Not My 
Thoughts, Then 
Who am I? 
 
Week 4  Present-
Moment 
Awareness 
8 Mindfulness 
 
 
 
Week 5 Values 11, 12 What are Values?; 
Choosing Your 
Values 
 
Week 6 Committed 
Action 
13 Committing to 
Doing It 
 
 
Therapist support was provided by telephone once a week. Each 
participant met with the researcher after three weeks and at the end of 
the intervention phase to complete the mid- and post-intervention test 
batteries respectively. Over the course of the intervention, each 
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participant completed a short daily ACT measure, and a weekly 
collection of measures (see Measures section).    
 
On completion of the intervention, each participant was invited to 
complete a Behavioural Approach Task (BAT), in this case, a public 
speaking task. If the participant agreed, he or she completed the task 
by giving a partially planned speech of up to 10 minutes on a chosen 
subject to an assembled audience. This took place around one month 
after completion of the intervention phase. Each participant’s 
performance was rated by certain members of the audience (see 
Measures section) and the length of time spent in the BAT was recorded.  
 
A change interview (Elliott, 2010) was conducted by an independent 
researcher who was blind to the participants’ scores on all measures. 
This change interview investigated each participant’s attitude towards 
the self-help workbook, perceived changes in their PSA, and their 
perception of the possible reasons for any change. If the participant 
completed the BAT, then the change interview was conducted within 24 
hours after completion. If not, the participant was interviewed one 
month after he or she completed the intervention phase (see Figure 4 
for the study procedure flow-chart). 
 
[See Extended Paper 2.3 for a discussion on ethical considerations] 
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Figure 4. Study procedure according to time and phase 
 
 
[See Extended Paper 2.4 for further discussion on the study procedure] 
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Measures 
 
Daily and weekly measures were administered during the study. The 
daily measure (a composite ACT measure of overall psychological 
flexibility) consisted of 12 items taken from the validated scales used for 
the weekly measure and were administered during the baseline phase, 
and throughout the intervention phase. A test battery was administered 
at the pre-, mid-, and post-intervention stages.  
 
Weekly Measures 
 
Due to the overlap between the six ACT processes (Hayes, Strosahl, & 
Wilson, 2012), the weekly measures contained questionnaires related to  
four key ACT principles: acceptance2, defusion, mindfulness (present-
moment awareness/self-as-context), and valued action 
(values/committed action). The weekly measures also include two PSA 
measures (see Table 5) (See appendix B for the Weekly Measures). 
                                                             
2 Only the sub-scale related to ‘acceptance’ from the PHLM was administered.  
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Table 5 
Characteristics and Psychometric Properties of the Weekly Measures 
 
Note. N items: Number of items; Inter con: Internal consistency; Const val: Construct validity; Discr val: Discriminant Validity; Self-as-cont: Self-
as-context; Pres-mom aware: Present-moment awareness; Com act: Committed action: PSA; Public speaking anxiety: neg: negative scale; pos: 
positive scale. α denotes Cronbach's alpha coefficient 
Measure Construct N items Example item Scale direction Inter con Const val Discr val 
Philadelphia Mindfulness Scale 
(PHLMS; Cardaciotto, Herbert, 
Forman, Moitra, & Farrow, 2008) 
Acceptance 10 “I try to put my 
problems out of 
mind” 
1 (never) – 5 (often) 
(items reversed) 
High score =↑acceptance 
.82α good good 
Cognitive Fusion Questionnaire 
(CFQ; Gillanders et al., 2013) 
Cognitive 
fusion 
7 “I struggle with 
my thoughts” 
1 (never) – 7 (always) 
High score = ↑ cognitive fusion 
.90α  
 
good good 
Mindfulness Attention Awareness 
Scale (MAAS; Brown & Ryan, 
2003) 
Self-as-
cont / Pres-
mom aware 
15 “I snack without 
being aware that 
I'm eating” 
1 (always) – 6 (never) 
High score = ↑ mindfulness  
 
.82α good good 
Engaged Living Scale (ELS; 
Trompetter et al., 2013)  
Values / 
Com act 
16 “I feel that I am 
living a full life” 
1 (disagree) – 5 (agree) 
High score = ↑ values/com act 
.91α good good 
Self-statements during Public 
Speaking Scale (SSPS; 
Hofmann & Dibartolo, 2000) 
PSA 10 (5 
pos & 5 
neg) 
“What I say will 
probably sound 
stupid” (neg) 
0 (disagree) – 5 (agree) 
High score (neg) = ↑PSA 
High score (pos) = ↓PSA 
.80α (pos) 
.86α (neg) 
Moderate Moderate 
Subjective Units of Distress 
Scale (SUDS; (Wolpe & Lazarus, 
1966) 
Willingness 
to approach 
imagined 
task  
1 “How willing would 
you be to be in 
this situation?” 
0 (not willing) – 100 (willing) 
High score = ↑ willingness 
- - - 
 Distress 
caused by 
imagined 
task 
1 “How much 
distress would this 
situation cause 
you?” 
0 (no distress) – 100 (max 
distress) 
High score = ↑ distress 
- - - 
 Desire to 
avoid the 
imagined 
task 
1 “How much would 
you avoid this 
situation?” 
0 (no avoidance) – 100 (max 
avoidance) 
High score = ↑ avoidance   
- - - 
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Daily Measure 
 
Participants completed a daily questionnaire to record regular time 
series data (Appendix C). This composite ACT measure of overall 
psychological flexibility included 12 items relating to four key ACT 
concepts (three items per concept): acceptance, defusion, 
mindfulness (present-moment awareness/self as context) and valued 
action (values/committed action). The items were derived from the 
weekly measures, based on face validity and high factor loadings 
found in previous research investigating their psychometric 
properties. For example, the statement, “There are things I try not to 
think about” was included to measure acceptance from the PHLMS, 
due to the question’s high factor loading (.66) and face validity for 
(non-) acceptance (Cardaciotto et al., 2008). High scores on the daily 
measure indicated high psychological flexibility.  
 
Test Battery  
 
The test battery consisted of the same psychometrics as included in 
the weekly measures, with the addition of the IRAP (Barnes-Holmes 
et al., 2006). The IRAP is an implicit measure that captures response 
tendencies with respect to propositional stimuli, allowing for the 
nuanced capture of cognitions/verbal responses towards target 
stimuli (Barnes-Holmes, Barnes-Holmes, Stewart, & Boles, 2010). 
The IRAP is a computerised latency assessment tool where, in the 
present study, respondents were instructed to respond to public 
speaking images in a manner that was alternately consistent, and 
inconsistent with their beliefs. The IRAP postulates that responses 
that are consistent with implicit beliefs occur more quickly (e.g., 
public speaking image – “makes me anxious”) than responses that 
are inconsistent (e.g., public speaking image – “does not make me 
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anxious”). The difference between the response latencies of 
consistent and inconsistent blocks is calculated and represented as a 
D-score (Hussey, Thompson, McEnteggart, Barnes-Holmes, & Barnes-
Holmes, 2015). In the present study, positive D-scores indicated a 
response bias towards public speaking anxiety (i.e., that participants 
are faster to coordinate with anxiety versus non-anxiety). The D-
scores recorded over the course of the intervention therefore 
indicated change in implicit anxiety towards public speaking images 
(See Appendix D for an example of the IRAP). 
 
Behavioural Assessment Task  
  
The final battery included a voluntary Behavioural Assessment Task 
(BAT; an impromptu speech task). This task assessed participants’ 
willingness to approach and complete a live public speaking task, and 
their performance in giving the speech. Participants were asked to 
give a talk for up to 10 minutes on a subject of their own choosing, to 
an assembled audience of clinical psychologists and trainee clinical 
psychologists. Six audience members were chosen at random to rate 
each participant’s performance on the Social Performance Rating 
Scale (SPRS; Harb, Eng, Zaider, & Heimberg, 2003). The SPRS is a 
behavioural assessment of social and speech anxiety. Respondents 
are rated on a scale of 0 (very poor) to 5 (very good) on their gaze, 
vocal quality, length of speech (e.g., concise and detailed sentences), 
and level of comfort. The SPRS has demonstrated good inter-rater 
reliability (.84) and internal consistency (.82) when used to evaluate 
individuals with PSA (Harb et al., 2003).   
This BAT only occurred at the end of the intervention. This was for 
three reasons: (1) a repeated BAT may have acted as an exposure 
intervention in and of itself, making it difficult to determine if the ACT 
intervention resulted in change; (2) the prospect of a final speech 
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task acted to motivate participants to engage in the workbook; and 
(3) it provided participants with a ‘real-life’ scenario in which to apply 
what they had learned from the self-help workbook, and to discuss 
during the post-intervention change interview.  
Analysis 
 
In order to achieve the first aim of the study (to investigate whether 
the ACT intervention reduced PSA, and the ACT processes involved), 
the daily and weekly measures were analysed to determine if 
changes had occurred over the course of the intervention on 
measures of PSA and ACT processes. To determine whether any 
recorded changes were deemed reliable (beyond what could be 
accounted for due to measurement error at 95% confidence), and 
clinically significant (placing the participant in a non-clinical range), 
Jacobson  and Truax's (1991) Reliable Change Index (RCI) and 
Clinically Significant Change methods (CSC; criterion C3) were applied 
respectively (See Table 6 for the RCI values, and CSC cut-offs that 
were applied for each measure).  
[See Extended Paper 2.5 for a further discussion on Jacobson and 
Truax's (1991) criteria for assessing reliable and clinically significant 
change] 
 
 
 
                                                             
3 According to Jacobson and Truax's criterion C method (1991), an individual achieves CSC if their post-
treatment score places them closer to the mean of a ‘normal’ population than that of a ‘clinical’ 
population. To achieve CSC, individuals must also have a pre-treatment score in the clinical range, and 
their pre-post change must be equal to or above the RCI value.  
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Table 6 
RCI Values and CSC cut-off Scores Applied to the Self-Rated 
Measures Completed during the Battery of Tests 
Measure  Critical 
RCI Value* 
CSC 
Cut-off 
SSPS-N (Public Speaking Anxiety) 6.53 9.48 
PHLMS (Acceptance) 7.59 27.66 
CFQ (Cognitive Fusion) 7.74 28.38 
MAAS (Present-Moment Awareness) 0.74 4.26 
ELS (Values and Committed Action) 8.16 56.41 
Notes. SSPS-N: Self-statements during public speaking scale-Negative; PHLMS: Philadelphia 
mindfulness scale-Acceptance; CFQ: Cognitive fusion Questionnaire; MAAS: Mindfulness 
attention awareness scale; ELS: Engaged living scale; RCI: Reliable change index; CSC: 
Clinically significant change 
 *Individual change-scores ≥ this value were statistically significant at p≤.05 
 
As the SUDS is a subjective measure used to monitor idiographic 
change during treatment (Milosevic & McCabe, 2015), this measure 
was not subjected to RCI and CSC analysis. However, these data 
were inspected for change over the course of the intervention to 
achieve the secondary aim: to determine whether the ACT 
intervention reduced participants’ distress and avoidance of an 
imagined public speaking scenario, whilst increasing willingness to 
approach it. 
For the participants who chose to complete the final BAT, an overall 
score was calculated by averaging each participant’s score from the 
four sub-categories of the SPRS. The percentage time each 
participant spent in the BAT was also calculated for comparison, thus 
indicating the number of participants who took part in the BAT, their 
performance, and the time spent in the task, to investigate whether 
the intervention facilitated the willing completion of a public speaking 
task. 
To achieve the final aim of the study, the transformed response 
latency data (D-scores) collected during the IRAP for both public 
speaking trials were averaged, and investigated to determine whether 
Page 71 of 259 
 
the ACT intervention led to changes in implicit responses towards 
public speaking stimuli/images. 
As visual analysis remains the ‘gold standard’ method for the 
evaluation of SCED data (Smith, 2012), the daily ACT time-series 
data, from the point of baseline to the end of the intervention phase, 
were inspected considering the parameters of central tendency, 
trend, variability, point of change, and overlap, as suggested by 
Morley, (2015) (see Appendix E for an example of these parameters). 
Investigation of this process measure enabled us to gauge when and 
where changes in the theoretically targeted ACT construct 
(psychological flexibility) occurred, enabling the investigation of the 
active phases/components of the intervention.  
To calculate the treatment effect size, the Percentage Exceeding the 
Median (PEM; Ma, 2006) method was used4 on the daily measures 
data. PEM scores ≥ .9 indicate a ‘highly effective treatment’. Scores 
between, .7 to .9, and scores < .7, indicate ‘moderately effective’ and 
‘not effective’ treatments respectively (Ma, 2006).  
Each participant’s responses in the change interview were tabulated 
and considered alongside quantitative findings, in order to strengthen 
or refute inferences made regarding the effect of the ACT intervention 
on reductions in PSA, and the possible mediating factors involved. 
Evaluation of the change interviews also allowed for the effects of 
factors extraneous to the treatment process to be considered.    
 
 
 
                                                             
4 Using the PEM method, the treatment effect size is produced by calculating the percentage of data 
points that exceed the median of the participant’s baseline scores. 
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Results  
 
Sample 
 
Seven participants took part in the study, however, one chose to 
withdraw after the third week5 (the partial data on this participant 
were not included for analysis as he/she did not complete the mid-
battery assessment). Table 7 displays the sample demographics of 
the participants who completed the study. 
Table 7  
Demographics of Sample 
Notes: Undergrad: Undergraduate; Ethn: Ethnicity; W/B: White British; B/Asian: British Asian; M/H 
diagnosis: Current mental health diagnosis; Prev PSA treatment: Previous treatment for public 
speaking anxiety 
The majority of the participants were female undergraduate students 
(83%). The average age of the participants was 28.66 years 
(SD=13.34). One participant had a current diagnosis of depression, 
but was not receiving psychotherapy or anxiolytic medication. No 
participant/s had previously sought help, or received any 
psychological or pharmacological intervention for their PSA. 
 
                                                             
5 This participant withdrew from the study due to work commitments which meant she was unable to 
complete the requisite reading each week. 
Participant Age  Gender Occupation Ethnicity M/H  
diagnosis 
Prev 
PSA treatment 
P1 39 Female Undergrad W/B 
 
N/A No 
P2 19 Female Undergrad W/B Depression No 
P3 20 Female Undergrad B/Asian N/A No 
P4 19 Female Undergrad B/Nigerian N/A No 
P5 51 Male Lecturer W/B N/A No 
P6 24 Female Undergrad W/B N/A No 
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Battery Measures and BAT Results 
 
RCI and CSC analyses were conducted on the SSPS-N6 (negative 
scale), and the four ACT process measures administered during the 
test batteries. Participants’ SUDS responses to the imagined public 
speaking task, and changes in their implicit responses to public 
speaking stimuli during the IRAP, were inspected for change. For the 
participants who chose to complete the BAT (n=4), their total SPRS 
score and the percentage of time in the BAT were calculated. (See 
Table 8 for these battery test results).  
                                                             
6 The SSPS-N results were subjected to analysis, without the inclusion of the SSPS-P (positive scale), as 
the presence of negative statements is more closely associated with the presence of PSA, than the 
absence of positive statements (Hofmann & Dibartolo, 2000). The SSPS-N is therefore more sensitive to 
PSA treatment than the SSPS-P (Hofmann & Dibartolo, 2000). 
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Table 8 
Outcome of Battery Measures Administered during the Study and Indications of Reliable and Clinically 
Significant Change on the SSPS-N, PHLMS, CFQ, MASS, and the ELS  
 
Participant 
 
Time SSPS-N SUDS-D SUDS-A SUDS-W PHLMS   CFQ MAAS   ELS IRAP SPRS 
P1 Pre     17    100    100    0    22    31    2.47    49    0.06 - 
 Mid     7R, C    90    50    30    32R, C    24    3.33R    55    0.94 - 
 Post     4R, C    90    20    60    38R, C    15R, C    3.37R    60R, C    0.56 4.1 / 74% 
P2 Pre     21    100    100    10    11    46    3.47    43    0.94 - 
 Mid     17    90    100    10    21    38    3.66    48    1.08 - 
 Post     16    90    100    10    26 R    39    3.47    50    0.81 DNC 
P3 Pre     18    90    60    10    16    46    2.93    52    1.06 - 
 Mid     12    70    70    80    33R, C    41    3.27    45    0.80 - 
 Post     11R    70    60    70    36R, C    31R    4.13R    56    0.35 3.5 / 100% 
P4 Pre     13    100    100    0    30    39    4.4    48    0.70 - 
 Mid     11    80    80    80    34    31R    3.87    53    0.65 - 
 Post     4R, C    60    50    70    39 R    19R, C    4.67    63R, C   -0.30 3.0 / 31% 
P5 Pre     9    100    90    0    31    27    4.13    55    0.20 - 
 Mid     6    80    80    20    31    30    4.33    55    0.80 - 
 Post     6    70    70    40    34    25    4.73    58    0.32 4.9 / 98% 
P6 Pre     18    100    90    10    21    37    3.07    61    0.60 - 
 Mid     15    100    100    10    22    20R, C    4.2R    65    0.64 - 
 Post     13    90    90    10    32R, C    17R, C    3.93R    65    0.73 DNC 
Note. SSPS-N: Self-statements during public speaking scale – Negative; SUDS-D: Subjective units of distress sale; SUDS-A: Subjective Units of 
Distress Scale-Avoidance; SUDS-W: Subjective units of distress-Willingness; PHLMS: Philadelphia mindfulness scale-Acceptance; CFQ: Cognitive 
fusion scale; MAAS: Mindfulness attention awareness scale; ELS: Engaged living scale; IRAP: Implicit relational assessment procedure; SPRS: 
Social performance rating scale (Score and percentage time in task); DNC: Did not complete 
 
R denotes Reliable Change at p<.05; C denotes Clinically Significant Change (from clinical to non-clinical range);  indicates Reliable improvement 
or Clinically Significant Change. 
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Self-reported PSA 
 
Although all participants experienced reductions in their negative 
thoughts associated with public speaking, only half showed reliable 
reductions, as measured by the SSPS-N (P1, P3 and P4) according to 
the RCI cut-off value (6.53). For two of these participants, these 
reductions were also clinically significant (P1 and P4)7 (see Figure 5). 
 
 
Figure 5. Scores on the SSPS-N outcome measure at baseline-, mid-, 
and post-intervention8 
 
[See Extended Paper 3.1 for the analysis of the self-statements 
during public speaking positive measure (SSPS-P)]  
                                                             
7 Although participant 5’s post-treatment score reached clinical levels on the SSPS-N, this change was 
not deemed reliable. This may been a consequence of possible ‘floor effects’, as participant 5’s pre-
treatment score was closer to the ‘normal’ than the ‘clinical range’ for individuals with PSA (although 
this participant still met the study’s inclusion criteria of a SSPS-N score of ≥ 6). 
8 Reduced scores on the SSPS-N indicate a reduction in PSA. 
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[See Extended Paper 3.2 for the analysis of weekly changes in PSA as 
measured by the SSPS-N] 
All participants recorded a reduction in distress when imagining their 
most feared public speaking scenario, as measured by the SUDS. On 
average, participant distress reduced by 23.3%. Half the participants 
showed a reduction in their avoidance of this scenario (P1, P4, and 
P5), however, the other half did not (P2, P3, and P6). Avoidance 
reduced by 25% on average for those who experienced change 
(Figure 6). 
Four participants also experienced an increase in their level of 
willingness to approach their feared public speaking scenario (P1, P3, 
P4 and P5; who also went on to complete the BAT). P2 and P6 
showed no change in this domain (and chose not to complete the 
BAT). Overall, levels of willingness increased by 31.6% (see Figure 6 
for all SUDS outcome scores). 
 
 
Figure 6. Imaginal SUDS outcome scores at baseline-, mid-, and post-
intervention 
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[See Extended Paper 3.3 for the analysis of weekly SUDS ratings 
related to the imagined feared public speaking scenario] 
P2 and P6 showed either the least change (distress), or no change 
(avoidance and willingness) in their SUDS scores over the course of 
the intervention. This measure appeared to predict these participants’ 
behavioural responses, as they were the only participants who chose 
not to complete the BAT.  
The greatest change overall in the SUDS measure was observed for 
participants P1 and P4. Reductions in these participants’ scores on 
the SSPS-N were also deemed reliable, and they were the only two 
participants to achieve a clinically significant reduction on this 
measure. All participants who recorded an increase in their 
willingness to engage in their feared public speaking scenario also 
completed the final BAT. 
ACT Process Measures 
 
Reliable increases in levels of acceptance, as measured by the 
PHLMS, were evinced in all but one case (P5), with three participants 
demonstrating clinically significant increases (P1, P3, and P6). 
Cognitive fusion reduced reliably in four cases (P1, P3, P4, and P6), 
and reached clinically significant levels in three of these cases (P1, 
P4, and P6). Reliable increases in present-moment awareness was 
seen in three cases (P1, P3, and P6), however, this did not lead to a 
clinically significant increase in any case. Both reliable and clinically 
significant increases only occurred in two cases (P1, and P4) with 
regard to valued living and committed action, as measured by the 
ELS (see Figure 7).  
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Figure 7. Scores on ACT process measures at baseline-, mid-, and 
post-intervention9 
Overall, with the exception of P5, all participants experienced a 
reliable change in acceptance, and all but two (P2 and P5) in the area 
of cognitive fusion. P2, P4 and P510 did not show reliable changes in 
present-moment awareness, and no participant reached clinically 
significant levels post-intervention. Although all participants showed 
an increase in values and committed action, only P1 and P4 made 
reliable and clinically significant improvements.  
                                                             
9 Increase in score indicates improvement for the PHLMS, MAAS, and ELS, however, a decrease in score 
on the CFQ indicates improvement (de-fusion) 
10 Although P4 and P5’s final scores were above the cut-off for CSC, their overall change in score was not 
≥ the RCI value (a prerequisite before CSC can be considered)  
               = Clinically 
significant change                      
cut-off (criterion c) 
       *      = Reliable 
change from pre-
treatment score 
     (i.e., change 
greater  
than RCI 
Value) 
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Further analysis of the weekly ACT measures, revealed that the 
majority of reliable change (when considering all the ACT process 
measures) occurred during the present-moment awareness treatment 
phase (week 4). 
[See Extended Paper 3.4 for the analysis of the weekly ACT process 
measures and 3.5 for an overall synthesis of these results] 
Implicit Change  
 
Changes in implicit responses to public speaking stimuli, as measured 
by the IRAP, were mixed. The majority of participants showed either 
little reduction (P2), or an increase in their implicit anxiety associated 
with public speaking stimuli (P1, P5, and P6), however, one third of 
participants showed a decrease in their implicit anxiety related to 
public speaking stimuli (P3, and P4) (see Figure 8). 
 
Figure 8. D-scores at baseline-, mid-, and post-intervention11 
 
 
 
                                                             
11 Reduced D-IRAP scores indicate a reduction in implicit PSA 
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Public Speaking Task and Observer Ratings 
 
Four participants completed the final speech BAT (P1, P3, P4 and P5). 
The percentage of time spent in the BAT ranged from 32% (3:07 
minutes) to 100% (10 minutes). The observer ratings of speech 
performance ranged from 3.0 (fair) to 4.9 (very good), on the SPRS. 
The average SPRS score for the BAT was 3.88. All participants 
received a SPRS score higher than the average of a speech-anxious 
cohort, (2.98; Harb et al., 2003) (indicating a higher performance / 
level of comfort) (see Figure 9). 
 
Figure 9. Average observer-rated scores on the SPRS and time spent 
in BAT  
Time-Series Visual Analysis and Treatment Effect Size 
 
Time-series data collected from the daily ACT measures (composite 
measure of psychological flexibility) were graphed and visually 
inspected for change across phase and time (see Figure 10). The 
treatment effect size was also calculated for each participant using 
the PEM method (Ma, 2006).12 
 
                                                             
12 Increases in daily ACT scores indicate greater psychological flexibility. 
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Participant 1.                             Participant 2. 
    
Participant 3.                                                                                           Participant 4. 
   
  Participant 5.               Participant 6. 
  
Note.          Denotes the (predicted) baseline trend line, and     denotes the treatment phase trend line.  
Figure 10. Time-series data inspected for change in phase and time using visual analysis and treatment effect using the 
PEM (Ma, 2006) method 
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Visual inspection revealed that, during the baseline phase, all 
participants’ psychological flexibility (as measured by the daily ACT) 
was either stable or in decline prior to the intervention phase. A 
moderate to large shift in central tendency between phases was 
observed for four participants (P2, P3, P4, and P6). All participants 
showed an overall upward trend following the introduction of the 
treatment phase, however, all participants showed either no change 
or a reduction in psychological flexibility during the ‘acceptance’ 
phase. Moreover, the introduction of the first treatment phase 
(acceptance) resulted in an immediate increase in psychological 
flexibility for only two participants (P4 and P5). The majority of 
participants also showed little change from baseline levels during the 
‘cognitive defusion’ phase, with the exception of P2. However, 
increases in psychological flexibility were evinced by accelerated 
trend lines from the point of the ‘self as context’ phase that continued 
into the remaining phases of ‘present-moment awareness’, ‘values’, 
and ‘committed action’, in five out of six cases (excluding P1). 
Variability between the baseline and intervention phase was observed 
in four cases (P2, P3, P4, and P6), with increases in variability 
occurring during the ‘self-as-context’, ‘present-moment awareness’, 
‘values’ and ‘committed action’ phases.  
The average treatment effect size was .73, indicating the treatment 
had an overall moderate effect in increasing psychological flexibility, 
as measured using the PEM (Ma, 2006; see Table 9). Treatment was 
deemed ‘highly effective’ for P2 and P4. Treatment was deemed 
moderately effective for three participants (P3, P5 and P6), and ‘not 
effective’ for P1. 
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Table 9 
Treatment Effect Size by Participant 
Participant PEM/effect size Interpretation 
P1 .17 Not effective 
P2 .93 Highly effective 
P3 .76 Moderately effective 
P4 .95 Highly effective 
P5 .73 Moderately effective 
P6 .81 Moderately effective 
 
Qualitative/Change Interview Results 
 
Each participant’s responses to the final change interview are 
presented in Table 10 below (see Appendix F for interview schedule). 
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Table 10 
Participant Responses to the Change Interview Questions 
Ptp  Understandable Recommend 
to other 
Influential 
chapter/s 
Changes in PSA Surprised 
by 
changes 
Attribute 
to 
workbook 
Importance 
of change 
N - PS 
during 
study 
Ext 
Events 
Therapist 
support 
Chose to 
complete 
BAT 
P1 Yes Yes Present- 
moment 
awareness 
Awareness & 
Acceptance of 
anxiety 
Somewhat Unsure Very 
important 
2 None Helpful Yes  
P2 No - “Hard to 
grasp” 
Yes Acceptance Acceptance of 
distressing 
private 
events/willingness 
Neutral Yes-likely Somewhat 0 None Helpful No – 
“Too 
anxious” 
P3 Yes Yes Values Acceptance of 
distressing 
private 
events/willingness 
Somewhat Yes-likely Important 0 None Helpful Yes 
P4 Yes Yes Present- 
moment 
awareness 
& Values 
Decreased 
avoidance of 
public speaking 
Somewhat Yes-likely Very 
important 
0 None Helpful Yes 
P5 Yes Yes  Present- 
moment 
awareness 
Separating self 
from thoughts. 
Acceptance of 
distressing 
private events 
Neutral Yes-highly 
likely 
Neutral 2 x 
weekly 
Raising 
a new-
born 
Helpful & 
supportive 
Yes 
P6 No – “a lot of 
theory attached 
to it” 
Yes Present- 
moment 
awareness 
Reduced anxiety Somewhat Unsure Very 
important 
0 Passed 
series 
of 
exams 
Helpful No – “I 
like to 
fully 
prepare” 
 
Note.  N – PS during study: Number of external public speaking tasks completed during the study; Ext events: Influential external events during 
study; Ptp: Participant; BAT: Behavioural approach task 
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The change interview revealed that P2 and P6 found the workbook 
difficult to read, and also chose not to complete the BAT due to 
feeling too anxious (P2) or feeling under-prepared (P6). All other 
participants found the book easy to read and also completed the BAT. 
All participants said they would recommend the workbook to others. 
The majority of participants found the present-moment awareness 
phase the most influential/useful, with P3 and P4 also stating that 
they found the values phase equally influential. Two thirds of 
participants stated that they noticed an increase in their acceptance 
of distressing private events associated with public speaking, whilst 
the remaining two participants noted either a decrease in their 
avoidance of public speaking (P4), or a reduction in anxiety 
associated with public speaking (P6). Four participants attributed this 
change to the workbook, whilst two participants were unsure whether 
the workbook was responsible (P1 and P6). In all but one case (P5), 
changes in PSA were deemed to have been important to the 
participant. Only two participants gave external 
speeches/presentations during the life of the study (P1, and P5), and 
only two participants reported possibly influential life events during 
the study (P5; raising a new-born child and P6; passing a series of 
exams). All participants found the weekly therapist support useful. 
[See Extended Paper 3.6 for a summary of results for each 
participant] 
 
 
 
 
 
 
Page 86 of 259 
 
Discussion 
 
This study investigated whether a self-help ACT intervention (1) 
reduced PSA (and the possible mechanisms involved), (2) reduced 
distress and avoidance, whilst increasing willingness to approach an 
imagined public speaking scenario, (3) led to an increase in 
psychological flexibility that preceded reductions in PSA, (4) 
facilitated the willing completion of a speech BAT, and (5) altered 
implicit responses towards public speaking stimuli.  
Reductions occurred in the primary measure of PSA (SSPS-N) for all 
participants by the end of the intervention, however, these changes 
were only deemed reliable in three cases and clinically significant in 
two, according to Jacobson and Truax's (1991) RCI and CSC criteria. 
The majority of participants (four), however, showed reductions in 
avoidance, and an increase in their willingness to approach their 
idiographic feared public speaking scenario. These participants also 
chose to complete a final speech BAT, and all received observer 
ratings above the average for individuals with PSA (Harb et al., 2003; 
indicating less anxiety). Two participants reported that they found the 
workbook hard to understand, and they were the only participants 
who chose not to complete the BAT. However, both of these cases 
demonstrated increases in psychological flexibility as measured by a 
moderate to high treatment effect size. This suggests that for these 
two participants, increases in psychological flexibility did not lead to 
an increase in willingness to engage in public speaking, and that they 
may have benefited from a more direct therapeutic approach, to 
facilitate understanding and behavioural change. However, as both of 
these participants found the workbook hard to understand, the 
increase in psychological flexibility in these cases, may reflect 
socialisation to the ACT model (e.g., the use of ‘ACT language’), 
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rather than an indication that the intervention was having an effect or 
genuinely increasing psychological flexibility.  
The time-series data indicated that the treatment was moderately to 
highly effective for the majority of cases in increasing psychological 
flexibility, as measured by the daily measures (excluding P1). Visual 
analysis and the qualitative information gathered from the change 
interview suggest that the ACT processes of mindfulness (self-as-
context, and present-moment awareness) and values (values and 
committed action) may be possible mechanisms of change that led to 
this increase in psychological flexibility, which preceded increases in 
willingness and reductions in PSA for the majority. 
Additionally, the evidence from the weekly measures suggest that all 
ACT processes may be important, as the participants who went on to 
complete the final speech BAT (with the exception of P5) experienced 
reliable shifts in either all (P1), or the majority (P3 and P4) of ACT 
processes that preceded, or occurred concurrently with increases in 
willingness, followed by reliable reductions in PSA. However, the 
majority of these shifts (when considering all the ACT processes) 
occurred during the mindfulness phases (self-as-context and present-
moment awareness), again indicating that the ACT process of 
mindfulness may be an important mechanism of change.  
Conversely, the participant who experienced the least change in PSA, 
and chose not to complete the BAT (P2), also experienced little 
change in (weekly) ACT processes. Thus, this indicates that shifts in 
all ACT processes appear to be influential in increasing willingness to 
approach public speaking tasks, and reducing self-reported negative 
thoughts associated with public speaking, for those who went on to 
complete the BAT. 
[See Extended Paper 4.1 for a discussion on participants five and six] 
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Participants’ implicit anxiety associated with public speaking, either 
remained largely unchanged, or increased. However, the largest 
reduction in implicit anxiety was seen in the case where the 
intervention produced the largest effect (P4; .97). This may be due to 
a number of hypotheses: (1) treatment must be highly effective to 
result in implicit change, (2) implicit responses do not need to alter to 
result in increased willingness to engage in public speaking, (3) the 
treatment was not effective in altering underlying/residual PSA for all, 
(4) the IRAP used in the current study was not sensitive enough to 
measure change and requires calibration, (5) ACT may not result in 
immediate implicit change, but change may occur over time, or (6) 
the results reflect the goal of ACT; to produce behavioural change 
without altering distressing private events.  
[See Extended Paper 4.2 for a discussion on the IRAP findings, and 
recommendations for its use in future research] 
In line with findings from previous studies investigating ACT to treat 
PSA (e.g., Block, 2002; Block & Wulfert, 2000; Eifert et al., 2009), 
we found that the ACT intervention appeared to reduce avoidance, 
and increase willingness to engage in public speaking. Although 
reliable and clinically significant reductions in anxiety associated with 
public speaking were not observed in all cases, our findings appear to 
reflect previous findings, that public speaking behaviour can increase 
in the absence of large decreases in anxiety (e.g., Block & Wulfert, 
2000; England et al., 2012). Given the focus of ACT on altering the 
function, rather than the form of private events (Hayes & Strosahl, 
2004), this may explain why only two cases recorded clinically 
significant reductions in anxiety, but two thirds chose to complete the 
speech BAT. Moreover, the measure used to capture reductions in 
PSA in the current study (SSPS-N) was created within Clark and 
Wells's (1995) cognitive framework of social anxiety, which views 
reductions in negative self-statements as an ameliorative sign 
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(Hofmann & Dibartolo, 2000). However, reducing such statements is 
not the aim of ACT, as the ACT model predicts that increases in 
willingness/engagement either precede or are independent of shift in 
anxiety. Hence, a measure more sensitive to functional change may 
have resulted in more cases reaching clinical significance. 
Nevertheless, although reductions in PSA were not all seen as 
‘clinically significant’, all participants’ scores on this measure reduced, 
and all but one participant reported that the changes they noticed in 
their PSA had been personally important. 
 
[See Extended Paper 4.3 for a further discussion on the findings in 
the context of extant research and theory] 
 
Strengths and Limitations 
 
The multiple baseline design used in the current study strengthens 
inferences made regarding treatment effectiveness, as all participants 
demonstrated stable or declining levels of psychological flexibility 
during the pre-treatment baseline phase. All participants also began 
the intervention stage at different times, thus reducing threats to 
internal validity (Barlow, Nock, & Hersen, 2008; such as history, or 
maturation). The study design also allowed for both quantitative and 
qualitative data to be considered in parallel, when making inferences 
regarding the possible mediating processes involved in ACT to treat 
PSA (self-as-context, present-moment awareness, values and 
committed action), however, only tentative support can be given for 
this hypothesis at this stage. Moreover, as most participants 
(excluding P5) who completed the BAT also experienced reliable 
changes in ACT processes, in addition to measures of present-
moment-awareness, and values, it seems that all ACT processes may 
play a mediatory role. However, as two participants experienced an 
increase in psychological flexibility, in the absence of changes in 
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committed action outcomes (e.g., willingness and BAT engagement), 
this weakens the notion that ACT processes are responsible for 
changes in PSA. Moreover, this finding also indicates that the ACT 
intervention was ineffective for a third of participants. This suggests 
that further research is needed to investigate whether ACT is a 
genuinely effective alternative treatment to existing treatments (e.g., 
as opposed to CBT) for individual’s with PSA, and (2) which 
individuals may or may not respond to this form of therapy.  
 
Hence, it is possible that increases in psychological flexibility (seen at 
the end of the intervention) may have been the result of the 
establishment of a therapeutic relationship between participant and 
researcher. However, the temporal precedence of ACT process 
change prior to increases in willingness, followed by reductions in PSA 
for the majority of those who completed the BAT, indicates a 
treatment effect/mediatory relationship for those who engaged with 
the workbook. 
 
Although the majority of participants did not engage in external 
public speaking tasks during the study, two participants who chose to 
complete the final speech BAT did (one of whom received the highest 
observer rating score). This indicates that exposure to the feared 
stimuli, rather than the ACT intervention, may have resulted in an 
increase in willingness, and a reduction in anxiety in these cases. 
Although it can be inferred that the ACT intervention was not the 
most influential independent variable in this instance, the ACT 
intervention may have (1) increased the participant’s willingness to 
engage in public speaking tasks, and (2) enabled the participant to 
habituate successfully during exposure (as a consequence of the 
development of present-moment awareness). Thus, in these cases, 
the ACT intervention may have resulted in an increase in exposure to 
public speaking behaviour throughout the study, and the findings 
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may reflect the effects of a decrease in experiential avoidance, that 
facilitated this exposure.   
 
The study also only included a behavioural assessment of public 
speaking anxiety post-intervention, precluding the temporal 
assessment of willingness to approach in-vivo public speaking 
scenarios, and speech performance. However, as noted in the 
Methods section, such an inclusion may have acted as repeated 
exposure/confounding variable, thus contaminating the results. 
Nevertheless, all participants remarked at the beginning of the 
intervention that they would not have completed a baseline speech 
task, thereby strengthening inferences that the treatment resulted in 
this behavioural change for at least four participants. 
 
Finally, to reduce the burden on participants (especially considering 
the study included a final speech BAT) no follow-up was included in 
the current study. However, such an inclusion may have allowed us 
to investigate whether improvements in psychological flexibility 
continued post-intervention, and resulted in further public speaking 
behaviour change (both explicit and implicit).  
 
[See Extended Paper 4.4 for a further discussion on the strengths and 
limitations of the study]  
 
Conclusion 
 
A non-concurrent single-case experimental design investigating the 
effects of an ACT self-help intervention to treat PSA was presented. 
The findings offer partial support for the use of ACT, in a self-help 
format, to treat PSA. Although only tentative support can be given to 
ACT for PSA at this stage, services may consider how offering 
patients with such difficulties ACT self-help material in the first 
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instance, prior to offering direct therapeutic support may be beneficial 
for those who do not seek treatment if this requires clinic attendance 
(Bebbington et al., 2000), or for those who find traditional forms of 
CBT exposure therapy too anxiety provoking (Dalrymple & Herbert, 
2007). Such an approach may also reduce the cost of treating PSA, 
and provide an accessible intervention for individuals who may be at 
risk of developing a more general form of social phobia if left 
untreated (Craske, 1999).  
 
Triangulation of the time series, weekly ACT processes and qualitative 
findings indicate that mindfulness may be a key mechanism of 
change in ACT. However, the weekly process measures also 
highlights that all ACT processes may play a role in increasing 
willingness to approach public speaking. As such, clinicians should 
ensure that ACT treatment for PSA encapsulates all core elements; 
however, the development of mindfulness skills may be particularly 
important for those with PSA. As such, future research may be useful 
in determining whether the inclusion of mindfulness-based practice 
increases the effectiveness of traditional exposure-based treatments 
for PSA (such as CBT), or whether mindfulness is most effective when 
part of a wider ACT intervention. 
 
As our data indicate, some individuals may require additional support 
to approach public speaking situations, even after undergoing the 
self-help intervention; nevertheless, for these individuals, such 
further intervention may only require a ‘light-touch’ approach to 
consolidate new learning, and to encourage in-vivo application.  
 
[See Extended Paper 4.5 for a further discussion on the clinical 
implications of the findings] 
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Future Research 
 
This study offers partial support for the use of ACT to treat PSA. As 
such, future research in this area may strengthen support for its use 
by investigating the long-term effects on both self-rated and 
observer-rated anxiety/speech performance by employing a follow-up 
design. This research should include a gender-balanced sample and a 
varied age range to allow for greater generalisability. Research should 
also continue to consider the mechanisms of change involved in ACT 
for anxiety disorders, such as PSA. Given that present-moment 
awareness/mindfulness appeared to be an influential mechanism of 
change reported in our quantitative (time-series, weekly, and battery 
measures) and qualitative findings (change interview), and a recent 
study found that mindfulness may be the most influential process 
when treating SAD related disorders (Kocovski, Fleming, Hawley, 
Ringo Ho, & Antony, 2015); future research should seek to 
investigate whether (1) mindfulness is indeed an important 
mechanism in treating SAD difficulties such as PSA, and (2) why 
mindfulness may lead to ameliorative change. This may be possible 
with the further use of SCEDs designed to investigate the temporal 
effects of delivering ACT in differing sequences to investigate whether 
an immediate treatment effect occurs for those who undergo present-
moment awareness related interventions first. Finally, further 
research in this field should continue to use implicit measures to 
investigate the effects that psychotherapeutic interventions have on 
underlying implicit beliefs, whether implicit beliefs predict behavioural 
change, and whether these truly need to alter in order for treatment 
to be considered effective.   
 
[See Extended Paper 4.6 for a further discussion on future research]  
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[See Extended Paper 5. for a critical reflection on the research 
process] 
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1. Extended Background 
 
1.1 Epidemiology and Impact of Public Speaking Anxiety 
 
Although public speaking is a common fear in the general population, 
around 31-34% of individuals experience substantial PSA when 
preparing or delivering a speech (Stein, Walker, & Forde, 1996; 
Stein, Walker, & Forde, 1994). The onset for PSA typically occurs 
between the age of 13 to 20 (Stein et al., 1996), similar to the age of 
onset of social anxiety disorder in clinical samples (Amies, Gelder, & 
Shaw, 1983; Ruscio et al., 2008; Solyom, Ledwidge, & Solyom, 
1986), and appears to be most common in women (71.9%; Stein et 
al., 1996). Those with PSA are less likely to receive post-high school 
education, are more likely to be unemployed, and are more likely to 
have a lower personal income, than individuals without significant 
public speaking anxiety (Stein et al., 1996). 
Those with PSA often report fearful cognitions relating to 
embarrassing one’s self, one’s mind going blank, not being able to 
continue talking, and/or displaying explicit signs of physiological 
discomfort (Stein et al., 1996). Again, such cognitions are also 
prototypical of individuals with wider social anxiety disorder (Clark & 
Wells, 1995). Those with PSA also experience a number of distressing 
physiological symptoms when anticipating, or during a speech (such 
as palpitations, muscle tension, confusion, and gastrointestinal 
discomfort) (Harris, Kemmerling, & North, 2002). To avoid such 
discomfort, those with PSA often engage in avoidant strategies in 
anticipation of public speaking (Tillfors & Furmark, 2007). This 
avoidant behaviour may explain why PSA is associated with higher 
rates of unemployment and the reduced likelihood of continued 
education (England et al., 2012). 
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According to epidemiological data, around 10% of individuals with 
PSA (in the general population) fulfil the Diagnostic Statistical Manual 
of Mental Disorders (DSM-4; American Psychiatric Association, 1994) 
criteria for social anxiety disorder, due to their levels of distress and 
reduced functional ability (Stein et al., 1996). Since the 
aforementioned epidemiological study was conducted, however, the 
DSM-4 has been updated (DSM - 5; American Psychiatric Association, 
2013) and now advises that a diagnosis of social anxiety disorder 
(non-generalised) can be given to individuals with specific 
performance fears, such as a fear of public speaking. Hence, it is 
likely that more than 10% of individuals with PSA would reach clinical 
levels of social anxiety, by modern standards of diagnosis.  
Individuals with PSA often report that their speech anxiety is 
responsible for a number of social and occupational difficulties. For 
example, people with PSA reported that their distress related to 
public speaking often interfered with their education, made it difficult 
to find a job (or advance their career,) and/or caused a marked 
interference with their normal social activities (Stein et al., 1996). 
Models of occupational stress and wellbeing indicate that an individual 
with severe PSA may be at risk of reduced wellbeing and therefore of 
developing further psychological difficulties. For example, the Job 
Demand-Control model (JDC model; Karasek, 1979), suggests that 
stress and wellbeing (in the workplace) is mediated by the 
psychological demands caused by an individual’s job and their 
perceived control (see Figure 11).  
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Figure 11. Job demand control model  
This model indicates that when an individual experiences high 
psychological demands, but their level of perceived control is also 
high, they are likely to develop skills/learn (B). However, if an 
individual experiences high psychological demands, but their level of 
perceived control is low, then an individual is likely to experience high 
levels of psychological and physiological strain (B) (Van der Doef & 
Maes, 1999) (Figure 9). A review of studies investigating the JDC 
model revealed it is empirically well supported (Van der Doef & Maes, 
1999), and that job demand and control shows several interactional 
effects with well-being and health (De Jonge, Dollard, Dormann, Le 
Blanc, & Houtman, 2000). 
As individual’s with PSA often believe others are negatively evaluating 
them, they are performing badly, and that they are going to 
embarrass themselves (Clark & Wells, 1995), they are likely to 
experience distressing physiological sensations, with which they may 
become pre-occupied with when contemplating or delivering a speech 
(Wells, 1997). Hence, according to the JDC model, someone with PSA 
may feel a high level of strain, if their job entails speaking with 
groups of people or delivering information in presentation/public 
speaking formats; due to the psychological and physiological 
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demands of the task, and their perceived lack of control. The JDC 
model may therefore explain why those with PSA are more likely to 
be unemployed, or struggle to advance their career (Aderka et al., 
2012; Stein, Walker, & Forde, 1996). Moreover, levels of anxiety and 
depression have been found to increase linearly along with increasing 
demands, strain, and reduced control (Sanne, Mykletun, Dahl, Moen, 
& Tell, 2005). This suggests that someone with PSA may be at risk of 
developing further mental health problems (if their job requires the 
completion of public speaking related tasks), or reduced well-being 
(as a consequence of avoiding desired/values-based career paths, if 
such paths involve public speaking).  
 
1.2 Theories and Treatment of Public Speaking Anxiety 
 
1.2.1 Cognitive Theory  
 
From a cognitive perspective, phobias such as PSA arise and are 
maintained by the beliefs an individual holds regarding the object of 
fear (here, public speaking situations; Clark & Wells, 1995). These 
beliefs are shaped by the individual’s developmental experiences 
(Beck, 1976). Wells (1997) suggested that three categories of belief 
content (schema content) play an integral role in SAD, and thus PSA. 
These are; (1) beliefs regarding the self (core-beliefs; e.g., “I am 
incompetent”), (2) conditional assumptions (e.g., “If they see I’m 
nervous, they’ll think I’m stupid”), and (3) rigid rules for social 
performance (e.g., “I must pronounce each word perfectly to be 
taken seriously”). Hence, public speaking situations are perceived as 
dangerous. On contemplating, or entering such situations, an 
individual’s negative automatic thoughts activate distressing somatic 
symptoms (e.g., heart racing) which the individual interprets as 
further evidence that they are failing to perform (Clark & Wells, 
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1995). The individual becomes pre-occupied with their somatic 
responses, resulting in a shift in their focus of attention towards 
internal events. As such, individuals with PSA interpret how others 
see them based on these distressing physiological symptoms 
(interoception). Furthermore, this ‘self-focus’ of attention prevents 
the individual from being exposed to evidence that counters their 
unhelpful beliefs (e.g., an interested audience).  
Individuals with social phobias, such as PSA, also engage in 
behaviours designed to reduce their anxiety (safety behaviours), 
however, such behaviours often have a paradoxical effect and act to 
increase an individual’s anxious sensations (e.g., speaking quickly, 
results in breathlessness). Similarly to self-focus, safety behaviours, 
especially avoidance of public speaking altogether, can also prevent 
ameliorative experiences. Figure 12 provides an example of how PSA 
occurs and is maintained using Clark and Wells’ (1995) model.  
 
Figure 12. Cognitive model of public speaking anxiety 
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1.2.2 Cognitive Treatment 
 
Treatment from a cognitive perspective seeks to restructure the 
patient’s unhelpful cognitions by using thought challenging techniques 
(e.g., reviewing the factual evidence to support or refute unhelpful 
beliefs) and behavioural experiments (Wells, 1997). For example, 
someone who fears being ridiculed for not speaking perfectly, may be 
encouraged to mispronounce selected words during a speech, and 
then observe the reaction of others. Such experiments often provide 
the client with evidence against their feared outcome (e.g., people 
did not seem to notice), thus reducing the strength of their unhelpful 
beliefs, and therefore their anxiety in future public speaking 
scenarios.  
As successful disconfirmation of an individual’s negative appraisals is 
moderated by attentional and behavioural responses during in-vivo 
behavioural experiments (Wells, 1997), clients are encouraged to 
reduce their safety behaviours and self-focus of attention, and attend 
to external stimuli, during behavioural reattribution tasks (Wells, 
1997). Treatment finally focuses on challenging the individual’s 
unhelpful core conditional assumptions, regarding social situations, by 
supporting the generation of counter evidence (e.g., a pie-chart 
demonstrating a number of alternative explanations for someone 
trembling, to test the assumption, “if people see me shaking, they’ll 
think I’m stupid”). 
 1.2.3 Behavioural Theory 
 
Behavioural theory posits that phobias, such as PSA, occur through a 
dual process of classical (Pavlov, 1927) and operant conditioning 
(Mowrer, 1947; Skinner, 1974). In the case of PSA, one may 
associate public speaking stimuli with an aversive consequence (e.g., 
distressing physiological reactions) following a negative event (e.g., 
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freezing on stage). Future avoidance of such stimuli is (negatively) 
reinforcing (Mowrer, 1947), and therefore, further public speaking 
scenarios are avoided. This reduces the likelihood that a learning 
experience will take place to counter this association, thus 
maintaining PSA.  
1.2.4 Behavioural Treatment 
 
Although treatment of PSA often includes interventions informed by 
cognitive and behavioural theories (CBT; Allen, Hunter, & Donohue, 
1989), behavioural treatment alone has been shown to be as 
effective as CBT when used to treat social phobias (Feske & 
Chambless, 1995). 
Behavioural treatment of anxiety often takes the form of an exposure 
intervention, whereby the patient is exposed to the phobic stimuli for 
a prolonged period of time, until their anxiety reduces and they learn 
that the stimuli is not dangerous (habituation; Foa & Kozak, 1986). 
This treatment can be delivered during one session (2.1 hours; Ost, 
1989) and is referred to as ‘flooding’. However, as such a treatment 
can be initially too distressing for the patient (Orsillo et al., 2005), 
modern behaviourally informed treatments for phobia’s often take the 
form of ‘systematic desensitisation’ (McGlynn, Smitherman, & 
Gothard, 2004). In this approach, originally developed by Wolpe 
(1958), the patient establishes a hierarchy of anxiety provoking 
stimuli/situations (e.g., imagining giving a speech, up to, an in-vivo 
speech), and is then supported in exposure tasks related to this 
hierarchy (from low-anxiety stimuli, to high), in a stepwise fashion.  
Systematic desensitisation has been shown to be effective in treating 
PSA (Kirsch & Henry, 1979); with more recent research 
demonstrating the efficacy of this intervention delivered using virtual 
reality technology, designed to gradually immures the patient in 
increasingly anxiety provoking virtual public speaking environments 
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(Anderson et al., 2013; Harris et al., 2002; Safir, Wallach, & Bar-Zvi, 
2012; Wallach, Safir, & Bar-Zvi, 2009).  
 1.2.5 Learning / Skills Acquisition Theory 
 
Both cognitive and behavioural treatments rely on the notion that 
those with PSA possess the requisite skills to ‘perform’ during a 
speech task, once their anxiety has been alleviated (Fremouw & 
Zitter, 1978). However, research has demonstrated that teaching 
anxious individuals skills in public speaking, acts to reduce their 
anxiety during public speaking situations (e.g., Fawcett & Miller, 
1975), suggesting PSA is the result of a lack of skills in effective 
communication/speech. Hence, as supported by social learning theory 
(Bandura, 1963), a person develops PSA as the skills needed to 
complete speech tasks have never been learnt through the processes 
of live, verbal (instructional), or symbolic (e.g., skills guide) 
modelling.  
 1.2.6 Skills Acquisitions Training 
 
Treatment therefore involves developing the phobic individual’s skills 
in public speaking through modelling, behavioural rehearsal, and 
videotape feedback on speech tasks of increasing complexity 
(Fremouw & Zitter, 1978). Although shown to be an effective 
treatment for PSA (Wright, 1976), Fremouw and Zitter (1978) 
suggest that skills training is most effective in treating PSA when 
combined with cognitive restructuring. Moreover, as skills training 
involves exposing the individual to public speaking tasks during 
treatment, it is possible that the mechanism of change in such a 
treatment also includes exposure, as described above.  
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1.3 Acceptance and Commitment Therapy (ACT) and Public 
Speaking Anxiety 
 
The following section presents the underpinning theory of ACT; 
Relational Frame Theory, and how this theory has shaped the 
therapeutic process of ACT. ACT is discussed in relation to public 
speaking anxiety, and a rationale for its use with this population is 
described.  
1.3.1 Relational Frame Theory 
 
ACT is grounded in Relational Frame Theory (RFT; Hayes, Barnes-
Holmes, & Roche, 2001), a theory of human language acquisition and 
cognition developed through functional contextual (see 
epistemological section in extended methodology) behavioural 
research (Hayes & Strosahl, 2004). A key goal of ACT is to target the 
processes of language that have been shown to directly control 
human behaviour, through the application of six core therapeutic 
techniques (described in section 5.6).  
The core notion of RFT is that humans learn to relate events under 
arbitrary contextual control. For example, complex non-human 
organisms hold the ability to choose the larger of two randomly 
selected objects (non-arbitrary relations). However, humans are the 
only mammal with the ability to bring such responding under 
contextual control, and apply this process to events unrelated in a 
concrete/formal sense (Hayes & Strosahl, 2004). These relational 
responses are ‘arbitrarily applicable’. In other words, these responses 
can be socially-determined. For example, a young child may learn 
that “X” is larger than “Y”, and apply the words “larger than” to other 
situations e.g., a two pence piece is larger than a five pence piece 
(e.g., related to the physical size of objects). However, a slightly 
older child will learned that a five pence piece is larger than a two 
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pence piece by social attribution (e.g., the five pence piece’s socially-
determined arbitrary value).  
According to RFT, behaviour is considered to be verbal if it holds (1) 
mutual entailment, (2) combinatorial entailment, and (3) 
transformation of stimulus functional properties.  
 Mutual entailment - If an individual learns that A relates to B in 
a certain context, then this entails a relationship between B and 
A in that context (e.g., if one learns that the thought “I’m 
scared” is a cause for “running away”, one derives that 
“running away is an effect of the thought “I’m scared”; 
Blackledge, 2003).  
 
 Combinatorial entailment - multiple mutual entailments can 
combine. For example, if (in a given context) A is related to B, 
and B is related to C, then one can derive that A and C are 
mutually related (in that given context) (Hayes et al., 2001). 
Or, in another example, if one learns (in a given context) that a 
Huntsman spider is bigger than a Black Widow spider, and a 
Tarantula is bigger than a Huntsman spider, then one will 
derive that a Black Widow spider is smaller than a Tarantula.  
 
 Transformation of stimulus function – making relational 
responses between stimuli results in a transformation of 
stimulus function for all the stimuli involved (Blackledge, 2003). 
Using the previous example, a transformation of stimulus 
function would occur if someone with a fear of spiders who 
previously perceived large spiders to be the most dangerous, 
learnt that a Tarantula is less venomous than a Huntsman, but 
a Huntsman is less venomous than a Black Widow. In this 
example, it will be derived that the smallest spider (Black 
Widow) is now more dangerous than the biggest spider 
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(Tarantula), and therefore the smallest spider becomes the 
most feared (transformation of stimulus function) without the 
need for a direct learning experience.   
The above three properties combine to produce a ‘relational frame’. 
Relational framing is considered to be the basis for human language 
and thought (Hayes, 1989). 
1.3.2 RFT and Psychopathology 
 
This theory is clinically relevant because the relational networks 
developed over time influence an individual’s behaviour through the 
process of derived relations. For example, a child may experience 
distress, fear and anxiety after being trapped in a lift. In the future, 
that fear may transform the function of situations where the 
individual may feel “trapped”, such as in a job or relationship. Hence, 
these relational networks have the potential to cause psychological 
distress. RFT guided therapy (ACT) therefore targets these relational 
networks during psychotherapy, however, as relational networks 
work ‘by addition, rather than subtraction’ (Hayes & Strosahl, 2004), 
the aim of ACT is not to eradicate well-conditioned verbal relations, 
but to alter their behavioural function (Hayes & Strosahl, 2004). 
Moreover, from an RFT/ACT perspective, it is an individual’s attempts 
to control or reduce negative or distressing relational frames that 
results in psychopathology. 
Relational networks allow humans to solve problems, and plan for the 
future. In this sense, language has a repertoire broadening effect 
(Hayes & Strosahl, 2004). However, language also has a narrowing 
effect on behaviour, often when used in excess (e.g., 
thought/rumination). From an RFT/ACT perspective, psychopathology 
is therefore the result of the narrowing effects of language, and 
results in psychological inflexibility (the inability to change ones 
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behaviour, even when it is unhelpful/distressing) as a result of 
cognitive fusion and experiential avoidance.   
1.3.3 Cognitive Fusion 
 
Cognitive fusion is an individual’s ‘fused’ interaction with their 
thoughts. Someone who treats an event and their thinking about that 
event as the same thing, is considered to be ‘fused’ with their 
thoughts, and as such, their thoughts have the ability to alter their 
behaviour. For example, a ‘fused’ person’s thoughts about 
underperforming during a future speech, are about how they perceive 
they will actually perform, rather than being perceived as a cognitive 
process in the present. Therefore, this person may act in a manner to 
avoid this future performance, by avoiding the situation altogether. 
This is therapeutically relevant, as cognitive fusion has a narrowing 
behavioural effect, insofar as an individual has a tendency to act in 
accordance with their verbal relations (e.g., “I will fail my 
presentation”) and the event (e.g., the presentation), which often 
strengthens negative relational frames. In other words, an individual 
who is fused with their cognitions is controlled by their relational 
frames in a way that confirms them (Hayes & Strosahl, 2004).  
The notion that an individual’s thoughts affect their behaviour is a 
key principle of existing CBT models of psychopathology (e.g., Beck, 
1976; Clark & Wells, 1995; Wells, 1997), and as such, thoughts are 
often targeted for re-attribution, as they are considered to be 
unhelpful and/or irrational (Wells, 1997). From an ACT perspective, 
however, such an intervention may cause further distress, as this 
intervention implies that such thoughts must be controlled. ACT 
conceptualisation would predict that the more an individual tries to 
control such thoughts, the more fused they become with them 
(Hayes, Strosahl, Bunting, & Twohig, 2004). 
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1.3.4 Experiential Avoidance 
 
The second contributor to psychological inflexibility, and therefore, 
psychopathology, is experiential avoidance. This relates to an 
individual’s attempts to avoid distressing private events (suppression: 
thoughts, emotions, images, memories etc.) and/or situations 
(situational escape or avoidance), even if this results in psychological 
distress (Hayes, Wilson, Gifford, Follette, & Strosahl, 1996). For 
example, a socially anxious individual may attempt to avoid the 
worries, emotions, and physiological sensations that speaking in front 
of others cause, by avoiding contexts where groups of people may be 
present. However, such avoidance may result in poor interpersonal 
relationships (Antony, Roth, Swinson, Huta, & Devins, 1998) and 
impairment across the lifespan in social domains (Hayes et al., 2004).  
As the private events of an individual with PSA prior to, or during a 
speech, often cause distress, avoidance of such private events is 
likely to occur (for example, telling the self “If I don’t think about the 
speech or my racing heart, then I will feel better”). However, 
evidence suggests that attempts to suppress/avoid private events 
serve to intensify unwanted thoughts (e.g. Abramowitz, Tolin, & 
Street, 2001; Wenzlaff & Wegner, 2000), and can reduce the 
effectiveness of exposure based interventions (Feldner, Zvolensky, 
Eifert, & Spira, 2003). Experiential avoidance (sometimes referred to 
as ‘cognitive avoidance’ in this context) may account for why around 
25% of individuals with social anxiety related difficulties, such as 
PSA, fail to respond to exposure based therapy (Dalrymple & Herbert, 
2007), and continue to remain functionally impaired (Orsillo et al., 
2005).  
From an RFT/ACT perspective, such suppression and avoidance 
increases distress, as this behaviour prompts the feared private 
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event, since they inhabit/are based on the same relational frame 
(Hayes et al., 2004).  
1.3.5 ACT and Public Speaking Anxiety 
  
When applied to PSA, the principles of experiential avoidance and 
cognitive fusion appear to explain why an individual’s PSA develops 
and is maintained. For example, an individual with PSA may be 
unwilling to experience the normal physiological symptoms of anxiety 
(e.g., increase in heart rate and temperature) and/or their private 
experiences (“I could forget my lines”) when contemplating a speech, 
because they believe such reactions are abnormal and should 
therefore be eradicated. The PSA sufferer’s attempts to stop or 
control such thoughts and reactions, however, have a paradoxical 
effect; as these ‘distracters’, become related with the individual’s 
unwanted thoughts, such that they remind the individual of their 
unwanted thoughts, which become increasingly diffuse. 
The individual may then attempt to lower their distress by engaging 
in psychological (e.g., rumination) and behavioural avoidance 
strategies (avoidance of the presentation). This emotional and 
situational avoidance may temporarily reduce the individual’s 
distress, as it is (negatively) reinforcing, however the continuation of 
this dual avoidance may lead to a constriction of the individual’s 
behavioural repertoire, resulting in a reduction in functioning, and 
well-being. Hence, this exacerbation of symptomology may 
potentially lead to the development of further mental health 
difficulties (e.g. generalised social anxiety) (Orsillo, Roemer, Block-
Lerner, LeJeune, & Herbert, 2004). 
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1.3.6 The Six ACT Processes in treating PSA 
 
Hence, ACT posits that increasing an individual’s psychological 
flexibility produces ameliorative change. Although the goal of ACT is 
not to reduce distress per se, (but rather encourage willingness to 
experience distressing private events and contexts, in the service of 
moving towards/acting in accordance with values), evidence suggests 
that ACT reduces self-reported, and behavioural measures of distress 
for a number of anxiety disorders (e.g., generlised anxiety disorder, 
panic disorder, social anxiety disorder etc; Sharp, 2012), and PSA 
specifically (Block & Wulfert, 2000; Block, 2002; England et al., 
2012; Kishita, Muto, Ohtsuki, & Barnes-Holmes, 2014). This 
reduction in distress may be a ‘secondary effect’ that occurs after the 
avoidance cycle is broken. Hence, such reductions in self-reported 
and behavioural measures of distress may reflect the individual’s 
increased contact with previously distressing situations and their 
acceptance of uncomfortable private events.  
It is worth noting here that ACT is a non-disorder specific model, and 
therefore the principles described above apply to all forms of 
psychological distress (Hayes, 2005). As such, the six core processes 
of ACT (Figure 13) are used to increase psychological flexibility for 
individuals in psychological distress (regardless of clinical or non-
clinical presentation). The following processes are therefore designed 
to aid exposure to previously avoided private events, and contexts, 
through the use of mindfulness based practices, willingness, and 
behaviour change through value-directed action.  
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Figure 13. Six ACT processes targeted during therapy to increase 
psychological flexibility (Hayes, Strosahl, & Wilson, 1999) 
  
 Acceptance – After the client is made aware of the paradoxical 
effect that their desire to control their distress has on their 
psychological well-being, they are encouraged to take an 
accepting stance. The person is therefore encouraged to 
embrace their awareness of their physiological sensations, 
emotions, and thoughts as they arise in the moment. Graded 
exercises are used to show the individual that they can 
Page 124 of 259 
 
experience previously avoided experiences without coming to 
harm. 
 
 Defusion – This element of ACT seeks to alter the context in 
which distressing private events occur. As such, cognitive 
defusion interventions are aimed at encouraging the individual 
to view their thoughts, emotions, memories etc., as processes 
of relating, rather than the result of that process (e.g., a 
thought is just a thought, it is not inherently toxic). This is 
achieved by a number of experiential exercises designed to 
allow the individual to view their private events (e.g., thoughts) 
as processes in the moment, rather than distressing thoughts 
to be controlled (e.g., Titchener’s repetition – the client is 
encouraged to repeat a distressing thought until the words lose 
meaning).  
 
 Self-as-Context (or self as process) – In order to aid 
acceptance and defusion, the client is encouraged to 
differentiate between the content of their private experiences 
and the context in which they occur. In other words, a 
distinction between ‘a thought, and the thinker’. 
 
 Present-Moment Awareness (or mindfulness) – Individuals are 
taught to notice their surroundings, bodily sensations, and 
private events in the moment, without the influence of thoughts 
regarding the past or future. Clients are also encouraged to 
label their experiences in the moment (e.g., “now I am feeling 
tense”). Contact with the present-moment entails training in 
mindfulness based practice, and supports the other processes 
of defusion, acceptance, and self as context (Hayes et al., 
2004). Present-moment awareness is also encouraged during 
exposure interventions (to previously feared situations and/or 
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private events) to reduce the individual’s entanglement with 
their private experiences, and to teach the client that anxiety is 
not a ‘bad’ experience that has to be removed. 
 
 Values – To support the individual with addressing their 
experiential avoidance, they are encouraged to consider what 
they want their life to stand for in different areas (e.g., family, 
career etc.,) in order to orient them to their desired direction in 
life. In ACT, goals are considered as temporary targets, 
whereas, ‘valued behaviour’ is considered a long-term value 
driven behaviour change. For example, a person with PSA may 
have the value of continual career progression, however, their 
avoidance of private events and situations related to public 
speaking may be preventing this. The person’s values are 
therefore used as a rationale for engaging in exposure to these 
distressing experiences in order to achieve a valued life.  
 
 Committed Action – Once the individual has identified their 
values, and realised that they may not be attending to them 
due to cognitive fusion and experiential avoidance, they are 
encouraged to make goals in the areas of their ‘valued path’. 
For example, the individual with PSA may set the goal of 
speaking up during a meeting, whilst engaging in willingness to 
experience their anxious physiological sensations and private 
events (whilst also using acceptance and mindfulness processes 
to support this exposure).   
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1.3.7 Critique and Application to PSA 
 
ACT purports to be different from therapies such as CBT, as it does 
not seek to alter the form of the patient’s distressing private events 
(which is seen as damaging from an ACT perspective) but rather the 
context in which they occur (Hayes et al., 2004). Hence, from an RFT 
perspective the focus on change through the development of rules in 
CBT (e.g., “this way of thinking is counterproductive, so must be 
changed”) causes an increase in distress, as such conversations 
activate previously developed relational frames (Hayes et al., 2004). 
Rule governed behaviour is therefore often seen as damaging from an 
ACT perspective; however, taking an approach that does not 
encourage rule-governed behaviour (e.g., “don’t battle with your 
thoughts, be willing to accept them”), may paradoxically develop a 
set of behavioural rules for the client (e.g., I must not fight my 
anxiety”). According to RFT itself, one cannot engage in a 
conversation without relational networks being activated, and 
therefore, again, conversations around willingness and relinquishing 
control, may produce damaging private event (e.g., “I mustn’t think 
that I can’t be anxious”). In other words, using language during 
therapy to undo the damage of language, may be damaging in itself.  
Although this may be the case, a benefit of ACT to treat PSA may lie 
in its ability to support exposure interventions. As evidence suggests 
that exposure alone is as effective as CBT to treat social anxiety 
(Feske & Chambless, 1995) and the inclusion of cognitive elements 
produce no added benefit (Dobson & Khatri, 2000), then 
psychotherapy that is exposure based may be most efficacious in 
treating PSA. However, exposure based therapy alone is still 
ineffective for around a quarter of individuals who undertake such 
interventions (Dalrymple & Herbert, 2007). This may be due to the 
inability of the client to cope with their distress during exposure, 
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and/or their inability to fully experience the feared context, which has 
been shown to hinder habituation (Foa & Kozak, 1986).  
Hence, the focus of ACT on preparing and supporting the client to 
engage in exposure to previously feared situations and private events 
using mindfulness and acceptance based practice, combined with the 
emphasis on value-driven behaviour, may increase the willingness of 
individuals with PSA to engage in exposure tasks, and also enable 
them to benefit from such tasks. This makes ACT a potentially valid 
alternative to CBT or exposure based therapy for individual’s wishing 
to address their PSA.  
 
1.4 Efficacy of Self-help Interventions  
 
There is a growing evidence base for the efficacy of ACT in treating a 
number of conditions and client groups (Ost, 2008), however, the 
efficacy of ACT delivered in a self-help format has received less 
attention. 
The National Institute for Health and Care Excellence (NICE) defines 
‘self-help’ principally as a self-administered intervention, in which one 
uses evidence-based resources such as workbooks and manuals to 
treat a difficulty or disorder (NICE, 2004). Reviews of self-help 
psychological interventions, in a CBT format, indicate that both ‘pure’ 
self-help (without therapist support) and ‘guided’ self-help (with light 
therapist support) may be effective in treating disorders such as 
anxiety and depression (Coull & Morris, 2011; Newman, Szkodny, 
Llera, & Przeworski, 2011).  
Self-help psychological interventions for individuals with generalised 
and non-generalised SAD (such as PSA) have also been shown to be 
effective, when delivered with minimal therapist support (e.g., 
Furmark et al., 2009; Nordgreen et al., 2012). Such findings suggest 
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that guided and pure self-help may increase access to psychotherapy 
for a population who are typically reluctant to seek direct therapist 
support (Bebbington, Meltzer, et al., 2000; Nordgreen et al., 2012).  
 1.4.1 Self-help ACT  
 
Following the advent of third-wave cognitive-behavioural therapies, 
research has turned to investigating whether interventions such as 
ACT are effective in treating psychological difficulties when delivered 
in a self-help format (Cavanagh, Strauss, Forder, & Jones, 2014). In 
a meta-analysis of the extant literature, Cavanagh and colleagues 
(2014) evaluated the effectiveness of 15 studies employing 
mindfulness and acceptance based self-help interventions in reducing 
symptoms of depression and anxiety, and increasing levels of 
mindfulness and acceptance. Such interventions were found to result 
in significantly higher levels of acceptance and mindfulness and 
significantly lowers levels of depression and anxiety in clinical and 
non-clinical samples, when compared to control conditions. The 
average effect size was ‘small to medium’ (Cavanagh et al., 2014), 
suggesting acceptance and mindfulness can be learnt via self-help, 
and results in reductions in depression and anxiety; thus further 
supporting the notion that symptom outcomes may be mediated by 
changes in psychological flexibility (e.g., Wicksell, Olsson, & Hayes, 
2010).  
Self-help ACT interventions incorporating guided therapist support 
appear to yield a larger effect size compared to ‘pure’ self-help ACT 
interventions (Cavanagh et al., 2014), however, it is difficult to 
ascertain whether this is the result of a ‘higher dose’ effect, or the 
impact of the therapeutic relationship; a factor generally seen to 
increase treatment effectiveness (e.g., Lambert & Barley, 2001). 
As Cavanagh et al's (2014) review found a relationship between high 
levels of engagement and positive outcomes, the present study 
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ensured that engagement with the self-help workbook throughout the 
intervention was monitored, and supported, via weekly telephone 
support. The review above also suggested that future research should 
investigate the mediating role of ACT processes on symptom 
outcomes (Cavanagh et al., 2014); Hence, the present study 
repeatedly measured ACT processes during the self-help intervention, 
as well as public speaking anxiety, to investigate the possible 
mediating factors involved.  
1.4.2 Self-help Psychological Interventions for PSA 
 
Little research has been conducted on the use of self-help 
psychological interventions for the treatment of PSA. In a review of 
psychological interventions for PSA (Priestley, Moghaddam, & 
Dawson, 2014), only two of the studies reviewed employed a self-
help intervention. Both studies found that internet-delivered CBT led 
to a reductions in self- and clinician-rated measures of PSA when 
compared to no treatment controls (Botella et al., 2010; Gallego, 
Emmelkamp, Van der Kooij, & Mees, 2011). Moreover, the self-help 
treatments were comparable to therapist-delivered CBT, with regard 
to treatment effect. Both studies, however, had significant 
methodological weaknesses, such as inconsistent recording of control 
groups and female biased samples (Priestley et al., 2014). Both 
studies also observed high attrition rates (45.8% and 51.6%), 
suggesting a lack of engagement and/or that the intervention was 
ineffective for a significant number of participants. Hence, further 
methodologically rigorous research is needed to reliably investigate 
the effectiveness of self-help psychological treatments for PSA 
(Priestley et al., 2014). 
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1.5 Implicit Measures and the Implicit Relational Assessment 
Procedure (IRAP) 
 
1.5.1 Implicit Cognition 
 
The majority of human cognition takes place automatically (and is 
inaccessible to awareness/attention) and influences social perception, 
actions, and judgements (Nosek, Hawkins, & Frazier, 2011). Such 
implicit cognitions can lead individuals to make potentially inaccurate 
predictions about the intentions or beliefs of others (Dawson, Barnes-
Holmes, Gresswell, Hart, & Gore, 2009). In the case of PSA, for 
example, an individual with the implicit belief that people will 
evaluate them negatively, may be hypervigilant to audience members 
who are looking down, or whispering to each other, and interpret this 
behaviour as confirmation of a poor speech performance. Conversely, 
an individual with an implicit belief that people are generally 
welcoming and interested, may perceive the same behaviour as a 
sign that the audience members are concentrating or are enthusiastic 
about what is being said, and interpret their performance as a 
success. Such beliefs are therefore of clinical relevance when treating 
PSA and measuring the impact of treatment.  
1.5.2 Measuring Implicit Attitudes/Beliefs 
 
Such influential implicit beliefs are often measured using self-reports 
(e.g., Hofmann & Dibartolo, 2000; Leary, 1983) and/or clinical 
interviews (e.g., Wells, 1997), however, there is considerable 
evidence to suggest that, due to a lack of awareness or to secondary 
cognitions that moderate reporting (e.g., sensitivity to therapist 
expectations), self-reports can be unreliable (De Jong, Pasman, 
Kindt, & Van Den Hout, 2001). Such methods also rely on an 
individual’s ability to introspect, however, even for the well-
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motivated, identification of implicit beliefs through such a method is 
difficult (Dermot Barnes-Holmes et al., 2006; Greenwald & Banaji, 
1995). Moreover, introspection of the self, may also be influenced by 
the same implicit beliefs that produce an illusory view of others 
(Nosek et al., 2011). Hence, measurements that do not rely on self-
reflections are useful for measuring the underlying mechanisms of 
social behaviour (Nosek et al., 2011). This does not mean self-
reported information is incorrect, but rather the use of implicit 
measurements may serve as a useful tool in the gathering of clinical 
information (to inform treatment and/or evaluate treatment 
outcomes) in combination with self-reported measures.   
 1.5.3 The Implicit Association Test (IAT) 
 
The most commonly used implicit measure is the Implicit Association 
Test (IAT; Greenwald & Banaji, 1995). The IAT measures implicit 
beliefs by recording the strength of an association between two 
concepts using response latencies. According to the IAT, when asked 
to respond under time pressure, individuals should respond more 
quickly to two concepts that are closely linked in memory, than to 
two concepts that are less closely associated. In the IAT, the 
participant is required to categorise stimuli as it appears on a 
computer screen. For example, in Greenwald, McGhee, and Schwartz' 
(1998) study using the IAT to measure racial attitudes, participants 
were asked to categorise names as either ‘black’ or ‘white’. In this 
case, the target concept was race, and the keys the participants 
chose were labelled ‘black’ and ‘white’. Participants were then asked 
to categorise a series of words as either ‘pleasant’ or ‘unpleasant’ 
(e.g., cheerful vs. violent). The core element of this experiment, was 
the combination of both these tasks. Here, the participants were 
finally asked to complete two final tasks. The first, participants were 
required to use the response key of black/pleasant and 
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white/unpleasant, followed by the reverse response key of 
Black/unpleasant and White/pleasant. The study found that 
participants were significantly faster at responding when required to 
link black/unpleasant and white/pleasant, when compared to 
black/pleasant and white/unpleasant. The study concluded that this 
quicker response indicated a white in-group bias (Greenwald et al., 
1998). 
 1.5.4 Implicit Measurement of Public Speaking Anxiety 
 
Implicit measurement has since been applied to clinical settings, and 
has been used to measure the construct of PSA, with encouraging 
results. Specifically, a number of researchers have found that implicit 
measures appear to predict behavioural responses to public speaking 
tasks (Egloff & Schmukle, 2002) and predict treatment success by 
indicating the likelihood of a ‘return of fear’ following intervention 
(Vasey, Harbaugh, Buffington, Jones, & Fazio, 2012).  
In the former study, Egloff and Schmukle (2002) found a strong 
association between those who responded quickly to an IAT linking 
anxiety to the self, with high levels of observable anxiety/distress 
during a public speaking task. The researchers concluded that implicit 
measures may predict behavioural indicators of anxiety, and may also 
predict ‘non-verbal behaviours’ that are not captured using self-
reports (Egloff & Schmukle, 2002).  
In the latter study, Vasey and colleagues (2012) used a post-
treatment implicit attitude towards public speaking test (the 
Personalised Implicit Association Test; PIAT) following an exposure 
intervention. The researchers found that the PIAT predicted a ‘return 
of fear’ in that participants who’s automatically activated attitudes 
remained negative following treatment, were found to have benefited 
the least from the intervention. In other words, they discovered that 
in order for the PSA treatment to be effective, the treatment must 
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alter an individual’s automatically activated/implicit attitudes toward 
the feared stimulus (in this case, public speaking). These findings 
indicate that (1) implicit measures account for a significant variance 
in Behavioural Approach Tasks (BATs)/speech performance beyond 
what is predicted by explicit measures, and (2) implicit measures 
appear to indicate whether psychological treatments for PSA are 
effective or not.   
Although such studies provide evidence for the use of implicit 
measures in clinical settings, and support their inclusion in future 
research investigating treatments for PSA, research employing the 
IAT methodology (and other such relativistic methods) to measure 
implicit attitudes should be treated with caution (Dawson et al., 
2009). This is because such measures are a relatively indirect way of 
assessing implicit attitudes/beliefs as they provide an index of 
associations that are assumed to be linked to certain beliefs (De 
Houwer, 2002). For example, in the previously mentioned IAT race 
study conducted by Greenwald and colleagues (1998) the results may 
indicate three possibilities: 
1. Participant’s preferred white people over black people 
2. Participant’s liked both races, but preferred white people 
3. Participant’s disliked both races, but disliked white people less 
than black people.  
To counter the lack of precision inherent in such relativistic measures, 
a number of non-relativistic measures have been created such as the 
Go/No-Go IAT (GNAT; Nosek & Banaji, 2001) and the Extrinsic 
Affective Simon Task (EAST; (De Houwer, 2003). 
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 1.5.5 The IRAP and the Present Study 
 
Since the development of the IAT, a number of implicit measures 
have been created that provide a more direct measure of implicit 
beliefs. One such measure is the Implicit Relational Assessment 
Procedure (IRAP; Barnes-Holmes et al., 2006). Grounded in relational 
frame theory; a modern theory of human language asserting that all 
thoughts/cognitions are relational (RFT; Hayes, Barnes-Holmes, & 
Roche, 2001), the IRAP requires individuals taking the computerised 
task to respond to a statement in a manner that is either true or 
false, as quickly and as accurately as possible (for example, “Public 
speaking – Makes me anxious”). Those taking the IRAP are required 
to complete sets of ‘consistent’ blocks (public speaking = makes me 
anxious) and ‘inconsistent’ blocks (public speaking = does not make 
me anxious). The first block is therefore consistent with the beliefs of 
a person who has PSA, and the second is inconsistent with the beliefs 
of a person who has PSA.  
In line with RFT, it is assumed that an individual’s responses will 
reflect their verbal/non-verbal history. As such, the most likely 
immediate response will be produced most often. Therefore, during 
consistent trials, an individual’s response is likely to be faster and 
more accurate, than an individual’s responses to an inconsistent trial. 
Like the IAT, response latencies from consistent vs. inconsistent trials 
are compared to provide an indication of implicit beliefs. The 
response time differential between these trials is thought to provide a 
nonrelative index of the strength of the implicit belief being 
measured. This immediate difference in responding is named the 
“IRAP effect” (Barnes-Holmes, Murphy, Barnes-Holmes, & Stewart, 
2011).  
A number of studies have demonstrated that the IRAP appears to 
measure an individual’s relational networks and, therefore, their 
Page 135 of 259 
 
implicit beliefs (e.g., Barnes-Holmes, Waldron, & Barnes-Holmes, 
2009; Vahey, Barnes-Holmes, Barnes-Holmes, & Stewart, 2010). A 
recent review of IRAP studies also noted that the IRAP is a reliable 
and pragmatically valid measure that may complement self-reports in 
predicting future behaviours (Golijani-Moghaddam, Hart, & Dawson, 
(2013). Moreover, evidence also indicates that it is harder for 
respondents to ‘fake’ their responses to the IRAP (McKenna, Barnes-
Holmes, Barnes-Holmes, & Stewart, 2007) when compared to other 
implicit measures such as the IAT (Kim & Kim, 2003).   
Importantly, this non-relativistic measure uses four trial types that 
allow for four specific beliefs to be assessed. In the present study, 
participants were presented with two categories, “Makes me Anxious” 
or “Doesn’t make me Anxious”, and two sets of target stimuli; images 
of public speaking scenarios, and images of non-public speaking 
scenarios (relaxing scenes). The IRAP presented both target stimuli 
with either label. Hence, four trial types were presented (see Figure 
14). The structure of the IRAP, therefore enabled each participant’s 
response to be measured over all trial types over the course of the 
ACT intervention.  
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Figure 14. The four IRAP trial-types used in the current study 
Note: The arrows denote the responses that were consistent and inconsistent for an individual with PSA. 
These were not visible on the screen during the task. If the participant chose a consistent response 
during a consistent trial block, and an inconsistent response during an inconsistent trial block, then the 
next trial was present in 400 milliseconds. Conversely, if the participant chose an inconsistent response 
during a consistent trial block, and a consistent response during an inconsistent trial block, an “X” 
appeared on the screen until the correct response was chosen.   
Only one study has investigated the IRAP as a clinical tool for 
measuring the effects of an ACT intervention on individuals with PSA. 
Kishita, Muto, Ohtsuki, and Barnes-Holmes (2014) measured the 
effects of an ACT intervention (cognitive defusion) on a number of 
self-reported and behavioural measures, as well as an anxiety IRAP. 
The study found that significantly more participants completed the 
speech task in the ACT group than the control group, however, no 
significant group difference was found with regard to the self-
reported measure of PSA. Significant reductions were found in 
response latencies on the IRAP in the experimental group only, 
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however, these reductions occurred in both consistent and 
inconsistent trial types. The researchers hypothesised that the results 
reflected that ‘narrow and inflexible’ responding (fusion) inhibits an 
individual’s ability to respond to both trial types, and therefore, a 
defusion intervention produced significant change in both trials, 
beyond a practice effect (Kishita et al., 2014).  
Such research indicates that defusion may reduce response biases on 
the IRAP. Such a finding is theoretically consistent with ACT, as 
treatment is designed to reduce entanglement with thoughts, in a 
way that alters responses to both IRAP rules. 
Although our investigation into the effects of the self-help ACT 
intervention on the IRAP in the present study was largely exploratory, 
we tentatively hypothesised that the intervention would lead to a 
reduction in response bias between the inconsistent and consistent 
trial types, indicating a reduction in implicit speech anxiety (e.g., a 
move towards a D-score of 0 indicating a reduced bias towards 
responding to consistent blocks [public speaking image = “makes me 
anxious”] compared to inconsistent blocks [public speaking image = 
“doesn’t make me anxious”]).  
 
1.6 Clinical Relevance 
 
As indicated in the introduction and the epidemiological data, PSA can 
lead to significant distress and reduced functional ability that may 
reach clinical levels in some cases (Stein et al., 1996). Moreover, as 
with other social anxieties, PSA may become chronic if not treated 
(Craske, 1999). A proportion of social anxiety research has therefore 
been dedicated to investigating effective treatments for this difficulty. 
In a review conducted by Allen, Hunter, and Donohue (1989), 
effective treatments for PSA appeared to consist of cognitive 
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modification, exposure, or skills training; with the most effective 
treatments combining all three elements. However, as this review did 
not evaluate the methodological rigour of the reviewed studies, this 
conclusion must be treated with caution.  
In an up-dated review that included an assessment of methodological 
quality, Priestley and colleagues (2014) found that the most reliable 
evidence suggested that exposure-based treatments for PSA were the 
most efficacious, and that such treatments could be effectively 
administered in a self-help / computerised format. This review 
highlighted that developing treatments for PSA (such as ACT) showed 
promise, however further rigorous research was needed to determine 
their effects reliably (Priestley et al., 2014).  
Although exposure based therapy appears to be the most effective 
form of treatment for PSA (Acarturk, Cuijpers, van Straten, & de 
Graaf, 2009; Allen et al., 1989; Priestley et al., 2014), this treatment 
is still ineffective for around a quarter of those who undertake it 
(Dalrymple & Herbert, 2007), possibly due to the distressing nature 
of exposure therapy (Orsillo et al., 2005), and/or due to possible 
avoidance strategies that prevent habituation from taking place (Foa 
& Kozak, 1986). Hence, further rigorous investigation into the 
effectiveness of alternative therapies, or therapies that re-frame 
and/or support the process of exposure is warranted. Such further 
investigation may better inform clinicians tasked with treating the 
difficulty, and may provide alternative psychotherapy options for 
individuals with PSA.  
Acceptance and Commitment Therapy (ACT) may offer such an 
alternative treatment, due to the manner in which exposure is framed 
as an opportunity to increase engagement in valued behaviour 
(England et al., 2012). Moreover, ACTs focus on developing 
acceptance of anxiety provoking private events, and present-moment 
awareness may lead individuals to willingly engage in exposure-based 
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tasks, and benefit from them (due a reduction in experiential 
avoidance/cognitive avoidance), respectively (Gloster, Hummel, 
Lyudminskaya, Hauke, & Sonntag, 2012). The extant research 
investigating ACT for PSA suggests that this model may be beneficial 
in treating PSA, however, further methodologically rigorous research 
is needed to substantiate such claims (e.g., Block & Wulfert, 2000; 
Block, 2002; England et al., 2012). 
As many individuals with social anxiety related difficulties, such as 
PSA, do not seek treatment (Bebbington, et al., 2000), the 
investigation of ACT delivered in a self-help format, may have clinical 
implications for those who do not seek treatment (due to wider social 
anxiety difficulties), or for individuals who wish to address their public 
speaking difficulties independently.  
A self-help ACT programme for individuals with PSA may also reduce 
the immediate and potential long term cost to services of treating the 
difficulty, as such an intervention (1) requires minimal therapist 
contact, and (2) may act as an early intervention, thus preventing 
the potential development of further associated chronic difficulties 
(which may become costly to treat). The development of more cost-
effective interventions for presentations of anxiety is clinically 
pertinent, given that the number of people with anxiety is projected 
to rise in England, along with the cost of treating the disorder for 
services, such as the National Health Service (NHS; McCrone, 
Dhanasiri, Knapp, & Lawton-smith, 2008).  
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2. Extended Methods 
 
2.1 Inclusion Criteria 
 
To ensure that the participants included in the study were 
representative of a PSA cohort, each participant was required to score 
≥ 6 on the Self-Statement during Public Speaking Scale – Negative 
sub-scale (SSPS-N; Hofmann & Dibartolo, 2000). This cut-off was 
chosen as it ensured that all participants fell within one standard 
deviation (SD=6.3), or above, of the mean of a speech phobic sample 
(12.3; Hofmann & Dibartolo, 2000). The SSPS-N was used as the 
screening measure, as this sub-scale is more sensitive to detecting 
PSA than the SPSS – Positive, or the SSPS scale as a whole (Hofmann 
& Dibartolo, 2000). As participants were also aware that they would 
be receiving payment for taking part in the research, this inclusion 
criteria reduced the likelihood of including individuals who solely 
wished to take part for monetary gain.  
As the present study was limited to investigating the effects of ACT 
for adults with PSA, individuals < 18 were excluded. Although it was 
unlikely that prospective participants would not meet this criteria 
(given that advertisements were placed around the University of 
Lincoln), it was included to ensure no children or young people were 
recruited who may have seen the advertisement, but who did not 
attend the university. 
As the current study investigated the effects of ACT to treat PSA, 
participants in receipt of, or due to receive, any form of 
psychotherapy were excluded from the sample. Individuals receiving 
psychotropic medication for anxiety related difficulties were also 
excluded. This decision was made to increase the likelihood that any 
changes observed throughout the intervention stage, could be 
attributed to the ACT intervention; thereby strengthening inferences 
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regarding treatment effectiveness. Participants prescribed long-term 
psychotropic medication (for difficulties unrelated to anxiety) were 
considered (excluding Anxiolytic medication). 
As the ACT workbook is written in English, and the participants 
received therapist support from an English speaking researcher, only 
English speaking subjects (who demonstrated an acceptable level of 
comprehension during the initial meeting) were included in the study 
sample.  
 
2.2 Epistemology and Single-case Experimental Designs 
 
2.2.1 Functional Contextualism 
 
The present study was designed and conducted from a functional 
contextualist position. Functional contextualism (FC) is a philosophy 
of science that underlies modern behavioural psychology (Fox, 2008). 
Developed using principles of behavioural analysis, FC assumes that 
all behaviours occur in a context, and have a function (Hayes, 
Strosahl, & Wilson, 2012). For example, a thought can be either 
‘normal’ or ‘problematic’ according to the context in which it occurs. 
Hence, thoughts are behaviours that serve a function/purpose in the 
current context. From a FC perspective, thoughts are not considered 
to be rational or irrational; or result in an emotional response 
(Ciarrochi, Robb, & Godsell, 2005). Therefore, it is the context that 
behaviours (such as thoughts) occur in that is the target of 
investigation and concern; in order to develop a greater 
understanding of the current and historical contexts in which 
behaviour evolves (Fox, 2008), with the goal of generating general 
rules for predicting and/or influencing psychological events with 
precision, scope, and depth (Biglan & Hayes, 1996). 
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FCs principal concern is the functional relationship between 
psychological events, and (manipulable) events in the individual’s 
environment (Fox, 2008). Hence, research from this perspective, 
seeks to identify which elements of an individual’s environment 
influence psychological events (both private and overt). In order to 
achieve this goal, it is necessary to systematically manipulate 
contextual variables, and measure the subsequent impact on the 
psychological event of interest (Biglan, 2011). Thus, correlational or 
descriptive methodologies are not appropriate as they do not isolate 
which contextual features influence change (Fox, 2008). Group 
comparison and single-case experimental designs, however, are 
favoured from this perspective, due to their use in suggesting which 
independent (contextual) variables may influence events of interest 
(Fox, 2008). Although qualitative methodologies may also be 
conducted within a FC framework, such methodologies are not 
considered as effective as experimental procedures in investigating 
the influence of contextual change on behaviour (Fox, 2008). 
Single-case experimental designs have been traditionally employed 
within behavioural and contextual science, especially when 
investigating outcomes and processes of psychological interventions 
(Smith, 2012).   
2.2.2 Single-Case Experimental Designs 
 
The single-case experimental design (SCED) is an alternative method 
to the group comparison design (Barlow, Nock, & Hersen, 2008). The 
SCED is able to demonstrate the efficacy of treatments, whilst 
reducing the likelihood that change can be attributed to chance or 
confounding variables (Rassafiani & Sahaf, 2010). Moreover, the 
capacity of the SCED to also measure detailed time-series individual 
level change (Rassafiani & Sahaf, 2010), means that such a design is 
advantageous for addressing the aims of the current study (above 
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and beyond a group comparison design).  
The SCED typically requires a smaller sample, compared to group 
comparison design, as the focus is on individual, rather than group 
difference. Unlike single subject research designs, SCEDs are often 
used to test hypotheses via the examination of a cause and effect 
relationship using multiple subjects (Backman, Harris, Chisholm, & 
Monette, 1997).  
Typically, the SCED takes the form of a ‘withdrawal’ or ABA design, 
whereby a non-treatment phase (A) is proceeded by a treatment 
phase (B), followed by the withdrawal of the treatment and a return 
to a non-treatment phase (A). The ABA design is therefore used to 
establish a causal relationship, between an independent variable and 
a dependent variable. For example, if the dependent variable (e.g., 
child’s mood) changes following the introduction of the treatment 
phase/independent variable (e.g., parental praise), but then returns 
to baseline levels once the independent variable is removed (e.g., no 
praise), then one can infer a causal relationship between the 
independent variable (parental praise) and the dependent variable 
(child’s mood). However, such a design has both practical and ethical 
limitations, with regards to the testing of treatments that cannot be 
unlearnt (e.g., psychotherapy) and/or the removal of potentially 
ameliorative interventions, respectively (Rassafiani & Sahaf, 2010). 
Hence, the ABA design was not appropriate for use in the current 
study.  
The multiple-baseline AB design allows for a causal relationship to be 
investigated, without the need for the removal of treatment, and is an 
ethical and practical way of examining newly developed 
psychotherapeutic interventions (Rassafiani & Sahaf, 2010). Similarly 
to the ABA design, subjects undergo a baseline/no-treatment phase 
prior to the introduction of the treatment phase. In a multiple-
baseline design, however, the start of each participant’s baseline 
Page 144 of 259 
 
phase is staggered, in that no participant begins the treatment phase 
at the same time. This design involves the repeated measurement of 
the same behaviours (dependent variables) during the baseline 
phase, and the continued measurement of the same variables during 
the treatment phase. As such, each subject’s baseline acts as the 
control phase. Hence, any observed change in the dependent variable 
during the treatment phase (beyond the variations observed during 
the baseline phase) can be attributed to the treatment. Inferences 
regarding treatment effectiveness are strengthened if the same 
change is observed across multiple-subjects. Moreover, as each 
participant undergoes the treatment at a different time, this reduces 
threats to internal validity, such as maturation or history effects 
(Barlow, Nock, & Hersen, 2008).  
As (1) participants came forward to take part in the current study at 
different times, (2) the treatment could not be removed, and (3) the 
principal aim of the research was to determine the effects of a 
staggered ACT intervention on multiple measures, a multiple-baseline 
SCED was employed. As the intervention phase was separated into 
the six core ACT processes, with the introduction of a new process 
each week, the treatment phase was split into six different phases 
(see Figure 15) This allowed us to infer which ACT process or 
processes may result in reductions in PSA (if observed across multiple 
subjects).  
 
Figure 15. Multiple-baseline phases in the present study 
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2.3 Ethical Considerations 
 
The procedure of the current study was designed and carried out with 
reference to the code of human research ethics of the British 
Psychological Society (BPS, 2010). Ethical approval for the present 
study was granted by the University of Lincoln’s School of Psychology 
Research Ethics Committee (SOPREC; see Appendix G for the 
confirmation of ethical approval). 
Potential participants who answered the advertisement were informed 
of the nature of the study, and provided with a copy of the research 
information sheet, via e-mail (see Appendix A). If potential 
participants still wished to take part in the study after reading the 
information sheet, then they were invited to meet the researcher to 
discuss the study in further detail, and ask any questions. During this 
meeting, prospective participants were informed that the study was 
experimental, hence, the ACT treatment for their PSA may not be 
effective.  
As many individual’s with PSA are likely to have wider social anxiety 
related difficulties (Stein et al., 1996), prospective participants were 
required to complete the Liebowitz Social Anxiety Scale (LSAS; 
Liebowitz, 1987) to indicate the presence of clinical levels of social 
anxiety. Participants who scored ≥ 95 on this scale (indicating ‘severe 
social phobia’; Liebowitz, 1987) were encouraged to seek advice from 
their General Practitioner in the first instance, before agreeing to take 
part in the study.   
Once participants understood the nature of the research, and the 
commitment required, they signed a written consent form (Appendix 
H) before beginning the baseline phase. This form was also signed by 
the researcher and then stored in a locked cabinet at the University of 
Lincoln.  
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To uphold participant confidentiality, each participant was assigned a 
randomly generated numerical identifier (using the website 
http://www.randomnumbergenerator.com). This number, and the 
participant it was linked to, was recorded and stored on a password 
protected memory-drive, only accessible to the researchers. These 
numbers were used throughout the study to identify each participant 
during the processes of data collection and analysis. Participants were 
also informed that their identity would remain confidential during the 
study and the dissemination phase.  
Participants were provided with a unique hyperlink so they could 
access an online version of their daily and weekly measures (hosted 
on the website: www.esurv.org); the results of which were only 
accessible to the researchers. 
Participants were made aware that their involvement in the study was 
voluntary, and that they had the right to withdraw at any stage 
without reason. Participants were compensated according to the 
amount of time they spent in the study (£4.00 a week, and an 
additional £4.00 after the successful completion of the change 
interview). Participants completing the whole study were therefore 
given £28 on completion. Participants who partially completed the 
study were compensated according to the time spent in the study. For 
example, a participant unable to compete the study after the fourth 
week would be given £16. Given the study’s time-intensive nature, 
the researchers agreed that this level of payment was a fair 
reimbursement that was not inducement. Participants were also 
reminded prior to signing the consent from, and after completing the 
intervention phase, that participation in the in-vivo public speaking 
BAT was entirely voluntary, and that their choice to participate did not 
influence their compensation.  
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Participants who agreed to complete the in-vivo BAT were asked to 
plan a ten minute speech on a topic of their choosing, fifteen minutes 
prior to the beginning of the BAT. Participants were provided with a 
note pad on which they could make notes. Participants were also 
given the option of using a PowerPoint presentation. The participants 
were encouraged to remain in the BAT for the allotted ten minutes, 
however, they were informed that they could stop at any stage, by 
raising their right hand; at which point the researcher would thank 
them, and accompany them out the room. Each participant was 
introduced to the audience using a pre-agreed pseudonym, to 
maintain confidentiality.   
Participants were informed that they had the right to withdraw their 
data from the study within two weeks of either completing, or 
withdrawing from participation. Participants were, however, also given 
the option to withdraw from the study without withdrawing their data 
if they wished (see appendix H). On completion of the study, each 
participant was given the option to receive a summary of their results 
and a brief interpretation if they wished.  
 
2.4 Procedure 
 
2.4.1 Initial Phase 
 
Participants who satisfied the inclusion criteria, and agreed to take 
part in the study after reading the ‘study information sheet’ 
(Appendix A), were invited to meet with the researcher to discuss the 
study in detail and ask further questions. Participants who agreed to 
take part signed the consent from (Appendix H). They were then 
asked to rate a series of 28 photographs related to public speaking 
(Appendix I) on a scale of 0 (least anxiety provoking) to 100 (most 
anxiety provoking). Figure 16 displays an example of an image rated 
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by a participant. The top six most distressing photographs were used 
as the target stimuli in the IRAP.  
 
Figure 16. Public speaking image and anxiety slider seen by each 
participant during the initial phase 
Participants completed a second computerised survey regarding their 
most feared public speaking situation (Appendix J). This was used to 
create the feared scenario that respondents were asked to imagine, 
whilst completing the SUDS measures, during the battery, and 
weekly assessments. Both steps described above were taken to 
ensure that the IRAP and the imagined scenario (as measured using 
the SUDS) presented stimuli that reflected each participant’s 
idiosyncratic PSA fears. 
The participant then completed the pre-intervention battery of 
measures13. Each participant completed these measures on a laptop 
provided by the researcher, and was instructed to answer each 
question carefully. No time limit was given in which to complete the 
battery. 
 
                                                             
13 Please see the main article for a description of all the measures discussed. 
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2.4.2 IRAP Procedure  
 
On completion of the self-reported measures, the participant was 
then asked to complete the IRAP, on the laptop provided. 
Instructions on how the participant should respond were provided on 
screen. Participants were required to respond in a manner 
alternately consistent (Figure 17) and inconsistent, with their fear of 
public speaking (Figure 18), as quickly and accurately as possible on 
two practice blocks. During the practice blocks (and subsequent test 
blocks) the participant was shown an image, and then instructed to 
answer true or false to each statement presented with the image, by 
pressing the computer key d or k respectively (see Figure 19 for an 
example).  
 
Figure 17. Consistent trial            Figure 18. Inconsistent trial  
  
Figure 19. Example of an IRAP image, statement, and the answer 
options 
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On completion of the practice blocks (a block is a consistent trial and 
an inconsistent trial), the participant began four test blocks.  
If the participant answered correctly according to the trial type (e.g., 
consistent trial - public speaking image “makes me anxious” = True) 
then the next image and statement were presented. If they 
answered incorrectly according to the trial type (e.g., consistent trial 
– public speaking image “makes me anxious” = False), then a red ‘X’ 
appeared on screen (see Figure 20) until the correct answer was 
provided, at which point the next image and statement were 
presented.  
 
Figure 20. Example of an incorrect response indication 
 
Participants were also asked to respond to non-public speaking 
related stimuli (relaxing images; Figure 21) during all trial blocks. 
The Image types and statements were randomly presented.  
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Figure 21. ‘Relaxing image’ trial type example 
 
Figure 22 displays an example of the four different image types 
(public speaking image and relaxing image) and statements 
(“DOESN’T make me anxious” and “makes me ANXIOUS” that were 
presented during the IRAP. 
 
Figure 22. Example of the four trial types 
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Each participant was required to complete each trial, within each 
block, to a minimum standard (at least 75% correct and a median 
response time less than 2500 milliseconds) in order for appropriate 
data to be collected for analysis. As such, if the participant did not 
meet this minimum standard, they were informed of this minimum 
requirement on-screen and instructed to complete the blocks again 
(Figure 23).  
 
Figure 23. Screen presented to participants to remind them of the 
minimum accuracy and speed requirements for successful 
completion 
The participant continued to complete the test blocks until they 
achieved this minimum standard on all four trial types, at which 
point a message appeared on screen asking the participant to notify 
the researcher.  
2.4.3 Baseline Phase 
 
Each participant was then asked to complete the daily measure for a 
week. Participants were provided with a website link via their e-mail 
address where they could access this electronic questionnaire. All 
self-reported measures used in the study were created using the 
website: www.esurv.org.  
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After completing the daily measure for a week, each participant’s 
response was graphed and visually analysed. If these data indicated 
a stable or declining trend (indicating decreasing psychological 
flexibility) on at least five consecutive data-points, then the 
participant began the intervention phase. If an upward trend 
appeared (indicating an increase in psychological flexibility), then the 
participant was asked to continue completing the daily measure until 
a stable or declining trend was achieved, on at least five consecutive 
data-points. A minimum of five observations is often used in SCED 
baseline periods to ensure enough data is gathered to determine the 
presence of ‘stable behaviour’ (Morgan & Morgan, 2008), and to 
exclude ‘day to day’ changes (Backman et al., 1997).   
2.4.4 Intervention Phase 
 
Once a stable baseline was achieved, each participant was provided 
with the introductory chapters to ACT, and the chapters related to 
the concept of (1) Acceptance from the self-help workbook, Get out 
of Your Mind and Into Your Life (Hayes & Smith, 2005). They were 
instructed to read these chapters over the course of a week. A 
suitable time each week was arranged for the researcher to contact 
the participant via telephone, so therapist support could be provided. 
At the end of each week, participants were instructed to complete 
the weekly measures. Again, each participant was provided with a 
hyperlink so they could access the weekly measure on their 
computer or smart-phone. At the end of the first week, participants 
were provided with the next set of chapters pertaining to the next 
ACT concept, (2) cognitive defusion. This process was repeated for 
six weeks, which allowed each participant to complete the workbook 
in a systematic fashion, one core ACT process at a time. Hence, each 
participant completed further chapters related to (3) self-as-context, 
(4) present-moment awareness, (5) values, and (6) committed 
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action over the course of six weeks. The book was split in this way 
so the participants could not read ahead, thus ensuring each week 
measured a separate ACT process. As the participants completed the 
workbook at different times, arranging the book in this manner 
allowed for stronger inferences to be made regarding the influence 
that the workbook had on any recorded change, and the possible 
mechanisms responsible. For example, if the majority of the 
participants’ distress related to public speaking reduced during week 
two of the intervention, then it can be inferred that this was likely to 
have occurred due to the ACT process of cognitive de-fusion rather 
than other extraneous variables (as no participant completed this 
section at the same time).  
Each participant met with the researcher to complete the mid-
battery of tests, including the IRAP, after three weeks (after 
completing the self-as-context chapters), and again at the end of the 
intervention, after six weeks (after completing the committed action 
chapters). 
2.4.5 Post-Intervention Phase and Behavioural Assessment       
Task (BAT) 
 
After the final battery of tests, each participant was asked if they 
were willing to complete a live public speaking task in front of an 
assembled audience of clinical psychologists and trainee clinical 
psychologists, for a maximum of 10 minutes on a topic chosen on 
the day of the task. If the participant agreed, then a suitable date 
was arranged (this date was around one month after completion of 
the intervention stage, to allow a volunteer audience to be 
assembled, and a venue at the University of Lincoln to be arranged). 
If the participant chose not to take part in the BAT, then they were 
thanked, and the final change interview was arranged (see section 
2.4.6 below).  
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Those who chose to complete the BAT were given 15 minutes prior to 
the talk, in which to plan their speech, using notes if they wished. 
They were instructed to deliver a speech on a topic of their choosing 
for a maximum of 10 minutes, and were encouraged to continue until 
this time was up. However, each participant was also instructed to 
raise their hand and look at the researcher, if they wished to stop the 
talk at any stage prior to this. If they did so, the researcher thanked 
them, and accompanied them out the room. During the speech, six 
audience members were chosen at random to complete an adapted 
version of the Social Performance Rating Scale (SPRS; Harb, Eng, 
Zaider, & Heimberg, 2003). The SPRS is an observer rated 
assessment of social and speech anxiety (Fydrich, Chambless, Perry, 
Buergener, & Beazley, 1998). This measure has demonstrated good 
interrater reliability (.93), internal consistency (.72), and convergent 
validity (.55-.65) (Fydrich et al., 1998), and has been validated for 
use as an assessment tool for PSA (Harb et al., 2003).  
Observers rated the participant’s speech performance on a scale of 0 
(very poor) to 5 (very good) on their gaze, vocal quality, length of 
speech (e.g., concise and detailed sentences), and level of comfort 
(rated from 0 – very uncomfortable to 5 – very comfortable). The 
fifth scale, ‘conversation’ was omitted as this related to dyadic 
speeches. On average, there were 10 people in the audience during 
the BATs. Each participant’s total speech length was also recorded.   
2.4.6 Change Interview 
 
All participants completed a change interview (Elliott, Slatick, & 
Urman, 2001) after the intervention phase. Those who chose to 
complete the BAT, were interviewed after its completion. Those who 
did not, were interviewed around one-month after completion of the 
workbook. This change interview was conducted by an independent 
researcher (a trainee clinical psychologist) blind to the participants’ 
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scores on all measures. The interview was structured and completed 
within the framework of Elliott and colleauges' (2001) change 
interview protocol. Essentially, this change interview format allows 
those who have undergone psychotherapy to provide qualitative 
information on which elements of the therapy they found helpful or 
important, what changes they attribute to the psychological 
intervention, and what ‘extra-therapy’ factors may have resulted in 
any perceived change (Robert Elliott, 2010). In the current study, 
the findings from this change interview were used to support or 
refute any inferences made following the analysis of quantitative 
data (see Appendix F for the change interview questions). Following 
the change interview, participants were thanked for their time, and 
provided with payment for taking part (£28 in total).  
2.5 Determining Reliable and Clinically Significant Change 
 
Jacobson and Truax (1991) suggested two methods for determining 
whether an individual experiences meaningful change following a 
psychotherapeutic intervention: whether they experienced (1) 
Reliable Change (RC) and whether this change was a (2) Clinically 
Significant Change (CSC). 
2.5.1 Reliable Change (RC) or Reliable Change Index (RCI) 
 
The reliable change index (RCI) is a statistic used to determine 
whether the change in an individual’s psychometric score (from pre- 
to post-intervention) is statistically significant. The RCI is defined as 
the change in an individual’s score, divided by the ‘standard error’ of 
the difference for the test being used. This indicates the number an 
individual’s score must increase or decrease by (dependent on the 
direction of improvement demarcated by the test) in order for change 
to be attributed to reasons other than chance (at 95% confidence) 
(Jacobson & Truax, 1991).  
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The RCI value is the individual’s pre-intervention score (x1), minus 
their post intervention score (x2), divided by the standard error of the 
difference (sdiff) of the test (calculated using the standard deviation 
of the test-takers scores, and the internal consistency of the 
measure) (Figure 24). 
 
Figure 24. RCI calculation (Jacobson & Truax, 1991) 
 
Hence, if the difference between an individual’s pre-treatment score 
(e.g., 57), and post-treatment score (e.g., 28) is equal to, or greater 
than the RCI value (e.g., 12.74), then the individual is classed as 
having made a reliable change at 95% confidence (Jacobson & Truax, 
1991). However, if this difference is less than the RCI value, the 
individual is said to have not made a reliable change (Jacobson & 
Truax, 1991). 
The Standard error of difference is calculated by initially calculating 
the standard error of measurement (SEM). The formulation for the 
SEM is: the standard deviation of the test takers’ scores (SD), 
multiplied by the square-root (1 minus the coefficient of reliability [r]) 
(Figure 25). 
  
Figure 25. Standard error of measurement formula 
 
This allows for the standard error of difference to be calculated (sdiff) 
using the following formula (Figure 26). 
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Figure 26. Standard error of difference formula 
 
2.5.2 Clinically Significant Change (CSC) 
 
If an individual is observed to have made a reliable change, then 
their post-treatment score can be investigated to determine whether 
this change can be deemed as clinically significant.  
Jacobson and Truax (1991) proposed that this can be done using one 
of the following three criteria: 
Criterion a – CSC is achieved if the individual’s post-treatment score 
is more than two standard deviations from the mean score of a 
clinical group.  
Or 
Criterion b – CSC is achieved if the individual’s post-treatment score 
is within two standard deviations of the mean score of a non-clinical 
group. 
Or 
Criterion c – CSC is achieved if the individual’s post-treatment score 
is closer to the mean of the non-clinical group than the clinical group.  
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Figure 27 displays Jacobson and Truax's (1991) three suggested cut-
off points (a, b, and c) for CSC in a graphed format. 
 
Figure 27. Jacobson and Truax’s (1991) three CSC criteria  
2.5.3 Critique of the RCI and CSC Method 
 
Although the use of the RCI and CSC method allows an individual’s 
treatment response to be investigated; something that is often 
neglected when using between group pre to post designs (where 
group scores rather than individual scores are analysed; Wise, 2004), 
using such criteria to determine reliable and significant change has 
received criticism. 
Kazdin (2001) argued that symptom change may not be the ‘gold 
standard’ for assessing meaningful change, and improvements in 
criteria such as quality or life, or impact on others should be 
considered. Kazdin (2001) also suggested that it is hard to prove that 
passing from one group (clinical) to another (normative) results in a 
change in daily functioning, or that a failure to move from one group 
to another, means that treatment has been unsuccessful.  
The RCI method for determining reliable change may lead to the 
assumption that a small improvement in an individual’s score (not 
reaching the RCI cut-off) is purely down to measurement error, when 
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in some cases, such a change may represent a meaningful shift 
(Hageman & Arrindell, 1993).  
Given these criticisms, it is important to use ‘real world’ measures 
designed to assess both symptom reduction and functional ability 
when investigating the effects of psychotherapeutic treatments (Wise, 
2004). Nevertheless, the RCI and CSC methodology has withstood 
rigorous debate, and demonstrates a welcomed shift from studying 
the general outcomes of groups, to investigating the individual 
change within those groups (Wise, 2004). 
Considering the criticisms highlighted above, the present study 
investigated the effects of the ACT self-help intervention on 
behavioural/functional ability, as well as on symptom reduction (as 
measured using the RCI and CSC method), to determine whether the 
participants experienced significant change. This was achieved by 
measuring each participant’s willingness to approach a public 
speaking task, and their performance during this task. Participants 
were also asked directly about the effects of the intervention on their 
lives as part of the final change interview. Inclusion of such functional 
measures was also judicial as symptom reduction is not a primary 
goal of ACT, but increasing valued behaviour is (Hayes, Luoma, Bond, 
Masuda, & Lillis, 2006).  
2.5.4 Critical Discussion on the use of the RCI and CSC Method 
in the Present Study 
 
As suggested by Jacobson and Truax (1991), the most accurate way 
in which to calculate the RCI value is to use the standard deviation of 
the test-takers scores, and the reliability of the measure in question. 
However, this raises difficulties for studies employing methodologies 
that do not require a high number of participants, and therefore only 
have a few observations (such as SCEDs). In this scenario, it is 
therefore advised to calculate the RCI value using data (SD and 
Page 161 of 259 
 
measure reliability) reported for the same measure in a large sample, 
as representative to the population of interest as possible (Jacobson 
& Truax, 1991). Hence, in the present study, the RCI values (for the 
measures subjected to reliable change analysis) were calculated using 
the data reported in studies examining the psychometric properties of 
the measures in question. As the sample in the present study 
represented an analogous clinical PSA population, the decision was 
made to use the data gathered from clinical populations, rather than 
non-clinical populations, when calculating the RCI-values and CSC 
cut-off scores applied. Table 11 provides information on the studies 
used to calculate the RCI values and CSC cut-off scores in the present 
study, and the type of clinical sample used.  
Table 11 
Studies and the Clinical Sample Type used to Calculate the Reliable 
Change Index in the Present Study 
Measure (construct) Psychometric study Clinical sample Type 
SSPS-N (Speech 
anxiety) 
Hofmann and Dibartolo 
(2000) 
Social anxiety  
PHLMS (Acceptance) Cardaciotto et al., (2008) Mixed mental health 
CFQ (Cog fusion) Gillanders et al., (2013) Mixed mental health  
MAAS (pres-mom-
aware) 
Carlson and Brown., (2005) Cancer patients 
ELS (Values/comm 
act) 
Trompetter et al., (2013) Chronic pain 
Notes. SSPS-N; Self-statements during public speaking scale – Negative: PHLMS; 
Philadelphia mindfulness scale-Acceptance; CFQ: Cognitive fusion scale; MAAS: 
Mindfulness attention awareness scale; ELS: Engaged living scale; Cog fusion: 
Cognitive Fusion; Pres-mom-aware: Present-moment awareness; Values/comm act: 
Values and committed action 
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Although the clinical sample used in the SSPS-N study consisted of an 
equivalent sample to the one used in the present study, the clinical 
samples used to calculate the RCI values and CSC cut-off scores for 
the remaining four measures ranged from individuals diagnosed with 
a variety of mental health disorders (PHLMS and CFQ) to those with 
cancer (MAAS) or chronic pain difficulties (ELS).  
Hence, one must consider how similar these sample-types are to 
individuals with PSA, and the implications of using clinical reference 
groups that may not be representative of a PSA cohort (as this may 
result in the use of RCI values and CSC cut-offs that are not suitable 
for use with a PSA sample). For example, the present-moment 
awareness of individual’s with cancer may be lower than the present-
moment awareness of individual’s with PSA (pre-treatment), resulting 
in the use of inaccurate boundaries for determining whether the 
participants in the present study achieved reliable and CSC. 
To investigate the homogeneity between the current sample and the 
clinical reference samples used to calculate the RCI values and CSC 
cut-off scores, the mean pre-treatment scores of the participants in 
the present study were compared to the mean scores of the clinical 
reference groups on all measures that were subjected to RCI and CSC 
analysis (see Table 12). 
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Table 12 
The Mean Pre-treatment Scores of the Present Study’s Sample and 
the Mean Scores of the Clinical Reference Samples used to Calculate 
Reliable and Clinically Significant Change  
Measure Mean (SD) pre-
treatment score of 
the study sample 
Mean (SD) score of 
clinical reference sample 
SSPS-N 16 (4.9) 12.3 (6.3) 
PHLMS 21.8 (7.78) 24.62 (5.48) 
CFQ 37.7 (7.74) 34.3 (8.06) 
MAAS 3.4 (0.74) 4.08 (0.74) 
ELS 51.3 (6.22) 50.90 (9.81) 
Notes. SSPS-N; Self-statements during public speaking scale – Negative: PHLMS; 
Philadelphia mindfulness scale-Acceptance; CFQ: Cognitive fusion scale; MAAS: Mindfulness 
attention awareness scale; ELS: Engaged living scale 
 
Table 9 indicates a degree of homogeneity between the current 
sample and the clinical samples, as the current study sample’s mean 
pre-treatment scores were within one standard deviation of the mean 
scores of the clinical reference group on all measures. However, the 
mean pre-treatment scores of the sample in the present study were 
higher on the SSPS-N, the CFQ, and the ELS; and lower on the 
PHLMS, and the MAAS, than the scores of the clinical reference group 
on the same measures. This indicates that (on average) the sample 
used in the present study had higher levels of PSA, were more 
cognitively fused, were less mindful and had lower levels of 
acceptance, but were slightly more engaged with their values at pre-
treatment than the clinical reference sample.  
Using the previous example of present-moment awareness, although 
the RCI value is the same whichever reference group is used (study 
sample or clinical reference sample; RCI value = .74), the CSC cut-
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off differs according to which sample is used (study sample = CSC 
cut-off score of 3.91 vs. clinical reference group sample = CSC cut-off 
score of 4.26). Hence, on this measure (MAAS), the participants in 
the present study were required to reach a score of ≥ 4.26 to achieve 
a CSC, which may be considered too high when considering the CSC 
cut-off score would have been 3.91 had the present study’s sample 
been used to calculate this cut-off rather than a clinical reference 
group (as advised by Jacobson and Truax, 1991). 
Considering this difference between the samples, and the critique of 
the RCI and CSC methodology, it is recommended that other factors 
should be considered when determining whether treatment has 
resulted in a meaningful change for the individual (Wise, 2004). 
Hence, the present study also considered changes on individualised 
measures (such as the SUDS), responses to an implicit measure, a 
behavioural assessment task, and participants’ responses to the 
change interview, when making inferences regarding the 
effectiveness of ACT to treat PSA.  
 
 
 
 
 
 
 
 
 
 
Page 165 of 259 
 
3. Extended Results 
 
3.1 Effects on Positive Self-Statements during Public 
Speaking 
 
Further analysis were conducted on the SSPS-Positive (SSPS-P; 
Hofmann & Dibartolo, 2000) to investigate the effect the intervention 
had on positive self-statements related to public speaking. As such, 
Jacobson and Truax’s (1991) RCI and CSC method were used to 
determine which participant’s SSPS-P scores were ≥ the RCI value 
(7.44), and the CSC cut-off (14.78) (see Table 13). 
Table 13 
Scores on the SPSS-P at Baseline, Mid, and Post-intervention, and 
Indication of Reliable and Clinically Significant Changes 
Participant SSPS-P 
Pre-score 
SSPS-P 
Mid-score 
SSPS-P 
Post-score 
P1 8 15 17R,  C 
P2 4 3 7 
P3 13 13 17 
P4 10 14 21R,  C 
P5 13 13 12 
P6 7 9 8 
Note. SSPS-N: Self-statements during public speaking scale – Negative  
R denotes Reliable Change at p<.05; C denotes Clinically Significant Change (from clinical to 
non-clinical range);  /  indicates directionality of Reliable or Clinically Significant Changes 
 
Five participants reported an increase in positive self-statements 
associated with public speaking, with the exception of P5. Reliable 
and clinically significant changes were observed in two cases (P1 and 
P4). P3’s final score was not deemed clinically significant, as reliable 
change had not taken place (see figure 28). 
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Figure 28. Scores on the SSPS-P outcome measure at baseline, mid-, 
and post-intervention 
P1 and P4 also recorded reliable, and clinically significant reductions 
in negative self-statements during public speaking, as measured by 
the SSPS-N. Moreover, P5 also reported the least change on the 
SSPS-N, suggesting those who experienced a reduction in negative 
self-statements, also experienced an increase in positive cognitions 
associated with public speaking over the course of the intervention.  
 
3.2 Analysis of the Weekly PSA measure (SSPS-N) 
 
To determine at which point changes occurred in PSA during the 
intervention, participants’ weekly responses to the SSPS-N were 
graphed. The data were inspected for reliable (RCI) and clinically 
significant changes (CSC; criterion c), according to Jacobson and 
Truax’s (1991) methodology.  
Figure 29 displays the weekly responses on the primary measure of 
PSA (Self-statements during Public Speaking Scale – Negative; SSPS-
N) for each participant.  
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Notes: Self-statements During Public Speaking – Negative Score: SSPS-N Score; Present-moment awareness: Pres Moment; Committed Action: Comm Action; * = Reliable change from pre-treatment score (i.e., change 
greater than RCI Value: 6.53); -------- = Clinically significant change cut-off (criterion c) 
 
Figure 29. Weekly responses to the SSPS-N for each participant according to intervention phase 
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Four participants recorded a reliable reduction in negative self-
statements associated with public speaking; P1 following the third 
week (self-as-context phase), P6 following the fourth week (present-
moment awareness phase), and P3 and P4 following the fifth week 
(values phase). P1 and P4’s scores also reached clinical significance 
at the point of reliable change. P2 and P5 did not report any reliable 
reductions on this measure at any stage.   
 
3.3 Analysis of weekly responses to the imagined public 
speaking Scenario (distress, avoidance, and willingness 
to approach)  
 
To investigate the point at which change occurred in levels of 
distress, avoidance, and willingness associated with the imagined 
public speaking scenario, each participant’s weekly responses to the 
SUDS measure were graphed. As RCI and CSC values are not 
available for the SUDS, the graphs were visually analysed (for point 
of change/drop in score).  
3.3.1 Distress 
 
Figure 30 displays each participant’s weekly level of distress related 
to their feared imagined public speaking scenario, as measured by 
the SUDS-D, over the course of the intervention. 
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Notes: Subjective Units of Distress Scale Score: SUDS-D Score; Present-moment awareness: Pres Moment; Committed Action: Comm Action 
 
Figure 30. Weekly levels of distress (SUDS-D) associated with the imagined public speaking task for each 
participant according to intervention phase 
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P1 and P6 reported the greatest drop in distress associated with the 
imagined task following the present-moment awareness week; with 
both cases showing an immediate increase in distress following this 
phase. Participants P3 and P4 reported a steady decline in distress 
from the point of the second week (cognitive defusion phase). P5 
reported a slight reduction in distress following the first and second 
week (acceptance and cognitive defusion phases), and again in the 
final week. P2 and P6 reported little change in distress over the 
course of the intervention, however, P6 reported a dip in distress 
following the present-moment awareness phase. 
3.3.2 Avoidance 
 
Figure 31 displays each participant’s weekly desire to avoid their 
feared imagined public speaking scenario, as measured by the SUDS-
A, over the course of the intervention. 
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Notes: Subjective Units of Distress Scale - Avoidance Score: SUDS-D Score; Present-moment awareness: Pres Moment; Committed Action: Comm Action 
 
Figure 31. Weekly desire to avoid (SUDS-A) the imagined public speaking task for each participant according to 
intervention phase   
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P2 and P6 reported no overall change in avoidance, however, P6 
reported a slight drop in her desire to avoid the imagined scenario 
after the first week (acceptance), but this was soon followed by an 
increase during the following two weeks (cognitive fusion and self-as-
context phase). P1 and P3 both reported a drop in avoidance 
following the self-as-context phase following week three, however, P3 
reported an increase in her desire to avoid the imagined scenario 
following the first intervention week. P4 experienced a large reduction 
in avoidance following the final week of the intervention (committed 
action), whereas P5 reported the greatest reduction in avoidance 
following the first week (acceptance phase).  
3.3.3 Willingness 
 
Figure 32 displays each participant’s weekly level of willingness to 
approach their feared imagined public speaking scenario, as 
measured by the SUDS-W, over the course of the intervention. 
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Notes: Subjective Units of Distress Scale - Willingness Score: SUDS-W Score; Present-moment awareness: Pres Moment; Committed Action: Comm Action 
 
Figure 32. Weekly willingness to approach (SUDS-W) the imagined public speaking task for each participant 
according to intervention phase   
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Both P2 and P6 showed no overall change in willingness to approach 
the imagined task, however, P6 reported a decrease in levels of 
willingness following the second week (cognitive fusion phase), after 
a brief increase in the first (acceptance phase). Both P3 and P4 
reported a large increase in willingness following the self-as-context 
phase. P5 reported small increases in willingness after the 
acceptance, cognitive fusion and committed action phase. P1 showed 
large increases in levels of willingness following the second week 
(cognitive fusion) and the final week (committed action) of the 
treatment phase.  
 
3.4 Analysis of the Weekly ACT Process Measure 
 
To investigate whether changes occurred in the ACT process 
measures concurrently with, or following, the ACT component being 
completed by the participant (e.g., did reliable change occur in the 
measure of acceptance in concordance with the acceptance 
component of the intervention) each participant’s responses to the 
weekly process measure were graphed. The data were inspected for 
reliable (RCI) and clinically significant changes (CSC; criterion c), 
according to Jacobson and Truax's (1991) methodology.  
3.4.1 Acceptance 
 
Figure 33 displays each participant’s weekly response on the measure 
of acceptance (Philadelphia Mindfulness Scale – Acceptance; PHLMS).  
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Notes: Philadelphia Mindfulness Scale (Acceptance) Score: PHLMS Score; Present-moment awareness: Pres Moment; Committed Action: Comm Action; * = Reliable change from pre-treatment score (i.e., change greater than RCI 
Value: 7.59); --------- = Clinically significant change cut-off (criterion c). 
Figure 33. Responses to the ACT process measure capturing acceptance (PHLMS) for each participant according to 
intervention phase 
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Two participants recorded a reliable increase in levels of acceptance 
a week after completing the acceptance intervention (during the 
cognitive defusion phase) (P1 and P2). One participant experienced a 
reliable increase in acceptance two weeks after the acceptance phase 
(P3; during the self-as-context phase), and two participants 
experienced reliable increases in acceptance either at the end of the 
intervention (P4; committed action phase) or during the penultimate 
week (P6; values phase). Change was deemed clinically significant at 
these points for P1, P3 and P614. P5 did not achieve a reliable change 
at any point during the intervention.  
3.4.2 Cognitive Fusion 
 
Figure 34 displays each participant’s weekly response on the measure 
of cognitive defusion (Cognitive Defusion Questionnaire; CFQ).  
 
 
 
 
 
 
 
 
 
 
 
                                                             
14 CSC was not achieved for P4 and P5 as (1) their baseline-score began above the CSC cut-off value, or 
(2) they did not achieve the prerequisite reliable change.   
Page 177 of 259 
 
   
   
Notes: Cognitive Fusion Questionnaire Score: CFQ Score; Present-moment awareness: Pres Moment; Committed Action: Comm Action; * = Reliable change from pre-treatment score (i.e., change greater than RCI Value: 7.74);                
-------- = Clinically significant change cut-off (criterion c). 
Figure 34. Responses to the ACT process measure capturing cognitive fusion (CFQ) for each participant according to 
intervention phase 
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One participant experienced a reliable reduction in cognitive defusion 
in concordance with this phase in the intervention (P2). P4 and P6 
recorded reliable reductions in cognitive fusion a week following the 
cognitive defusion phase, whereas P1 and P3 experienced reliable 
reductions in cognitive fusion two weeks after this phase in the 
intervention (during the present-moment awareness phase). P5 did 
not report a reliable reduction in cognitive fusion at any stage. 
Change was deemed clinically significant for P1, P4 and P6.  
3.4.3 Self-as-context and Present-Moment Awareness 
 
Figure 35 displays each participant’s weekly response on the measure 
of self-as-context and present-moment awareness (Mindful Attention 
Awareness Scale; MAAS).  
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Notes: Mindful Attention Awareness Scale score: MAAS Score; Present-moment awareness: Pres Moment; Committed Action: Comm Action; * = Reliable change from pre-treatment score (i.e., change greater than RCI Value: .74);                
-------- = Clinically significant change cut-off (criterion c). 
 
Figure 35. Responses to the ACT process measure capturing self-as-context and present-moment awareness (MAAS) for each 
participant according to intervention phase  
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Three participants experienced a reliable increase in present-
moment awareness in concordance with the present-moment 
intervention phases of either self-as-context (P6) or present-moment 
awareness (P3 and P5). P1 showed a reliable increase in present-
moment awareness during the acceptance phase, two weeks prior to 
the target treatment phase, however, achieved CSC a week after the 
target phase (during the values phase). P2 and P4 did not 
experience a reliable improvement in present-moment awareness, 
with P4 demonstrating a reliable reduction in present-moment 
awareness during the first two weeks of intervention. P5 was the 
only participant to reach the CSC cut-off, and maintain this gain until 
the end of the intervention.   
3.4.4 Values and Committed Action 
 
Figure 36 displays each participant’s weekly response on the measure 
of values and committed action (Engaged Living Scale; ELS).  
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Notes: Engaged Living Scale score: ELS Score; Present-moment awareness: Pres Moment; Committed Action: Comm Action; * = Reliable change from pre-treatment score (i.e., change greater than RCI Value: 8.16);                              -
------- = Clinically significant change cut-off (criterion c) 
Figure 36. Responses to the ACT process measure capturing values and committed action (ELS) for each participant 
according to intervention phase 
Page 182 of 259 
 
P4 reported a reliable increase in values/committed action in 
concordance with the values/committed action treatment phase. P1 and 
P6 also reported a reliable increase, however, this occurred a week prior 
to the values/committed action treatment phase, during the present-
moment awareness phase. P2, P3 and P5 did not report a reliable 
increase in values/committed action at any stage. P1 and P4’s scores 
reached clinical significance. 
 
3.5 Overall Synthesis 
 
Reliable change in target ACT processes occurred either in concordance 
with, or proceeded, the respective intervention phase for all but one 
participant (P5), during the first and second treatment phases 
(acceptance, and cognitive fusion).  
During the third and fourth treatment phases, related to the ACT 
processes of present-moment awareness (self-as-context and present-
moment awareness), three participant’s recorded reliable improvements 
immediately after the treatment phase in the target measure (P3, P5 and 
P6). P1 also showed a reliable improvement in present-moment 
awareness, however, this occurred a week before this treatment phase. 
P2 and P4 made no reliable improvement in present-moment awareness 
during, or after, this treatment phase. Present-moment awareness was 
the only ACT process that showed a reliable improvement for P5 
throughout the whole intervention phase.  
P4 was the only participant to record a reliable increase in 
values/committed action during the respective treatment phase. P1 and 
P6 recorded a reliable improvement in values/committed action, but this 
occurred during the previous present-moment awareness treatment 
phase. P2, P3 and P5 showed no reliable improvements in 
values/committed action during this intervention stage.  
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The most frequent occurrences of reliable shifts in the ACT processes 
(when considering all the ACT process measures) occurred during the 
present-moment awareness phase of the intervention, closely followed 
by the self-as-context treatment phase. This indicates that this treatment 
phase may also aid the development of the other four ACT processes 
(acceptance, cognitive defusion, values and committed action) in addition 
to the development of mindfulness based techniques, and that these two 
treatment phases were potentially the most influential ACT processes of 
the six during the intervention.  
 
3.6  Summary of Results for each Participant 
 
The following section presents a narrative synthesis of the findings for 
each individual participant, with reference to their results on all measures 
conducted during the study (please refer to the journal paper and/or the 
previous section for tabulated/graphed results). 
3.6.1 Participant 1 (P1) 
 
P1 reported a reliable and clinically significant reduction in negative self-
statements related to public speaking after the third week of the 
intervention / the self-as-context phase. This reduction in PSA was 
preceded by an increase in willingness to approach her feared imagined 
public speaking scenario, and a decrease in distress and desire to avoid 
the same scenario. Reliable increases in the ACT process measures of 
acceptance, self-as-context, and present-moment awareness also took 
place prior to the reduction in the key measure of PSA. P1 also reported 
reliable and clinically significant improvements in the other ACT 
processes measuring cognitive fusion and values, however, these 
changes occurred following the fourth week (present-moment awareness 
phase).  
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P1’s level of psychological flexibility remained at baseline levels for the 
majority of the treatment phase, however, P1 reported a slight increase 
in psychological flexibility during the final two phases related to values 
and committed action respectively. The treatment effect size (with 
regard to the development of psychological flexibility) was deemed to be 
small (.17)15. P1’s responses to the IRAP also indicated an increase in 
implicit anxiety towards public speaking images/stimuli. 
P1 chose to take part in the BAT and remained in the task for the 
majority of the allotted time (74% of the BAT time). P1’s performance in 
the BAT was rated highly by the audience (mean observer-rated score of 
4.1). 
P1 reported that the present-moment awareness phase of the 
intervention was the most influential, that she became more accepting of 
her PSA, and that the change she experienced as a result of the 
intervention had been very personally important.  
3.6.2 Participant 2 (P2) 
 
P2 did not report a reliable reduction in negative self-statements related 
to public speaking during the intervention. She also reported little change 
in her levels of distress related to her feared imagined public speaking 
scenario, and no change with regards to avoidance of, or willingness to 
approach, the same scenario. P2 reported a reliable increase in the ACT 
processes of acceptance and cognitive defusion during the second week, 
however, this change was not deemed clinically significant, and P2’s final 
score on the measure of cognitive defusion returned to ‘unreliable’ levels. 
No other ACT process measure reliably changed during the intervention 
phase for P2.    
                                                             
15 Although P1’s achieved a stable baseline period of psychological flexibility, her high baseline scores suggest 
that either (1) the treatment had little effect on increasing P1’s psychological flexibility, or (2), P1’s baseline 
psychological flexibility may have been uncharacteristically high, and a longer baseline period may have been 
more appropriate to establish greater stability prior to the treatment phase.  
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However, P2’s psychological flexibility increased following the first week 
of treatment, and continued to improve. As such, treatment overall 
(according to this measure alone) was deemed to have been highly 
effective (.93). P2’s responses to the IRAP indicated a negligible 
reduction in implicit anxiety towards public speaking images/stimuli.  
P2 chose not to complete the voluntary BAT. She also reported that she 
found the workbook “hard to grasp” and confusing at times. Additionally, 
P2 reported that she had a diagnosis of depression, and that she found it 
difficult to motivate herself to complete the workbook exercises at times. 
Nevertheless, P2 reported that she found the acceptance phase of the 
intervention the most influential, and subsequently noticed an increase in 
her acceptance of anxiety in general.  
3.6.3 Participant 3 (P3) 
 
P3 reported a reliable reduction in PSA (as measured by the SSPS-N) 
following the fifth week of the intervention (values phase); however, this 
change was not clinically significant. This reduction in negative self-
statements associated with public speaking was preceded by a reduction 
in distress elicited by the imagined public speaking scenario, and an 
increase in willingness to approach this situation. However, no change 
occurred in P3s desire to avoid this situation.  
This reduction in PSA was also preceded by reliable improvements in the 
ACT processes of acceptance, present-moment awareness, and cognitive 
fusion; all of which occurred during the self as context stage (acceptance) 
or the present-moment stage (cognitive fusion and present-moment 
awareness). P3 did not report a reliable increase in the values process 
measure.  
P3 demonstrated a reduction in implicit anxiety associated with public 
speaking stimuli by the end of the intervention. P3 also chose to complete 
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the BAT, and remained in the task for the maximum allotted time. P3 was 
given a moderate to good observer rated score during the BAT (3.5). 
P3’s psychological flexibility increased following the third week (self-as-
context) and continued to increase throughout the intervention. The 
treatment was deemed moderately effective, according to this measure 
(.76).  
During the change interview, P3 reported that the values phase was the 
most influential, she noticed an increase in her acceptance of distressing 
private events, and she reported that this change had been important for 
her.  
3.6.4 Participant 4 (P4) 
 
P4 reported a reliable and clinically significant reduction in negative 
thoughts associated with public speaking following the fifth week of 
intervention (values phase). This was preceded by a reduction in P4’s 
level of distress and avoidance caused by the imagined task, and an 
increase in levels of willingness to approach this task. P4 also reported a 
reliable and clinically significant decrease in the ACT process of cognitive 
fusion prior to this reduction in negative thoughts surrounding public 
speaking. Reliable and clinically significant increases in values/committed 
action took place in concordance with ameliorative reductions in PSA (as 
measured by the SSPS-N). A reliable increase in levels of acceptance also 
occurred, however, this took place a week later (during the committed 
action phase). P4 did not report a reliable increase in her levels of 
present-moment awareness at any stage.  
P4’s psychological flexibility increased following the first week (acceptance 
phase) and the third week (self-as-context); and then continued to 
increase throughout the intervention. The treatment was deemed highly 
effective, according to this measure (.95).  
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P4’s responses on the IRAP indicated a large reduction in implicit anxiety 
by the end of the intervention. P4 also chose to complete the BAT, 
however, she spent the least time in the task of the BAT completers 
(31%), and received the lowest observer-rated score (3.0). Nonetheless, 
this score still represented a moderate performance.  
P4 reported that the present-moment awareness intervention was the 
most influential, she experienced a reduction in her desire to avoid public 
speaking, and that the change she noticed had been very important to 
her. 
3.6.5 Participant 5 (P5) 
 
P5 reported no reliable reduction in PSA, as measured by the SSPS-N. P5 
did however report an increase in his willingness to approach his feared 
imagined public speaking scenario, and a decrease his distress and desire 
to avoid the same scenario.  
P5 only reported a reliable (and clinically significant) improvement in one 
ACT process measure; present-moment awareness. This reliable change 
occurred following the fourth week (present-moment awareness phase), 
but returned to ‘unreliable’ levels post intervention.  
P5’s responses to the IRAP indicated a slight increase in his implicit 
public speaking anxiety over the course of the intervention, however, P5 
chose to complete the BAT and was rated as giving a near perfect 
performance by the audience (4.9). P5 also remaining in the task for 
nearly all of the allotted time (98%).  
P5’s daily measure indicated that his psychological flexibility increased 
slightly during the initial phases of the intervention, and began to 
accelerate during the final week (committed action phase). As such, 
treatment was deemed to have been moderately effective (.73) in 
increasing P5’s psychological flexibility. 
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P5 reported that the present-moment awareness phase was the most 
influential, and that he had begun to separate himself from his unhelpful 
thoughts; however, he was unsure whether this change had been 
important to him. P5 also spoke of his difficulty in completing the 
exercises in the workbook, due to the demands of being a new father.  
3.6.6 Participant 6 (P6) 
 
P6 reported a reliable (but not clinically significant) reduction in the 
principal measure of PSA (SSPS-N) following the fourth week (present-
moment awareness phase). This change was preceded by reliable 
improvements in the ACT processes of cognitive defusion, and self-as-
context/present-moment awareness. P6 also reported a reliable 
improvement in values/committed action in concordance with reliable 
reductions in PSA, but this change returned to ‘unreliable’ levels post 
intervention. P6 also reported a reliable (and clinically significant) 
increase in acceptance. This reduction occurred after the fifth week of the 
intervention (values phase).  
P6’s responses to the IRAP indicated a slight increase in her implicit 
anxiety towards public speaking stimuli. She also chose not to take part 
in the final speech BAT.  
P6’s psychological flexibility, however, began to increase during the third 
week (self-as-context phase) and continued to do so throughout the 
intervention phase. As such, the treatment was deemed to have had a 
moderate effect (.81) in increasing P6’s psychological flexibility.  
During the final interview, P6 reported that she found the workbook hard 
to understand due to the “high level of theory attached to it”. However, 
she stated that she found the present-moment awareness chapter the 
most influential, and stated that the intervention had reduced her 
anxiety; however, she found the nature of the BAT (unprepared speech) 
too anxiety provoking.  
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4. Extended Discussion 
 
4.1 Participants Five and Six 
 
The findings with regard to P5 and P6 are particularly interesting, given 
their paradoxical nature. Although P5 reported a slight increase in 
psychological flexibility, this increase was generally small and did not 
differ greatly from his baseline scores. Additionally, P5 did not report an 
overall lasting improvement in any of the ACT processes. P5 did report 
improvements on all SUDS measures (reduced distress, reduced 
avoidance, and increased willingness) related to the imagined public 
speaking task, however, he did not show a reliable reduction in PSA as 
measured by the SSPS-N. Overall, P5 reported the least change on the 
self-rated measures of any participant. Yet, he still went on to complete 
the BAT, and received the highest observer-rated score from the audience 
members compared to the other participants. 
Conversely, P6 reported a much greater increase in psychological 
flexibility, than P5. Although her reduction in PSA, as measured by the 
SSPS-N, was not deemed to have reduced beyond the RCI index value, 
her score reduced more than P5’s (however, P6 only reported an overall 
reduction in the SUDS measure of distress related to the imagined public 
speaking task). She also reported reliable improvements in three ACT 
processes (acceptance, cognitive defusion, and mindfulness). Her post-
scores on these ACT processes were also clinically significant on two 
measures (acceptance and cognitive defusion). Despite these 
improvements in psychological flexibility, PSA and ACT processes, P6 
chose not to complete the BAT. 
The following section discusses these participants in further detail and 
offers hypotheses for these findings.  
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4.1.1 P5 
 
P5 was the only male participant to take part in the study. He was also 
the only participant who was not a student. He was a lecturer, who 
engaged in public speaking around 2/3 times a week. Nevertheless, he 
explained when agreeing to take part in the study, that he had 
experienced PSA all his life, and often found himself in distress prior to, 
and during public speeches, both in his personal and occupational life. P5 
described his most feared public speaking scenario as having to deliver an 
unplanned speech to a large audience of peers (fellow colleagues).  
During the intervention, P5 explained that he managed to read the 
workbook each week, however, he struggled to complete the majority of 
the exercises the workbook suggested. P5 explained that he did not have 
the time due to his new role as a father. Over the course of the 
intervention, P5 reported finding the workbook easy to read, however, he 
stated that he felt the book catered for individuals with greater, more 
serious psychopathologies than PSA.  
Prior to the BAT, P5 requested that the audience members consist of non-
university employed staff. He explained that he felt confident to complete 
the BAT, however, would feel embarrassed if his fellow colleagues knew of 
his speech anxiety. During the BAT, P5 found the preparation stage 
difficult, as he had to choose the topic for the speech, rather than have 
one provided. P5 was not expecting this, so he spent the majority of the 
15 minutes before the BAT thinking of a topic to talk about. During the 
BAT, P5 delivered a comprehensive speech on the anatomy of the ear to a 
group of trainee clinical psychologists, who rated his speech as nearly 
perfect (4.9) on the observer-rated measure. P5 came within seconds of 
reaching the maximum time allowance. During the change interview, P5 
reported feeling anxious during the task, and worried whether the 
audience were engaged and/or cared about what he was saying.  
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There could be a number of hypotheses explaining why P5 took part in 
the BAT, even though he did not report vast reductions in PSA or shifts in 
ACT processes: 
1. P5 may have agreed to take part in the BAT as this task may not 
have replicated a feared public speaking context for him, as the 
audience consisted of students. Given P5 reported that his most 
feared public speaking situation involved audience members 
comprising of his peers, P5 may have declined to take part in the 
BAT, if the audience included fellow colleagues.  
2. P5 may have felt pressured to adhere to the demands of the 
researcher, and took on the role of ‘the good-participant’ (Nicholas 
& Maner, 2008; attempting to prove the researchers hypothesis). A 
characteristic that may have been strengthened by the therapeutic 
relationship that occurred between the researcher and P5 over the 
course of the six week intervention. 
3. P5’s participation in the BAT may have reflected his continued 
attempts to unsuccessfully habituate to public speaking contexts. In 
other words, the ACT intervention may have been unsuccessful in 
reducing P5’s use of cognitive avoidance techniques, such that 
continued exposure to these situations (in P5’s occupational role/ 
the BAT) has not led/did not lead to habituation; and perhaps 
therefore continues to sensitise P5 to public speaking scenarios 
(e.g., Marshall, 1988). 
4. The intervention may have been successful in increasing P5’s 
willingness to approach public speaking scenarios, however, may 
not have been successful in developing P5’ ACT related skills (e.g., 
present-moment awareness) or led to a large reduction in speech 
anxiety. 
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4.1.2 P6 
 
P6 was a female who reported regularly avoiding public speaking tasks 
related to her university course, and placements. P6 reported having PSA 
when delivering speeches in most contexts, to small or large audiences. 
She described her most feared public speaking scenario as giving a 
speech to a large group of assessors on a complicated topic.  
During the intervention, P6 completed the requisite reading on time and 
reported completing the exercises in each chapter. However, during 
telephone contact and the completion of the battery measures, P6 
reported that she found the workbook unnecessarily complicated, and 
disliked the use of American phrasing throughout. She also reported that 
this frustrated her at times, which led her to disengage slightly from the 
book.    
On completion of the treatment phase, the final speech BAT was 
discussed. P6 immediately said that she did not want to take part, and 
had never intended to. She reported that the anxiety the task would 
cause would be too demanding on her considering the level of her 
university commitments.  
A number of hypotheses could explain why P6 did not take part in the 
final speech BAT, despite reporting improvements in psychological 
flexibility, three ACT processes, and a reduction in distress caused by the 
imagined public speaking scenario: 
1. As briefly mentioned in the journal paper, P6’s responses on the 
self-reported measures may have reflected her becoming socialised 
to the ACT model (e.g., the use of ACT vernacular to describe her 
experience) rather than the success of the ACT intervention. This 
hypothesis is perhaps supported by evidence from the idiographic 
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SUDS scores that either showed little change (distress), or no 
change at all (avoidance and willingness). 
2. The intervention may have been partially successful in developing 
P6’s psychological flexibility (as evinced by shifts in both the daily 
and weekly measures), however, this change was not enough to 
increase P6’s willingness to engage in public speaking behaviour. 
Therefore raising the possibility that P6 may have required a ‘higher 
dose’ of ACT than is provided through self-help methods alone; in 
order to increase her understanding, and encourage experiential 
exposure.  
3. The nature of the BAT may have reflected P6’s most feared public 
speaking scenario, to the point that engagement in this task was 
too anxiety provoking, even though her psychological flexibility had 
increased. This indicates that the intervention was not effective in 
altering P6’s willingness to approach public speaking, but may have 
been successful in developing P6’s psychological flexibility in other 
areas of her life. This was possibly reflected in P6’s refusal to 
engage in the BAT (i.e., resisting experimenter demands / focussing 
on own valued actions). 
4. P6’s results (as with P5) could indicate that self-report measures 
are not appropriate / accurate in measuring ACT treatment, and 
that behavioural/functional measures are the most accurate in 
determining treatment success; given the foci of the ACT model on 
altering behavioural responses, rather than private events. 
 
 
 
Page 194 of 259 
 
4.2 The IRAP Findings, and Recommendations for its use in 
Future Research 
 
The mixed IRAP findings suggest a number of hypotheses that are 
presented in the journal paper. The most likely hypothesis, however, is 
that the IRAP was not designed in a manner that was sensitive to the ACT 
treatment. In the present study, the IRAP was designed to measure first-
order change / public speaking propensity (e.g., public speaking stimuli = 
“makes me anxious”) rather than second-order change / public speaking 
sensitivity (e.g., public speaking stimuli =”I cannot tolerate public 
speaking”)16. This may have been an oversight, and could explain why the 
IRAP failed to predict all the participants’ behavioural responses to the 
BAT.  
As the goal of ACT is to develop an individual’s willingness to experience 
unpleasant private events and feared situations, in the context of 
pursuing values-based ends (Hayes & Strosahl, 2004), first-order change, 
or reducing an individual’s public speaking anxiety propensity was not the 
principal aim of therapy. Hence, the design of the IRAP used in the 
present study was somewhat incongruent with this model, and was 
therefore measuring a construct not thought to be influenced by ACT. 
Therefore, an IRAP measuring second-order change, or public speaking 
sensitivity, may have been more accurate in capturing the type of change 
predicted by the ACT model (to reduce the negative manner in which 
distressing private events are experienced / appraised).  
Support for this notion comes from a study investigating the development 
of an IRAP designed to examine the role of implicit disgust in obsessive-
compulsive tendencies (Nicholson & Barnes-Holmes, 2012). This study 
found that an IRAP created to measure disgust sensitivity (e.g., 
                                                             
16 Anxiety propensity refers to how anxious an individual becomes. Anxiety sensitivity refers to how negatively 
this feeling is appraised (Nicholson & Barnes-Holmes, 2012). 
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disgusting image = “I cannot tolerate it”) accurately predicted avoidance 
behaviour on a series of BATs, whereas, the IRAP created to measure 
disgust propensity (e.g., disgusting image = “I am disgusted”) did not. 
As such, future research using implicit measures such as the IRAP to 
measure treatment effects, should carefully consider the theoretical 
underpinnings of the treatment under examination to determine whether 
the implicit measure should be calibrated to capture first- (Propensity) or 
second-order change (sensitivity). 
 
4.3 The Findings in the Context of Previous Research and Theory 
 
4.3.1 Support for the Cognitive Model of PSA 
 
Although ACT is a treatment model underpinned by behavioural theory 
(Hayes & Strosahl, 2004), the model, and the findings of the current 
study may provide support for the cognitive model of SAD / PSA. Clark 
and Wells' (1995) cognitive model of social phobia / PSA postulates that 
an individual’s pre-occupation with their negative appraisal of themselves, 
others, and their physiological reactions during public speaking scenarios, 
leads to the experience of PSA. According to this model, PSA is 
maintained until an individual stops engaging in this ‘self-focus’ of 
attention, and allows themselves to attend to their surroundings. This 
attentional shift enables the individual to experience the situation 
objectively, which in turn challenges their negative assumptions (e.g., 
with regard to their ability, the behaviour of others, and the effects of 
their somatic responses) (Clark & Wells, 1995). A key method in cognitive 
therapy for PSA is therefore the development of the individual’s ability to 
shift their attention to external processes, in order for exposure 
experiments to produce optimal belief change (Clark & Wells, 1995).  
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In many respects, the ACT model of PSA is similar to the cognitive model, 
in that an individual’s attempts to rid the self of distressing private events 
(e.g., thoughts, emotions, and somatic sensations) leads to the 
development of a pre-occupation / entanglement with them, which in turn 
maintains PSA through psychological rigidity.  
In the present study, it seems that the development of mindfulness / 
present-moment awareness, may have been the most influential 
treatment phase for the majority of participants. Hence, it seems that, 
similarly to cognitive treatment for PSA, the development of external 
attentional strategies (cognitive) / present-moment awareness (ACT) 
appears to have led to ameliorative change. However, the reason why the 
development of these skills leads to this change, differs according to 
which perspective one takes. From a cognitive perspective, this shift of 
attention enables an individual to gather counter evidence in order to 
challenge the negative thoughts that are maintaining their PSA (Clark & 
Wells, 1995). From an ACT perspective, the development of present-
moment awareness allows an individual to notice their surroundings, 
bodily sensations, and private experiences, without being influenced by 
their thoughts, and thus not engage in acts of experiential avoidance. 
From an ACT perspective, contact with the present-moment during 
exposure exercises is also theorised to reduce an individual’s 
entanglement with their private experiences, thereby allowing the 
individual to remain in the feared context and learn that anxiety is not 
‘bad’ and therefore does not need to be removed (Hayes & Strosahl, 
2004).  
Hence, although both schools of thought may differ in why the 
development of present-moment awareness / external attentional 
strategies reduce PSA, the findings from the present study offers support 
for both models and highlights the importance of fostering present-
moment awareness skills when treating PSA.  
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4.3.2 Exposure Therapy 
 
In a study examining traditional exposure, versus acceptance-based 
exposure treatment for PSA, England and colleagues (2012) found no 
significant difference between the two groups. However, the researchers 
noted that the participants’ baseline level of mindfulness and acceptance 
moderated treatment response, with regard to state anxiety and public 
speaking related cognitions. In other words, individuals with higher levels 
of mindfulness and acceptance at baseline, experienced greater increases 
in positive self-statements and reductions in anxiety post-treatment, 
compared to individuals with lower levels of mindfulness and acceptance 
at baseline. The authors concluded that this indicated that one’s ability to 
be ‘mindfully aware’ of one’s environment / experience may enhance 
one’s capacity to engage in, and benefit from exposure (England et al., 
2012). 
Similarly to the findings of England and colleagues (2012), the present 
study found that the participant with the lowest overall baseline scores on 
the ACT theoretical processes (P2), showed the least overall 
improvement, and also chose not to complete the BAT. This adds further 
support for the notion that one’s level of mindful awareness and 
acceptance may (1) predict engagement in exposure-based tasks (e.g., 
ACT exercises and BATs), and (2) determine how effective an exposure-
based treatment may be. 
These findings are important when considering an individual’s suitability 
for ACT self-help treatment for PSA, as it seems those who initially report 
low scores on ACT related processes, may require a greater level of 
support than a self-help approach can provide, in order for the treatment 
to be effective. In such a case, a higher level of intervention (e.g., 
individual 1:1 ACT) may be required in order for such individual’s to 
develop the skills needed to approach, and benefit from exposure to 
public speaking related stimuli.   
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England and colleagues also noted that providing an acceptance and 
valued-action based rationale for exposure therapy, may benefit those 
with PSA who would otherwise avoid such forms of treatment (England et 
al., 2012). This notion is supported in the findings from the present study 
as (1) the participants who chose to complete the BAT all said that they 
would not have completed such a task prior to the intervention; indicating 
that the ACT treatment provided a rationale for doing so, and (2) the 
participants who chose not to complete the BAT, also found the workbook 
hard to understand; indicating that they did not engage in the BAT as 
they were not provided with, or fully understood, the rationale for doing 
so.  
4.3.3 Experiential Avoidance  
 
The present study demonstrated that the ACT intervention led to an 
increase in willingness that predicted engagement in the BAT. More 
specifically, the present study highlighted that those who became more 
willing to imagine themselves in their most feared public speaking 
scenario, went on to complete a ‘real-life’ public speaking task. This 
suggests that the ACT intervention in the present study reduced these 
participants’ experiential avoidance of private events (thoughts, emotions, 
and somatic sensations) and contexts related to public speaking. Thus 
indicating a relationship between the development of willingness (or a 
reduction in experiential avoidance) and valued-behaviour change, with 
regard to PSA. 
Such findings concord with previous research investigating ACT to treat 
PSA (e.g., Block & Wulfert, 2000) or more generalised SAD (e.g., 
Dalrymple & Herbert, 2007; Ossman, Wilson, Storaasli, & McNeill, 2006), 
as such studies also found that the ACT intervention appeared to produce 
decreases in experiential avoidance, that preceded increases in 
functioning and value-directed behaviour. This provides support for the 
ACT model of SAD/PSA, and also highlights the importance of targeting 
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experiential avoidance behaviour when using ACT to treat PSA and more 
generalised forms of SAD.  
 
4.4 Strengths and limitations  
 
4.4.1 Treatment fidelity  
 
A number of steps were taken to increase the methodological rigour of 
the present study that were not presented in the journal paper. Such 
steps were taken to ensure the validity and reliability of the findings. One 
such step was to conduct treatment fidelity checks (Moncher & Prinz, 
1991) to ensure that the telephone support/advice given to each 
participant was delivered using the ACT model. These checks were 
conducted to strengthen inferences regarding the effects of the ACT 
treatment, and were done to ensure that the therapist offering support 
did not use other models of therapy (e.g., CBT; thought challenging) 
during the weekly telephone calls. As such, the telephone calls to each 
participant during the study were recorded using a Dictaphone and were 
reviewed by two independent researchers (trainee clinical psychologists).   
Guided by Plumb and Vilardaga (2010), 20% of the participant telephone 
calls were randomly selected and reviewed. Both independent reviewers 
rated the researcher’s adherence to the ACT model (on a three-point 
scale; 1 – no, 2 – somewhat, and 3 – yes) using the following criteria: 
1. Did the researcher ‘check-in’ with the participant? 
2. Was advice provided consistent with ACT or were discussions in line 
with the ACT model? 
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3. Was any advice provided that was inconsistent with ACT (e.g., 
thought challenging)?17 
4. Was the researcher competent in guiding the participant? 
There was 100% inter-rater reliability between the reviewers, and both 
reviewers gave the maximum score on all the phone calls reviewed. This 
indicated that the researcher providing participant support during the 
intervention phase remained adherent to the ACT model, thus 
strengthening any inferences that any recorded changes during the study 
were a result of the ACT self-help intervention, rather than alternative 
therapeutic approaches.  
4.4.2 Additional Methodological Considerations 
 
A number of additional steps were also taken to improve the study’s 
methodological rigour. All participants were pre-screened to ensure they 
reached a minimum level of PSA (using the SSPS-N) prior to inclusion in 
the study. This was done to ensure that the sample was representative of 
a PSA cohort, and also eliminated participants who may have wished to 
take part just to receive compensation.  
To demonstrate the relationship between changes in willingness to 
approach an imagined feared public speaking task, and actual behavioural 
change, a final BAT was included. This allowed us to demonstrate that 
increases in levels of willingness appeared to lead to behavioural change 
related to PSA (as only those who took part in the BAT experienced an 
increase in willingness); something that would not have been possible had 
a BAT not been included.  
Although the principal reason for the BAT was to assess the participants’ 
willingness to engage in public speaking behaviour post-intervention, the 
inclusion of the observer-rated speech-performance measure gave insight 
                                                             
17 This item was reversed for scoring 
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into each participant’s overt anxiety during the performance and allowed 
us to contextualise the participants’ performance against that of a clinical 
sample. Recording each participant’s time in the BAT also allowed us to 
measure the quality of engagement in the task. However, as the audience 
used during the BAT consisted of clinical psychologists and/or trainee 
clinical psychologists, one must exercise caution when interpreting the 
observer-rated results, as individuals in such a profession may be more 
empathetic and compassionate (Daw, 2006). Hence, the audience may 
have awarded higher scores than an audience consisting of members from 
the general population / mixed professions would have. 
The methodological rigour of the present study may have been improved 
if a follow-up design was included (potentially making the design an ABCA 
design). The addition of a follow-up element may have informed us of 
whether (1) treatment gains remained or improved for those who 
experienced an increase in willingness to approach public speaking 
contexts (and who also completed the BAT), (2) whether the participants 
who reported the least change during the intervention experienced 
improvements post-intervention, and (3) whether the BAT influenced the 
participants’ PSA (as the BAT may have acted as an intervention in and of 
itself). This latter point would have been of particular interest given that 
the BAT may have been a sensitising (versus habituating) event, and 
therefore may have increased rather than reduced the participant’s PSA. 
Hence, the inclusion of a follow-up may have informed us of whether the 
ACT intervention resulted in a lasting reduction in public speaking 
behaviour, and/or whether the ACT intervention appeared to support the 
participant’s to habituate to public speaking situations or not (as recorded 
following the BAT).  
As research allegiance is regarded as a potential risk to psychotherapy 
outcome research (Munder, Brütsch, Leonhart, Gerger, & Barth, 2013), an 
independent researcher, blind to the participants’ performance during the 
study, conducted the final change interviews. This was done to reduce the 
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chance that the participants’ responses during the interview were 
influenced by demand characteristics (e.g., attempting to please the 
researcher), and to prevent the interview from being influenced by the 
desires of the researcher (e.g., the use of closed questions to elicit a 
desired response).  
 
4.4.3 Limitations 
 
Although steps were taken to increase the methodological rigour of the 
study, there were still a number of possible limitations. 
4.4.4 Baseline / Daily Measure 
 
The measure used to record the baseline period prior to the onset of the 
intervention was a composite ACT measure designed to measure overall 
psychological flexibility. This provided evidence that each participant’s 
psychological flexibility was either stable, or in decline, prior to the onset 
of therapy. This baseline measure, however, did not include an 
assessment of PSA. This raises the possibility that, as no stable period of 
PSA was achieved prior to the treatment phase that reductions seen in 
PSA may have occurred due to factors not associated with the ACT 
intervention. However, this decision not to include a measure of PSA in 
the baseline phase was made for a number of reasons. 
The principal focus of the intervention was on ACT-relevant processes 
(increasing willingness to experience public speaking anxiety, in the 
service of acting in a more valued way) rather than on symptom 
reduction (as this is not an ACT hypothesised outcome), hence, capturing 
a stable baseline period of ACT processes (psychological flexibility) was of 
primary importance. Moreover, in order to reduce participant burden, the 
items included in the daily measure were kept to a minimum. As such, 
measures of PSA were administered during the weekly and battery 
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assessments, but not daily, in order to reduce the number of items 
included in the daily measure. 
Lastly, as the primary measure of PSA (SSPS-N) requires respondents to 
answer questions whilst imagining their last public speaking experience, 
and evidence suggests that repeated imaginal exposure may reduce social 
anxiety related difficulties (Vrielynck & Philippot, 2009), the repeated 
daily administration of this measure may have acted as an exposure 
intervention, and thus a confounding variable. 
Although no baseline measure of PSA was taken, PSA was captured on 
multiple occasions and via multiple data sources (self-report outcome 
questionnaires, change interview, behavioural task, and indirect/implicit 
data) over the course of the intervention.  
4.4.5 Acceptance Phase 
 
The participant’s read the ACT self-help workbook in stages, one core 
process per week. The number of chapters the participant’s read however, 
was dependent on how many chapters the workbook had assigned to 
each processes. For example, during the final week, participants were 
only required to read one chapter related to ‘committed action’, whereas 
during the first week, each participant was required to read four chapters 
relating to ‘acceptance’. This meant that during the first week of the 
treatment phase, each participant had to read the most compared to any 
other phase in the study. This may have resulted in a ‘higher dose’ of the 
ACT component, acceptance, compared to the other ACT components. 
However, as a number of participants reported either no-change, or a 
reduction in psychological flexibility during the first week, this ‘higher 
dose’ of reading associated with the component of acceptance may have 
been burdensome / aversive for many participants. Thus, the participants 
may have initially developed a counterproductive /negative association 
with ACT and the concept of acceptance. Conversely, as the following 
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phases only required the participants to read one (self-as-context, 
present-moment awareness and committed action) or two chapters 
(cognitive defusion and values); reported increases in psychological 
flexibility may have been, in part, due to relief and/or reduced response 
burden, rather than the effects of the ACT intervention alone. 
  4.4.6  Generalisability 
 
The sample in the present study predominantly consisted of female 
university undergraduates. Although this sample was partially 
representative of a typical PSA cohort (as more women are thought to 
experience PSA than men [71.9%; Stein, Walker, & Forde, 1996]), the 
generalisability of the findings are limited. Therefore, more research is 
required in this domain to strengthen inferences that ACT delivered in a 
self-help format is an effective treatment for PSA (that rivals the existing 
gold standard method of treatment; CBT), especially when considering 
the treatment of children, young people, and older adults.   
 4.4.7 Idiosyncratic Measurement 
Although an idiosyncratic measure was used to measure change in the 
form of SUDs responses to each participant’s feared imagined public 
speaking task, the present study could have benefitted from the use of 
more idiosyncratic measures and/or individual goals to determine 
treatment success. 
For example, many of the participants in the present study stated that 
they had different forms of public speaking fears (e.g., speaking-up 
during a meeting vs. delivering a speech at wedding). Hence, the use of 
an idiosyncratic measure designed to capture each participant’s core 
public speaking fear may have been more sensitive to capturing change 
relevant to each participants. Moreover, asking participants to set 
themselves individual treatment goals from the outset, may have more 
accurately determined which participants experienced the most 
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meaningful changes above and beyond the use of standardised / self-
reported measures.  
 4.4.8 Isolation of Variables 
Although the SCED methodology allowed us to measure the effects of 
each component of the ACT intervention on a number of measures, this 
methodology meant that it was difficult to isolate the variables 
responsible for any observed changes in public speaking anxiety, and 
public speaking behaviour. In other words, a range of interventions may 
have been responsible for the changes observed (in addition to, or 
extraneous to the ACT intervention). Hence, independent variables such 
as the weekly contact with the researcher, repeated measurement, the 
IRAP, and the imminence of the BAT may have influenced the manner in 
which the participants behaved.  
For example, participants may have:  
1.) modified or improved aspects of their behaviour in response to their 
awareness of being observed (observer effect / Hawthorne effect) 
(McCarney et al., 2007). 
2.) habituated to public speaking situations as a consequence of being 
exposed to public speaking stimuli during the IRAP, and/or being exposed 
to thoughts regarding public speaking (private events) as a consequence 
of the impending BAT. 
3.) responded in a manner to please the researcher as a consequence of 
the developing therapeutic relationship that took place during the weekly 
contact.18 
As such, it cannot be said with certainty that that the ACT intervention 
was solely responsible for recorded changes during the intervention 
phase. However, the isolation of variables may be an inherent difficulty in 
SCED research given the high number of measures participants are often 
                                                             
18 This is not an exhaustive list, but an example of the possible variables responsible for change.  
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required to complete, the number of tasks/interventions participants 
usually engage in, and the often regular contact with 
researchers/therapists.   
 4.4.9 Serial Dependency 
Judgements of clinical significance are often based on the visual analysis 
of graphed data in SCED research (Parsonson & Baer, 1986) (as with the 
time-series / daily measure in the present study). However, there is a 
lack of well-defined rules to determine whether clinically significant 
change has occurred across phases (Bloom, Fischer, & Orne, 1995), and 
some have argued that changes need to be extremely large to 
convincingly demonstrate the presence of an experimental effect 
(Parsonson & Baer, 1986).  
Due to this lack of consensus, practitioners / researchers often rely on 
‘visual common sense’ when making decisions about treatment effects 
(Bengali & Ottenbacher, 1998), which has raised questions regarding the 
reliability and suitability of visual analysis (e.g., inter-rater reliability; 
Ottenbacher, 1993).  
One factor thought to play an influential role in the judgement of visually 
analysed data is the presence of autocorrelation in the data-set (Bengali & 
Ottenbacher, 1998). Autocorrelation reflects the level of correlation (serial 
dependency) present, and is a consequence of the fact that responses by 
the same individual (to the same measure over time) will be related to 
one another (to a greater or a lesser extent) (Bengali & Ottenbacher, 
1998). This level of correlation is important, as research indicates that a 
high level of serial dependency may reduce the examiners ability to 
accurately interpret time-series data (Matyas & Greenwood, 1996). For 
example, in a study investigating the impact of serial dependency on 
visual judgements, Jones, Weinrott, and Vaught (1978) compared the 
conclusions of time-series data analysed using both visual inspection and 
statistical procedure (Time-series analysis). Jones et al., (1978) 
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discovered that the highest level of discrepancy existed between visually 
analysed data, and data analysed using statistical procedure in data-sets 
with the highest level of serial dependency. In other words, it seems that 
those using visual analysis in SCED research are more likely to make a 
type-I or type-II error if the data-set being analysed contains a high level 
of serial dependency. As such, it is recommended that data-sets are 
investigated to determine the level of serial dependency present, and the 
influence that this may have on the outcome of visual analysis (Bengali & 
Ottenbacher, 1997)19.  
As the time-series data-set (daily measure of psychological flexibility) in 
the current study was not investigated for the presence of serial 
dependency, it is possible that our findings (and suggestions of a 
treatment effect) were influenced by the presence of serially dependent 
data rather than a genuine treatment effect. As such, the conclusions 
drawn from the visual analysis in the present study should be treated with 
caution.  
 
4.5 Clinical Relevance 
 
4.5.1 Self-help ACT 
 
The current study lends partial support for the use of ACT to treat PSA. 
Moreover, the present study demonstrated that this form of therapy may 
be effective when delivered in a self-help format, with minimal therapist 
support. This suggests that successful ACT treatment for PSA may not 
require a high level of intervention (e.g., 1:1 therapy) for the majority of 
individuals seeking support. As such, services may wish to consider 
providing ACT self-help material to individuals with PSA in the first 
instance, prior to offering more direct and/or intensive forms of 
                                                             
19 It is possible to compute serial dependency and account for this (e.g., using Simulation Modelling Analysis) 
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treatment. Additionally, self-help ACT may also be offered as an 
alternative to traditional forms of therapy for PSA (e.g., CBT/exposure), 
especially for individuals who may find exposure therapy too anxiety 
provoking. However, further research is needed to determine whether (1) 
ACT is as effective as CBT in treating PSA, and (2) whether ACT may only 
be effective for certain individuals.   
As the present study demonstrated that ameliorative results can be 
achieved with a relatively miniscule dose of ACT (when compared to 1:1 
therapy), services should consider how offering self-help ACT 
interventions for individual’s with PSA may (1) reduce the overall cost of 
treating such presentations, (2) reduce the likelihood of individuals with 
PSA developing more debilitating difficulties (e.g., wider SAD) and (3) 
allow clinicians to dedicate more time to treating individuals with 
potentially more chronic and debilitating psychological difficulties.  
4.5.2 Suitability for Self-help  
 
Although the majority of participants in the present study reported a 
reduction in PSA, an increase in willingness to approach feared public 
speaking scenarios, and approached the final BAT; the self-help 
intervention did not lead to this change for two individuals. Both these 
participants reported that they found the workbook hard to understand, 
and one participant reported the lowest overall scores on the ACT process 
measures prior to intervention. This suggests that certain considerations 
should be made when determining an individual’s suitability for self-help 
ACT treatment for PSA. 
4.5.3 Pre-screening 
 
Like the extant literature (e.g., Dalrymple & Herbert, 2007; Ossman, 
Wilson, Storaasli, & McNeill, 2006), the present study found that the 
patient with the lowest ACT process scores at baseline, appeared to 
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benefit the least from the ACT intervention. As such, it may be 
appropriate for individuals to reach a minimum score on a number of ACT 
process measures to indicate their suitability for ACT treatment in a self-
help format, for PSA. Additionally, such a pre-screening method may also 
identify individuals who may require a more direct/intensive ACT 
intervention, or who may benefit from an alternative treatment approach. 
However, further research is required to identify this potential cut-off 
point.  
4.5.4 Self-help Material Modifications 
 
As previosuly mentioned, the two participants who did not report an 
increase in willingness to approach public speaking situations, and who 
consequently did not compelte the final BAT, also reported they found the 
workbook difficult to understand. One of these participants also remarked 
that she found the workbook too ‘Americanised’. As such, services 
providing ACT self-help material may need to consider how making slight 
adaptations to the text / material may increase its readability and 
therefore impact. Hence, altering or reducing jargonistic language, and 
simplifying theoretical passages may increase the treatment effects of the 
workbook. Additionally, altering the language to reflect the country in 
which the workbook is being distributed may also improve the 
effectiveness of self-help ACT material to treat PSA.  
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4.6 Future Research 
 
4.6.1 Determining a cut-off for Suitability for ACT Self-help 
Treatment 
 
As the previous section explained, individuals who report a low baseline 
score on ACT process measures may require a higher level of ACT 
intervention, in order for the intervention to have an effect. This indicates 
that a cut-off point exists that may determine whether an individual is 
suitable for ACT delivered in a self-help format, or not. As such, future 
research may consider investigating where this cut-off point lies, on either 
a battery of ACT process measures, or a unified ACT processes screening 
measure. Such research may lead to individuals being offered the 
appropriate treatment for their PSA. 
 
4.6.2 Future SCEDs 
 
4.6.3 Treatment Phase 
 
Future research employing a SCED methodology may need to consider 
the implications of delivering ACT in a phased manner. As the acceptance 
phase in the present study included a large amount of material (larger 
than any other phase during the intervention phase), future research may 
need to consider how each treatment phase can include an equal ‘dose’ of 
ACT, whether this is in a self-help format or not. This increases the 
likelihood that reported changes in the constructs of interest (in our case 
PSA and ACT processes), are due to the effects of the treatment, and not 
simply a result of increased or reduced participant burden.  
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4.6.4 Baseline Phase 
 
In the present study, the baseline phase only consisted of a composite 
ACT measure. Although this decision was made with careful consideration, 
it may have also meant that a comprehensive baseline assessment of PSA 
was not achieved, raising questions of whether all participants’ PSA was 
stable, or increasing, prior to the introduction of the treatment phase. 
Hence, to increase the validity of inferences made regarding the 
effectiveness of ACT to treat PSA, future studies should ensure that 
SCEDs include a baseline measure of PSA, as well as a measure of 
theoretical ACT processes. However, careful consideration should be 
taken to ensure that including a baseline measure of PSA does not 
overburden the participants and that the repeated administration of this 
measure does not act as a form of exposure in and of itself.  
 
 
4.6.5 Assessment of Mediators / Mechanisms 
 
The continued use of SCED methodology to investigate ACT to treat PSA 
may be a cost effective manner in which to assess the potential mediators 
involved in successful treatment, given the relatively cheap cost of such 
an approach (Kazdin, 2009). Hence, across many studies, certain 
mediators may repeatedly emerge as possible contenders, while others 
may fall by the wayside (Kazdin, 2009). Such continued replications may 
therefore support or refute the assertion that the ACT process of 
mindfulness may play a crucial role in the treatment of individuals with 
PSA. 
 
4.6.6  Measures of PSA 
 
In a recent systematic review of psychological treatments for PSA 
(Priestley et al., 2014), the measures used to determine treatment 
Page 212 of 259 
 
success in the reviewed studies predominantly consisted of self-reported 
measures of social anxiety (e.g., the Fear of Negative Evaluation: FNE; 
Leary, 1983); the majority of which were created in the context of Clark 
and Wells’ (1995) cognitive model of SAD. There was also an under-
reliance on behavioural/performance measures of PSA (Priestley et al., 
2015). This raises implications as (1) cognitions may not change as a 
result of ACT treatment, and (2) functional / behavioural changes (the 
primary outcome of ACT treatment) may have been ignored. 
 
As such, future research should consider using measures of functional / 
behavioural change when investigating the effects of ACT to treat PSA, 
rather than the use of self-reports designed to assess the effects of 
treatment within a cognitive framework. The use of BATs may achieve 
this goal, however, researchers may need to consider how the repeated 
use of in-vivo assessments may act as an exposure intervention, thus 
making it difficult to infer a causal relationship between ACT alone and 
changes in behaviour related to public speaking.  
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5. Critical Reflection 
 
This section presents my critical reflections on the research process, with 
a focus on how the scientist practitioner model influenced my decision to 
use an SCED methodology. I also present my critical reflections on the 
ethical and theoretical issues raised by the research. 
5.1 Scientist-Practitioner 
 
During the early stages of my research project, I felt a pressure to use a 
between groups, randomised control trial (RCT) design. This was not a 
pressure that I felt from my peers or course staff, but a pressure I felt 
from the scientific community in general. There seemed to be an 
assumption (and I believe there still is) that in order to reliably 
investigate the effects of a treatment, one must use a RCT design; and all 
other methodologies paled in comparison. I believe this discourse has 
emerged, especially within the field of Clinical Psychology, in parallel with 
the development of the National Institute for Health and Clinical 
Excellence’s (NICE) guidelines; where only the evidence gathered from 
RCTs appears to be referenced. Although I realise the methodological 
benefits of such a design, I wished to conduct my research in a manner 
that would allow me to learn skills that I could practically apply in both 
my role as a researcher, and as a clinician during, and after my training.  
During the developmental stage of my research, I became aware of the 
SCED. I immediately became interested in this approach, due to the 
SCEDs ability to demonstrate the effects of treatment, with the use of 
minimal resources. Moreover, the principal attraction of the SCED, was 
that it appeared to be a methodology that perfectly satisfied the 
contemporary role of the Clinical Psychologist; the scientist-practitioner. I 
believe this, as this methodology can be used to assess personal 
effectiveness as a Clinical Psychologist (practitioner), as well as a 
comprehensive method for investigating the effects of treatment across 
Page 214 of 259 
 
multiple-subjects for the purpose of research (scientist). Hence, I felt 
passionate about developing my knowledge of, and skills in administering 
SCED research, as I felt such an approach would allow me to conduct 
meaningful research, whilst also practicing as a Clinical Psychologist in the 
future.    
Although I liked the notion of the SCED, I initially felt overwhelmed by all 
of its components, and the different approaches that appeared in the 
literature. Hence, I decided to conduct a ‘practice’ SCED (examining the 
effects of the psychological treatment I was delivering), whilst on 
placement in order to learn the skills I would need to conduct the present 
research.  
I found conducting this preliminary SCED allowed me to develop my 
knowledge, but also highlighted key biases that I would have to address 
in the present study. I noticed that during this preparatory SCED, my 
desire to demonstrate that the treatment had produced a reliable effect, 
altered my behaviour. I found myself overly planning my psychotherapy 
sessions, and trying to please the patient. I also noticed that I would 
complete the outcome measure with the patient, so I could monitor her 
responses, and clarify any particularly low scores, to ensure their 
accuracy.  
I realised that these behaviours acted as ‘experimenter biases’, and may 
have resulted in the collection of data that magnified the treatment 
effect; as the patient may have not received a typical form of therapy, 
and most likely felt pressured to answer the outcome measure in a 
manner that did not invite further questioning. These findings highlighted 
that I had to take a number of steps to maximise the validity and 
reliability of the present research if I was going to be responsible for the 
administration of the treatment under inspection.  
This experience significantly influenced the design of the present study. 
To reduce the potential for experimenter bias, I decided to use a self-help 
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format of ACT. This improved the likelihood that each participant would 
receive a similar level of intervention, and also meant I would have 
minimal therapeutic contact with each participant (thereby reducing my 
influence over the intervention process). 
I also ensured that the outcome measures in the present study could be 
completed by each participants on-line. This choice was made largely for 
pragmatic reasons, however, as I would not be administering these 
measures directly, it reduced the likelihood that the participants would 
respond in a manner to please me, or avoid my disapproval.  
For the times I had contact with each participant, I ensured I recorded 
our conversations, and that these conversations were subjected to 
treatment fidelity checks. This was to ensure that (1) I was providing 
support from an ACT perspective, and (2) I was not using other 
therapeutic methods in an attempt to reduce the participants PSA.  
Finally, I requested a fellow trainee Clinical Psychologist conduct the 
change interviews. This again reduced any potential pressure each 
participant may have felt to respond in accordance with my explicit or 
implicit desires.  
I found myself wondering if other researchers employing an SCED 
methodology applied such protocols in order to improve the 
methodological rigour of their research. My general opinion when asking 
myself this question was, no. During the whole research process, I 
encountered a number of published SCEDs. The majority of these 
appeared overly reliant on visual analysis and did not analyse reliable or 
clinical change. Moreover, effect size calculations were rarely considered, 
and inclusion of alternative methods of measuring change (e.g., other 
than self-reports) were often neglected. Repeatedly finding such 
examples in the literature frustrated me, and I questioned whether my 
research would be seen as beneath, or less important that studies 
investigating a similar phenomenon, but with a RCT design.  
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On reflection, I believe the SCED is a valuable tool for understanding if 
and why changes occur during therapy. Unfortunately, this methodology’s 
greatest strength; that it can be conducted by the practicing clinician, 
may be its greatest weakness, as such researchers may not feel obliged 
to abide by the same rigour as those who are solely situated in the 
scientific community. However, if the same stringent guidelines for 
conducting RCTs are applied to SCEDs (e.g., Stanley, 2007), then I see 
no reason why SCED research cannot be considered alongside RCTs in 
terms of validity and importance. Moreover, this may facilitate a move 
from the question of which psychological therapies cause ameliorative 
change, to the potentially more clinically useful question of why such 
changes occur. 
5.2 Ethical Reflections 
 
A major component of the study was the BAT. I felt this was an essential 
element of the research, as it allowed us to measure participants’ 
willingness to engage in public speaking in an ecologically valid way. 
However, this part of the study raised some ethical difficulties for me. 
Most of the participants who took part in the present study were 
university undergraduates. As such, I found myself wondering if I would 
have completed such a task as an undergraduate, and how I would have 
coped. Although I would feel able to approach such a situation today, had 
I been placed in a similar position during my undergraduate years, I think 
I would have found the task extremely distressing. I therefore 
experienced a sense of guilt when discussing and arranging the task with 
the participants. I also questioned whether it was ethically right to place 
people in a situation that would have caused (and to some extent still 
would) me great discomfort.  
I thought about this for some time, especially after arranging the first 
BAT. I felt a sense of relief knowing that an ethics panel had agreed for 
the research to go ahead, and that the BAT was voluntary, but I 
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continued to feel a sense of guilt. However, thinking about psychological 
research in general, and the need to understand human suffering for 
benevolent purposes, allowed me to consider the negative impact of 
withholding such methodological components. Such a risk-averse 
research culture would greatly reduce our understanding of human 
behaviour, and therefore, the methods that can be employed to reduce 
distress. Hence, allowing myself to consider the potential impact of my 
research on the development of effective treatments for PSA, enabled me 
to realise the value of including such a task.  
5.3 Theoretical Reflections 
 
From a functional contextualist (radical behaviourist) position, everything 
an organism does is behavioural (Harris, 2009). This notion includes 
external and internal events (or private events in ACT); all of which serve 
a specific function. I subscribe to this way of thinking, and believe that 
considering the function of a behaviour is more important (especially for 
treatment purposes), than focussing on the form of the behaviour. A 
dominant model of social anxiety, often used to inform PSA treatment 
(e.g., Wells, 1997), is Clark and Wells's (1995) cognitive model. From this 
perspective, cognitions are seen as distinctly different from behaviour, 
and the form of these cognitions, are considered the root cause of 
distress in public speaking situations.  
Understanding thoughts as a form of behaviour, rather than cognitions 
that lead to behavioural change, may be a radical conceptual departure 
for a cognitive psychologist. However, I found myself wondering during 
the research whether this difference in opinion may be more of a 
semantic difference, rather than a theoretical one; as both models place 
importance on the impact of ‘thinking/thought’, whether this is 
understood as a private-event (behavioural) or a thought (cognitive).  
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From a treatment perspective, however, the two theoretical positions 
seem completely opposed. ACT suggests that altering the context in 
which behaviour (e.g., private events) occurs, produces remedial change, 
whereas the cognitive model suggest that altering an individual’s 
cognitions is the key to successful treatment. However, I again found 
myself wondering whether the mechanisms of change may be similar in 
both approaches. I wondered whether suggesting a client weigh up the 
evidence for the validity of their thoughts (cognitive) may ultimately alter 
the context in which these thoughts occur, by enabling the patient to see 
their thoughts from a more objective / observer-based position. 
Alternatively, I wondered whether the approach of separating a client 
from their thoughts (ACT), ultimately alters the form of thoughts 
themselves in the longer-term.  
Hence, from a pragmatic standpoint, it seems that both theoretical 
approaches may seek a similar treatment goal; however, one method 
may be suited to some individuals over others, and visa-versa. Hence, the 
further investigation into which methods of treatment suit which 
individuals, and why, should remain an important focus of future research 
to ensure individuals receive the most effective form of treatment. 
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Appendix A: 
Participant Information Sheet 
 
 
Information Sheet 
 
The study will investigate the effectiveness of Acceptance and Commitment Therapy (ACT) to treat 
Public Speaking Anxiety (PSA). Evidence suggests that ACT may reduce a person’s anxiety associated 
with public speaking; however existing research is in the early stages. ACT is a third wave Cognitive 
Behavioural Therapy (CBT) that uses a range of techniques to aid individuals to accept 
uncomfortable emotions and feelings, whilst simultaneously moving towards what they value most 
in life.  
The study will further investigate the use of ACT to treat PSA with the use of the self-help workbook 
‘Get out of your Mind and into your Life’, to examine if using this self-help guide will increase the 
chance of participants approaching a feared public speaking scenario and reduce their anxiety 
associated with a public speaking task. The study will also investigate at which points changes occur 
during the intervention. This will help us understand which elements of ACT appear to be useful 
when treating PSA. The study will achieve this by requesting that participants complete daily and 
weekly questionnaires, as well as a battery of measures including a computerised exercise at the 
start, middle, and end of the ACT intervention. Participants will be required to complete chapters 
and workbook tasks with regular telephone support from the researchers. Participants will also be 
given the option to complete a five to ten minute talk on a chosen subject at the end of the 
intervention. This talk will be to a small audience of Clinical Psychologists and trainee Clinical 
Psychologists, as well as the researchers involved in the study. As existing research has shown that 
changes may occur after the ACT intervention, a final element of the study will be a change 
interview conducted one-month after the intervention by an independent researcher. Participants 
will be compensated for their time by accruing £4.00 for every week of the study completed 
(measured by the number of chapters and self-reported measures completed) and a further £4.00 
on completion of the final interview. As the intervention stage requires participants to read the self-
help workbook for 6 weeks, participants will be compensated £28 in total on completion of the 
study. Should participants choose to withdraw before completing all stages of the study, they will be 
compensated for the time they have invested (measured by the number of chapters and self-
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reported measures completed) and can choose if they wish for their data to be removed or remain 
in the study.   
Therefore, the responsibility of the participant will be: 
1. To complete a battery of assessments at the start, middle, and end of the study.  
2. To complete a daily questionnaire and weekly questionnaires during completion of the 
workbook (Completion of the workbook will take a minimum of six weeks) with regular 
contact (once a week) with a researcher.   
3. To give a five - ten minute talk to a small audience after completing the workbook 
(optional). 
4. To attend a meeting with an independent researcher one-month following the intervention. 
 
If you have any further questions after reading this information sheet, or would like to discuss any 
concerns, then please contact me via e-mail on: 13451707@students.lincoln.ac.uk  
If you have concerns regarding the ethical practice or conduct of this study, please contact the 
Lincoln University Ethics Committee: soprec@lincoln.ac.uk 
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Appendix B: 
Weekly Questionnaire 
Acceptance (PHLMS) 
 
Cognitive Fusion (CFQ) 
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Present-moment Awareness (MAAS) 
 
 
Values and Committed Action (ELS) 
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Public Speaking Anxiety (SSPS) 
  
Distress, willingness, and Avoidance of Idiographic Feared Public Speaking 
Situation (SUDS) 
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Appendix C: 
Daily Questionnaire 
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Appendix D: 
The Implicit Relational Assessment Procedure Example 
 
 
Note: The arrows denote the responses that were consistent and inconsistent for an individual with PSA. These 
were not visible on the screen during the task. If the participant chose a consistent response during a 
consistent trial block, and an inconsistent response during an inconsistent trial block, then the next trial was 
present in 400 milliseconds. Conversely, if the participant chose an inconsistent response during a consistent 
trial block, and a consistent response during an inconsistent trial block, an “X” appeared on the screen until the 
correct response was chosen.   
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Appendix E: 
Parameters Considered when Visually Analysing the Daily Time-series Data (Psychological Flexibility) 
 
a. Raw data       b. Central tendency          c. Trend  
   
 
        d. Variability        e. Point of change                                         f. Overlap region 
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Appendix F: 
Change Interview Schedule 
 
Change interview 
(Introduce self and remind participant about confidentiality) 
 Can you please tell me how you found the intervention / workbook? 
 Was the book easy to read and understand? (If not, why?) 
 Would you recommend this book to others? 
 Were there any chapters in the book you found helpful? 
 What would you say has changed for you? 
 In your opinion were these positive or negative changes? 
 Can you rate how surprised you were by these changes on the following 
five point scale from 1 (not surprised by the changes) to 5 (surprised by 
the changes)? 
1 2 3 4 5 
Not surprised 
by the 
changes  
 Neutral   Surprised by 
the changes 
 
 Please rate how likely it is that these changes were a result of reading the 
workbook 1 (not likely) to 5 (likely)? 
1  3  5 
Not likely    Neutral   Likely  
 
 Rate the importance of these changes on a five point scale from 1 (not 
important) to 5 (important)? 
1  3  5 
Not 
important   
 Neutral   Important  
 
 Have you noticed a change in your fear of public speaking? And if so, it 
what area? (Willingness to approach, distress during, avoidance of?). 
 Did you decide to take part in the public speaking task? (If not, why not 
/ if so, how did you find it?) 
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 Did you deliver any public speeches during the intervention? 
 Did any external events occur during the study time period? (In the 
areas of work or relationships etc. for example). If so, do you think this 
may have had an effect? 
 Can you tell me how you found the researcher support? 
 Any additional comments? 
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Appendix G: 
Confirmation of Ethical Approval 
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Appendix H: 
Consent Form 
 
Title of Study: Acceptance and Commitment Therapy for Public Speaking Anxiety 
– a Case Series Study of Effects on Self-reported, Implicit, Imaginal, and In-
vivo Outcomes   
Name of Researcher: Joe Priestley       
Name of Participant: 
 
1. I confirm that I have read and understood the information sheet for the above study 
and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, and without my medical care or legal rights being 
affected. I understand that I have the right to withdraw my data from the study within 
two weeks of either completing or withdrawing from participation, however, should I 
withdraw, my data can still be used if I wish.  
 
3. I understand that data collected in the study may be looked at by authorised 
individuals from the University of Nottingham and Lincoln, the research group and 
regulatory authorities where it is relevant to my taking part in this study. I give 
permission for these individuals to collect, store, analyse and publish information 
obtained from my participation in this study. I understand that my personal details 
will be kept confidential. 
 
4.  I understand that I will be compensated for taking part in this research incrementally, and 
will accrue £4.00 per week of the intervention (according to the number of chapters and 
self-reported measures completed) and an additional £4.00 on completion of the final 
change interview; £28 in total. If I choose to withdraw from the study early, then I will 
be compensated for the number of weeks I have taken part (according to the chapters 
and self-reported measures completed). 
 
5. I understand that telephone contact with the researcher may be recorded in order for 
treatment fidelity checks to be completed.   
  
  
6. I understand that the final public speaking task is voluntary. 
 
 
7. I agree to take part in the above study. 
 
______________________ ______________     ____________________ 
Name of Participant   Date          Signature 
 
________________________ ______________     ____________________ 
 Name of Person taking consent  Date          Signature 
 (if different from Principal Investigator) 
 
________________________ ______________     ____________________   
Name of Principal Investigator  Date          Signature 
 
2 copies: 1 for participant and 1 for the project notes 
 
Please initial box 
 
*If you have 
concerns regarding 
the ethical practice 
or conduct of this 
study, please 
contact the Lincoln 
University Ethics 
Committee: 
soprec@lincoln.ac.uk 
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Appendix I: 
Public Speaking Image Selection 
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Appendix J: 
Feared Public Speaking Situation Questionnaire Used for the Imagined 
Task 
 
Please complete the sentences below according to how you truly feel when delivering a speech or 
giving a talk in front of others. Suggested options are provided, however, please complete the 
sentence according to what most reflects your opinion. 
 
1. I most fear talking in front of .................. (e.g., family, friends, people I know, people I 
don't know, assessors....) 
2. It causes me anxiety to talk to ....................................... groups of people (e.g., small, quite 
large, large, extremely large.......) 
3. I find it anxiety provoking to give a speech / talk in front of ..........................(e.g., under 10 
people, between 10 - 30 people, between 30 - 50 people, between 50 - 100 people, over 
100 people......) 
4. It makes me anxious talking in front of people when I'm ..................(e.g., in a small room, 
in a large room, in a lecture hall, in a meeting room, on a stage, behind a lectern........) 
5. It distresses me most when the speech / talk is ...............(e.g., planned, unplanned, 
partially planned..................) 
6. It makes me most distressed when I have to talk ......................... (e.g., with audio aids - 
microphone, without audio aids - having to project voice........) 
7. It stresses me out when I know the speech / talk is ..........................(e.g., being assessed, 
not being assessed, being marked as I speak...........) 
8. I find it distressing when I see people .......................... during a speech / talk I'm giving 
(e.g., not looking at me, looking at me, whispering to each other, talking to each other, 
giggling with each other, sitting in silence........) 
9. I find it causes me to panic when I look up and see that people are ............. (e.g., smiling, 
frowning, looking angry, looking sad, looking miserable, looking excited, looking 
anxious........) 
10. I feel most distressed when the speech is to do with my ..........(e.g., working life, personal 
life, both work and personal life.......) 
11. I feel extremely anxious when I ................. when giving a talk (e.g., use a computer - 
power-point, use hand-outs, don't use a computer, don't use hand-outs........) 
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12. It makes me feel anxious when the location I am talking in is .........................(e.g., 
extremely noisy, quite noisy, quite quiet, extremely quiet........) 
13. I become anxious if I am talking about a topic ....................... (e.g., I know really well, I 
know fairly well, I don't really know much about, I know nothing about........) 
14. I find myself getting anxious during a talk / speech if I'm ................... (e.g., sat down, 
stood up, above the audience, below the audience........) 
15. I feel most anxious when giving a speech / talk during the .......................(e.g., early 
morning, morning, mid-day, afternoon, early evening, late evening, any time........) 
16. Please add any additional situations and/or factors that increase your fear whilst giving a 
speech or talk in front of others. 
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